Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
36032269	s-testovl	pmol/l (pmol/l)	7405	12429	0.10%
36032269	s-testovl	— (—)	1048	1660	100.00%	Distribution not available
36032269	s-testo-vl	pmol/l (pmol/l)	886	1528	0.00%
36032269	testosteroni,vapaalaskettu	pmol/l (pmol/l)	231	389	0.00%
36032269	s-testo-vl	— (—)	224	382	100.00%	Distribution not available
36032269	s-testosteroni,vapaa,laskettu	pmol/l (pmol/l)	193	241	0.00%
36032269	s-testosteronivapaalaskettu	pmol/l (pmol/l)	73	92	0.00%
36032269	testosteroni,vapaalaskettu	— (—)	68	103	100.00%	Distribution not available
36032269	s-testosteroni,vapaa,laskettu	— (—)	43	54	100.00%	Distribution not available
36032269	s-testosteroni,vapaalaskettu	pmol/l (pmol/l)	23	26	0.00%
36032269	testosteroni,vapaa,laskettu	pmol/l (pmol/l)	20	25	0.00%
36032269	s-testosteroni,vapaalaskettu(ko)	pmol/l (pmol/l)	10	12	0.00%	Distribution not available
36032269	s-testostoni,vapaa,laskettu	pmol/l (pmol/l)	10	15	0.00%	Distribution not available
36032269	testosteroni,vapaa,laskettu,seerumista	pmol/l (pmol/l)	7	9	0.00%	Distribution not available
36032269	s-testosteroni,vapaa,laskettu,seerumista	pmol/l (pmol/l)	6	7	0.00%	Distribution not available	Distribution not available
36032269	s-testo,vapaa,laskettu	pmol/l (pmol/l)	6	8	0.00%	Distribution not available
36032269	testosteroni,vapaa,laskettu	— (—)	5	5	100.00%	Distribution not available	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Exclusions for E4_PCOS_CONSORTIUM

1263

2275

3.55

315.90

2.9

1.7

164.76

175.57

pmol/l

1.99

1219

2156

Sleep apnoea

2233

5398

2.75

307.65

2.2

1.8

190.83

207.31

pmol/l

10.18

2114

5132

Hypopituitarism

854

772

15.11

307.65

3.3

1.7

177.98

217.72

pmol/l

12.14

826

728

Disorders of other endocrine glands

1921

2678

7.59

307.65

2.9

1.6

173.02

195.98

pmol/l

10.46

1860

2535

Exclusions for E4_PCOS_BROAD

1072

1350

9.01

307.65

3.1

1.8

171.08

203.38

pmol/l

11.38

1037

1273

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

1122

1950

6.10

307.65

3.0

1.7

175.33

193.14

pmol/l

4.81

1071

1849

Testicular hypofunction

674

590

23.37

307.65

3.3

1.6

206.98

222.63

pmol/l

1.90

667

560

Sleep apnoea, including avohilmo

2256

5360

2.67

307.65

2.2

1.8

193.56

204.80

pmol/l

4.80

2143

5089

Testicular dysfunction

750

657

22.92

307.65

3.2

1.7

206.11

223.17

pmol/l

2.40

741

621

Hypogonadotropic hypogonadism

643

574

25.01

307.65

3.5

1.8

175.64

221.34

pmol/l

11.93

629

550

Other antidepressants

2350

5043

2.44

286.86

2.1

1.8

195.73

197.19

pmol/l

0.24

2218

4815

Sleep disorders (combined)

2273

4936

2.46

286.36

2.0

1.7

189.46

197.52

pmol/l

2.48

2146

4700

Depression or dysthymia

1590

3114

2.89

273.76

2.1

1.8

197.86

197.67

pmol/l

0.02

1489

2988

Selective serotonin reuptake inhibitors

2163

5047

2.28

230.15

2.1

1.8

193.32

197.22

pmol/l

0.81

2038

4817

Endocrine, nutritional and metabolic diseases

1899

4081

2.40

224.86

2.2

1.6

180.72

212.46

pmol/l

23.36

1817

3913

Polycystic ovarian syndrome

169

19.62

214.60

1.4

1.2

22.84

15.70

pmol/l

5.84

159

Ovarian dysfunction

177

111

16.75

209.31

1.4

1.1

24.03

14.93

pmol/l

7.35

165

Polycystic ovarian syndrome, broad definition

206

170

12.57

208.02

1.3

1.1

20.71

15.06

pmol/l

6.45

193

153

Recurrent or chronic depression

967

2300

3.03

195.69

2.1

1.8

195.12

198.50

pmol/l

0.38

901

2229

Benign neoplasm: Pituitary gland, craniopharyngeal duct

276

382

8.18

192.82

3.0

1.9

170.27

207.83

pmol/l

4.22

262

360

Polycystic ovarian syndrome, consortium definition

382

355

6.42

182.37

1.3

1.2

19.81

17.03

pmol/l

1.29

355

327

Depression medications

889

1462

3.15

170.45

2.1

1.7

198.11

208.80

pmol/l

1.57

846

1424

Episodal and paroxysmal disorders

2015

5078

2.05

164.97

2.0

1.7

185.47

199.90

pmol/l

6.68

1913

4830

Hypothyroidism (congenital or acquired)

735

1327

3.22

152.53

2.3

1.7

187.73

205.71

pmol/l

3.16

704

1292

Hypothyroidism and >3 levothyroxin purchases

727

1315

3.22

150.70

2.3

1.7

187.34

205.11

pmol/l

3.06

696

1281

Hypothyroidism, levothyroxine purchases

727

1315

3.22

150.70

2.3

1.7

187.34

205.11

pmol/l

3.06

696

1281

Mood disorders, excluding more controls

1880

5695

2.00

150.61

2.1

1.8

190.46

199.37

pmol/l

2.62

1756

5448

Used for control exclusion in common control thyroid runs

2180

5885

1.90

144.06

2.2

1.7

190.79

199.85

pmol/l

3.04

2076

5598

Medical observation and evaluation for suspected diseases and conditions

1465

3487

2.19

141.24

2.1

1.8

194.22

201.42

pmol/l

1.47

1398

3332

Mood [affective] disorders

1984

6853

1.90

140.41

2.1

1.8

189.83

198.65

pmol/l

2.71

1856

6554

Mood disorders

1986

6853

1.90

140.24

2.1

1.8

189.83

198.63

pmol/l

2.70

1858

6554

Behavioural syndromes associated with physiological disturbances and physical factors

1777

6563

1.95

137.50

2.0

1.8

193.97

196.72

pmol/l

0.46

1685

6271

Codeine

1779

5042

1.94

128.65

2.0

1.8

194.11

195.14

pmol/l

0.13

1690

4813

Tramadol

1486

4528

2.05

127.75

2.1

1.8

198.52

199.98

pmol/l

0.18

1378

4317

Benign neoplasm of other and unspecified endocrine glands

350

867

4.24

127.14

2.7

1.8

173.52

203.52

pmol/l

4.78

332

820

Depression

1831

6718

1.87

124.76

2.1

1.8

189.43

198.91

pmol/l

2.85

1717

6436

Neurological diseases

1576

4011

2.00

121.15

2.0

1.7

189.35

200.51

pmol/l

3.04

1499

3831

Opioids

1838

5118

1.89

121.10

2.1

1.8

195.78

195.16

pmol/l

0.08

1748

4885

Codeine or tramadol medication

2056

6284

1.81

120.60

2.0

1.8

194.96

195.03

pmol/l

0.01

1949

5979

Female infertility, associated with anovulation

116

12.42

116.79

1.2

1.3

19.68

18.60

pmol/l

0.17

107

Sleep disorders

1643

6399

1.88

115.14

2.0

1.8

194.84

196.77

pmol/l

0.28

1555

6119

Diseases of male genital organs

1891

5326

1.84

111.44

2.1

1.9

211.22

212.55

pmol/l

0.22

1823

5087

Irregular menses

230

346

5.29

104.23

1.2

18.45

17.03

pmol/l

0.46

216

319

Impotence

281

703

4.45

103.17

2.5

1.9

211.87

213.33

pmol/l

0.08

267

662

Hyperfunction of pituitary gland

154

226

7.28

100.92

2.8

1.5

152.20

204.10

pmol/l

3.88

148

212

Amenorrhoea

13.56

100.87

1.2

1.3

20.00

16.78

pmol/l

0.95

Insomnia

1567

6335

1.83

100.33

2.0

1.8

194.99

195.99

pmol/l

0.13

1484

6061

Hyperprolactinaemia

119

130

9.89

99.95

2.9

1.5

147.92

190.13

pmol/l

1.78

114

120

Coxibs

525

918

3.07

99.72

2.0

1.6

206.76

189.68

pmol/l

1.98

497

871

Neurological diseases, wide definition

655

1248

2.68

97.11

2.1

1.6

195.86

207.20

pmol/l

1.36

627

1204

Anxiety disorders, excluding more controls

1518

5443

1.84

97.09

2.1

1.8

193.08

199.96

pmol/l

1.51

1435

5226

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

1053

5132

2.03

96.98

2.0

1.9

206.94

199.06

pmol/l

1.51

997

4896

Female infertility

183

161

6.97

94.81

1.1

1.3

17.85

18.19

pmol/l

0.08

172

143

Abnormalities of breathing

1615

5323

1.78

91.47

2.1

1.8

192.12

195.51

pmol/l

0.59

1529

5086

Genitourinary diseases

1614

4563

1.80

90.80

2.1

1.9

199.59

211.23

pmol/l

4.42

1545

4364

General examination and investigation of persons without complaint and reported diagnosis

1274

3487

1.93

90.07

2.0

1.8

193.47

201.42

pmol/l

1.54

1206

3332

Use of hypnotics and sedatives

1888

6465

1.70

89.41

2.1

1.9

201.33

197.12

pmol/l

0.84

1776

6155

Anxiety (asthma-related co-morbidities)

1173

4883

1.89

84.10

2.1

1.8

185.43

200.01

pmol/l

4.09

1109

4705

Other dorsopathies, not elsewhere classified

1792

5581

1.70

83.75

2.0

1.8

192.70

196.02

pmol/l

0.60

1695

5320

Neurotic, stress-related and somatoform disorders

1606

6631

1.71

82.55

2.1

1.9

190.76

198.84

pmol/l

2.05

1519

6345

Parasetamol

1566

4565

1.76

82.05

2.1

1.8

196.17

200.76

pmol/l

0.77

1489

4366

Obesity and other hyperalimentation

1031

5257

1.92

80.84

2.1

1.8

151.56

193.59

pmol/l

29.99

955

5016

Anxiety disorders

1613

6685

1.70

80.53

2.1

1.9

190.86

198.67

pmol/l

1.94

1526

6392

Obesity

1027

5245

1.92

80.51

2.1

1.8

151.92

193.54

pmol/l

29.32

951

5004

Oxicams

394

728

3.13

79.62

2.1

1.7

193.24

190.99

pmol/l

0.13

372

688

Other nutritional deficiencies

1067

5454

1.87

76.97

2.1

1.8

152.34

193.48

pmol/l

29.49

992

5202

Dorsalgia

1720

5558

1.67

76.88

2.0

1.8

191.48

195.74

pmol/l

0.85

1628

5298

Psychiatric diseases

1678

5025

1.69

76.26

2.0

1.8

192.93

199.41

pmol/l

1.49

1571

4815

Pain in throat and chest

1479

5237

1.71

73.93

2.0

1.8

194.93

198.39

pmol/l

0.56

1402

5007

Panhypopituitarism

108

157

8.01

72.91

3.2

1.8

196.59

226.34

pmol/l

0.95

148

All anxiety disorders

1179

5287

1.79

71.49

2.1

1.9

184.54

199.01

pmol/l

4.07

1115

5073

Other intervertebral disc disorders

1410

5031

1.71

69.28

2.0

1.8

194.31

200.05

pmol/l

1.24

1322

4788

Obesity due to excess calories

760

3840

2.01

69.01

2.2

1.8

152.14

192.06

pmol/l

21.27

707

3659

Soft tissue disorders

1766

5687

1.61

67.94

2.0

1.8

191.93

195.74

pmol/l

0.66

1664

5438

Obesity related asthma

615

2908

2.16

67.13

2.3

1.9

180.14

197.49

pmol/l

3.87

576

2755

Deviated nasal septum

788

4087

1.97

66.74

2.0

1.9

209.48

203.65

pmol/l

0.81

744

3893

Other special examinations and investigations of persons without complaint or reported diagnosis

1213

3488

1.78

66.48

2.1

1.8

196.43

201.42

pmol/l

0.79

1153

3332

Shoulder lesions

1272

4519

1.72

65.12

2.0

1.9

201.13

200.12

pmol/l

0.12

1198

4306

Other anxiety disorders

864

4011

1.89

64.40

2.0

1.8

176.03

195.64

pmol/l

4.90

819

3860

Acetic acid derivatives and related substances

444

893

2.62

64.14

2.0

1.6

205.74

189.53

pmol/l

1.62

419

847

Nonorganic sleeping disorders, excluding more controls

379

1484

2.62

64.08

2.5

1.7

190.12

194.42

pmol/l

0.30

356

1427

Dorsopathies

1743

5601

1.60

63.97

2.0

1.8

193.44

196.17

pmol/l

0.46

1653

5340

Other diseases of upper respiratory tract

1721

5670

1.60

63.52

1.9

1.8

194.38

193.50

pmol/l

0.12

1618

5394

Mouth breathing

867

4711

1.88

63.50

2.1

1.9

198.63

202.31

pmol/l

0.50

815

4491

Female infertility, cervical, vaginal, other or unspecified origin

135

150

5.90

62.91

1.1

1.3

15.49

18.01

pmol/l

0.87

126

134

Lumbar disc prolapse

1091

4825

1.76

62.28

2.0

1.8

194.87

200.50

pmol/l

1.03

1022

4595

Symptoms and signs involving the circulatory and respiratory systems

1688

5376

1.59

60.39

2.0

1.8

194.00

195.90

pmol/l

0.27

1607

5138

Other joint disorders

1578

5231

1.61

59.98

2.0

1.8

194.69

194.05

pmol/l

0.08

1480

5019

General symptoms and signs

1857

6063

1.55

59.67

2.0

1.8

191.02

198.50

pmol/l

1.91

1765

5783

Hyperkinetic disorders, excluding more controls

280

948

2.91

57.40

2.2

1.7

183.21

193.92

pmol/l

0.74

271

916

Benign neoplasms

1810

6561

1.53

57.12

2.1

1.8

190.25

197.50

pmol/l

2.03

1704

6277

Benzodiazepine use

1605

7152

1.56

56.78

2.1

1.8

192.07

195.65

pmol/l

0.60

1494

6827

Antihypertensive medication - note that there are other indications

1122

3478

1.73

56.39

2.0

1.8

181.42

201.18

pmol/l

6.03

1072

3355

Any death

216

4407

0.35

55.85

1.7

1.9

175.42

199.44

pmol/l

3.38

198

4152

Exposure to other specified factors

1308

7536

1.61

55.62

2.1

1.8

202.62

195.11

pmol/l

1.66

1248

7171

Any mental disorder

1749

5728

1.54

55.28

2.0

1.8

189.74

199.04

pmol/l

2.79

1643

5477

L02BG Aromatase inhibitors

103

186

5.56

54.10

2.8

1.5

208.57

132.24

pmol/l

3.36

169

Diarrhoea and gastroenteritis of presumed infectious origin

1599

6879

1.55

54.09

1.9

195.57

195.32

pmol/l

0.03

1506

6548

Acute upper respiratory infections of multiple and unspecified sites

1185

5395

1.64

53.05

1.9

1.8

196.22

193.66

pmol/l

0.32

1131

5137

Pain (limb, back, neck, head abdominally)

1292

3981

1.64

53.03

2.0

1.8

198.23

202.80

pmol/l

0.72

1217

3820

Other headache syndromes

497

2364

2.12

53.03

2.0

1.8

183.24

189.89

pmol/l

0.65

480

2238

Exposure to unspecified factor

1581

7468

1.54

52.95

1.9

200.62

193.77

pmol/l

1.64

1492

7109

Chronic rhinitis, nasopharyngitis and pharyngitis

495

2366

2.13

52.53

2.1

1.8

202.43

191.41

pmol/l

1.28

460

2261

Intracranial trauma

887

3543

1.78

52.40

2.0

1.7

200.68

202.06

pmol/l

0.12

846

3392

Obesity, other/unspecified

502

2420

2.11

52.06

1.9

1.8

145.48

190.45

pmol/l

14.86

459

2313

Injuries to the wrist and hand

1581

7240

1.53

50.94

1.9

198.18

193.89

pmol/l

0.78

1501

6881

Rotator cuff syndrome

956

4022

1.72

50.87

2.0

1.8

201.13

201.75

pmol/l

0.06

904

3824

Hypertrophy of breast in women and men

201

632

3.23

50.79

2.2

1.8

165.18

174.96

pmol/l

0.57

185

593

Persons encountering health services for examination and investigation

1151

3488

1.67

50.61

2.0

1.8

202.20

201.42

pmol/l

0.07

1085

3332

Diseases of the musculoskeletal system and connective tissue

978

2840

1.74

50.22

1.9

1.7

201.13

195.11

pmol/l

0.75

926

2739

Noninflammatory disorders of female genital tract

164

191

4.33

49.62

1.2

1.3

18.44

19.01

pmol/l

0.14

156

172

Inflammatory diseases of prostate (prostatitis)

366

1626

2.34

47.62

2.0

1.9

205.65

205.05

pmol/l

0.04

355

1528

Low back pain

1175

5327

1.60

46.81

2.0

1.8

186.54

195.20

pmol/l

2.02

1107

5079

Non-selective monoamine reuptake inhibitors

419

1890

2.16

46.53

2.2

1.8

194.09

198.51

pmol/l

0.37

390

1795

Medicines for HER+ breast cancer

126

287

4.18

46.47

2.9

1.6

212.83

134.85

pmol/l

4.43

119

261

Other soft tissue disorders, not elsewhere classified

1447

5574

1.53

46.45

2.0

1.8

183.36

194.77

pmol/l

3.63

1359

5328

Oter anti-inflammatory and antirheumatic agents, non-steroids

278

557

2.79

46.39

1.9

1.7

195.80

194.89

pmol/l

0.04

259

522

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

769

2131

1.83

46.34

2.0

1.8

202.38

207.39

pmol/l

0.56

730

2054

Propionic acid derivatives

423

944

2.28

45.70

1.9

1.6

202.23

189.29

pmol/l

1.14

392

896

Dislocation, sprain and strain of joints and ligaments of knee

1101

6432

1.60

45.15

2.0

1.9

204.37

199.00

pmol/l

1.00

1052

6140

Concussion

752

3506

1.77

44.95

2.0

1.7

198.60

202.73

pmol/l

0.41

716

3356

Nonorganic sleeping disorders

379

1741

2.22

44.87

2.5

1.9

190.12

193.02

pmol/l

0.19

356

1655

Male infertility

261

1038

2.73

44.77

2.6

1.9

214.36

220.45

pmol/l

0.37

251

995

Arthropathies

1545

5237

1.51

44.29

2.0

1.8

196.85

194.10

pmol/l

0.41

1462

5025

Other specific joint derangements/joint disorders

1221

5079

1.57

44.01

2.1

1.8

194.73

193.17

pmol/l

0.19

1144

4878

Pain in joint

998

3902

1.65

43.95

2.1

1.8

193.66

202.47

pmol/l

1.78

931

3751

Anti-inflammatory and antirheumatic products, non-steroids

417

944

2.25

43.63

1.9

1.6

204.53

189.29

pmol/l

1.48

394

896

Lower back pain or/and sciatica

1614

7212

1.47

43.55

2.0

1.9

188.23

195.62

pmol/l

2.09

1522

6865

Spondylopathies

1174

4502

1.57

42.16

2.0

1.8

198.32

202.27

pmol/l

0.63

1100

4278

Other diseases of intestines

1709

6748

1.45

41.67

2.0

1.8

191.85

196.10

pmol/l

0.87

1609

6437

Persons encountering health services in other circumstances, wide

1873

6789

1.43

41.47

2.0

1.8

191.81

198.72

pmol/l

1.90

1747

6491

Injuries to the shoulder and upper arm

1361

7381

1.50

41.44

2.0

1.9

205.42

199.82

pmol/l

1.22

1291

7030

Chronic sinusitis

605

3357

1.82

41.30

2.1

1.9

198.43

195.12

pmol/l

0.33

576

3196

Paracetamol or NSAID medication

293

582

2.57

40.75

1.9

1.6

210.87

195.13

pmol/l

1.07

279

553

Statin medication

1156

4188

1.57

40.42

2.0

1.9

192.99

208.21

pmol/l

5.16

1110

4015

Disease of hard tissues of teeth, NOS

906

2866

1.67

40.40

2.0

1.8

198.60

203.69

pmol/l

0.67

855

2750

Viral hepatitis, IBD co-morbidity

154

480

3.34

40.12

2.4

1.8

186.31

223.18

pmol/l

3.22

148

464

Artrosis, including avohilmo

1407

5188

1.50

39.80

2.1

1.9

200.59

201.24

pmol/l

0.08

1335

4943

Sciatica+with lumbago

737

4017

1.71

39.58

1.9

1.8

186.07

197.66

pmol/l

2.39

687

3822

Arthrosis

1158

4116

1.56

39.35

2.1

1.8

202.66

200.92

pmol/l

0.22

1081

3938

Migraine

539

2355

1.87

39.01

1.8

1.7

163.44

182.21

pmol/l

3.07

515

2241

Hyperplasia of prostate

874

3026

1.67

38.95

1.9

204.39

201.49

pmol/l

0.39

833

2861

Intestinal infectious diseases

1707

6856

1.43

38.91

1.9

194.59

195.36

pmol/l

0.10

1605

6521

Disturbance of activity and attention

269

1116

2.43

38.73

2.1

1.8

185.11

192.55

pmol/l

0.45

260

1070

Transport accidents

779

4050

1.67

38.45

2.0

1.8

201.21

193.28

pmol/l

1.10

735

3863

Cardiovascular diseases

1108

3846

1.56

38.05

1.9

1.8

190.25

198.11

pmol/l

1.33

1056

3705

Continuous positive airway pressure

365

1469

2.13

37.92

2.1

1.8

197.74

215.69

pmol/l

2.69

340

1419

Personality disorders, excluding more controls

465

2476

1.91

36.57

2.1

1.8

176.66

197.22

pmol/l

3.31

435

2391

Headache

981

5052

1.56

36.52

2.0

1.8

179.80

196.56

pmol/l

4.66

932

4815

Neoplasms

1503

5530

1.45

36.35

2.1

1.8

193.61

198.77

pmol/l

0.99

1438

5305

Abnormalities of heart beat

427

2184

1.94

35.42

2.0

1.8

190.06

189.76

pmol/l

0.02

398

2068

Acute sinusitis

815

4724

1.61

35.34

2.0

1.8

191.95

194.15

pmol/l

0.23

777

4521

Hyperkinetic disorders

280

1229

2.29

35.33

2.2

1.8

183.21

192.88

pmol/l

0.67

271

1180

Special screening examination for infectious and parasitic diseases

578

2415

1.79

35.21

1.8

214.97

203.03

pmol/l

1.46

553

2327

Examination and observation for other reasons

942

3465

1.59

35.18

2.0

1.8

187.87

201.23

pmol/l

3.13

895

3311

Disorders of skin appendages

720

4392

1.66

34.99

1.8

1.9

161.88

196.01

pmol/l

11.03

679

4182

Hernia

1425

6675

1.44

34.73

2.0

1.9

204.06

201.23

pmol/l

0.48

1354

6357

Acute upper respiratory infections

1367

5824

1.45

34.60

2.0

1.8

191.10

192.45

pmol/l

0.16

1294

5522

Abdominal and pelvic pain

1706

6149

1.40

33.94

2.0

1.9

196.64

199.88

pmol/l

0.59

1616

5865

Hypertensive diseases (excluding secondary)

970

3642

1.56

33.93

2.0

1.9

186.75

211.36

pmol/l

10.82

916

3522

Monoamine oxidase A inhibitors

177

654

2.76

33.88

2.1

1.8

205.41

207.03

pmol/l

0.06

165

625

Irritable bowel syndrome

333

1624

2.08

33.67

2.1

1.7

188.09

188.32

pmol/l

0.01

320

1539

Other sleep disorders

197

774

2.61

33.43

2.4

1.8

190.17

213.76

pmol/l

2.25

187

723

Polyuria

340

1680

2.06

33.35

2.0

1.9

195.71

199.08

pmol/l

0.25

311

1563

Persistent mood disorders

283

1316

2.19

32.56

2.0

1.9

179.73

199.93

pmol/l

2.30

265

1261

Cervical disc disorders

511

2902

1.78

32.56

2.1

1.8

195.95

201.35

pmol/l

0.59

481

2741

Factors influencing health status and contact with health services

666

1974

1.71

32.33

2.0

1.8

208.49

213.17

pmol/l

0.49

631

1901

Spondylosis

711

3601

1.62

31.24

2.1

1.8

197.78

201.89

pmol/l

0.48

659

3409

Generalized anxiety disorder

260

1194

2.22

30.94

2.2

1.7

176.70

183.27

pmol/l

0.42

248

1146

ILD medications

1756

6990

1.37

30.90

2.0

1.9

197.39

195.13

pmol/l

0.38

1668

6647

Myalgia

293

1409

2.11

30.85

2.0

1.8

179.56

186.53

pmol/l

0.52

274

1343

Gonarthrosis

934

3480

1.54

30.78

2.1

1.8

197.50

201.34

pmol/l

0.53

871

3322

Nerve, nerve root and plexus disorders

1540

6809

1.39

30.77

2.0

1.9

191.11

197.65

pmol/l

1.61

1442

6482

First line medication for Crohn's disease

1733

6870

1.37

30.67

2.0

1.8

196.64

195.72

pmol/l

0.13

1645

6533

Internal derangement of knee

603

3639

1.67

30.25

2.1

1.8

195.48

198.25

pmol/l

0.29

563

3490

Hypothyroidism, other/unspecified

1045

4644

1.49

30.24

2.2

1.8

174.92

184.20

pmol/l

1.68

979

4388

Symptoms and signs involving the digestive system and abdomen

1681

6149

1.38

30.22

2.0

1.9

196.89

199.88

pmol/l

0.52

1597

5865

Mycoses

1259

7747

1.42

29.97

1.9

192.84

195.59

pmol/l

0.40

1202

7359

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

404

1948

1.88

29.73

2.1

1.7

180.72

188.23

pmol/l

0.55

389

1871

Hypertension, essential

1275

5070

1.43

29.47

2.0

1.9

187.04

209.50

pmol/l

12.31

1201

4869

Gastro-oesophageal reflux disease

942

5462

1.50

29.41

1.9

197.38

197.84

pmol/l

0.05

896

5184

Hypothyreosis and Thyroxine purchase for inclusion criteria

1050

4688

1.48

29.31

2.2

1.8

174.99

183.99

pmol/l

1.61

984

4424

Spinal stenosis

581

2641

1.68

29.20

2.0

1.8

195.35

199.42

pmol/l

0.44

537

2478

Cardiovascular diseases (excluding rheumatic etc)

1106

4363

1.47

29.11

2.0

1.8

190.63

201.33

pmol/l

2.38

1048

4212

Cardiac arrhythmias

939

4070

1.51

29.05

2.1

1.9

196.71

206.23

pmol/l

2.04

895

3913

Intestinal infectious diseases

1376

7533

1.39

28.65

1.9

196.33

194.90

pmol/l

0.18

1299

7170

Other pulmonary diagnosis

1228

4294

1.44

28.59

2.0

1.8

197.48

197.18

pmol/l

0.03

1164

4112

Restless leg syndrome

183

749

2.49

28.51

2.1

1.9

197.82

201.17

pmol/l

0.13

174

703

Meniscus derangement

868

3859

1.53

28.48

2.1

1.8

199.23

202.76

pmol/l

0.50

821

3693

Other disorders of male genital organs

152

579

2.80

28.29

1.8

1.9

218.27

222.55

pmol/l

0.18

147

545

Pain, not elsewhere classified

376

2036

1.87

28.12

2.1

1.8

177.83

193.50

pmol/l

2.31

352

1932

Type 2 diabetes, definitions combined, including avohilmo

1381

5781

1.40

28.11

1.9

164.31

204.48

pmol/l

34.17

1300

5516

Chronic diseases of tonsils and adenoids

1182

5244

1.43

28.00

2.0

1.8

197.41

194.79

pmol/l

0.35

1120

5010

Type 2 diabetes

1445

6124

1.39

27.88

1.9

166.22

204.67

pmol/l

32.24

1352

5855

Bronchitis

1473

6770

1.38

27.73

1.9

1.8

196.85

192.20

pmol/l

0.82

1396

6426

Symptoms and signs involving the urinary system

1056

5576

1.45

27.67

1.9

187.07

199.18

pmol/l

3.47

984

5292

Visual disturbances

579

3566

1.64

27.31

2.0

1.8

189.95

191.87

pmol/l

0.16

549

3381

Asthma, excluding more controls

1134

4116

1.45

27.09

2.1

1.8

190.17

197.40

pmol/l

1.40

1074

3946

Diabetes mellitus

1511

6490

1.37

26.95

1.9

168.99

204.34

pmol/l

28.22

1413

6206

Disorders of the thyroid gland

1176

5412

1.42

26.91

2.2

1.8

178.43

187.28

pmol/l

1.77

1096

5121

Diabetes, varying definitions

1505

6488

1.37

26.75

1.9

169.49

204.42

pmol/l

27.61

1410

6202

Hypertensive diseases

1281

5179

1.41

26.60

2.0

1.9

185.82

209.42

pmol/l

13.72

1213

4975

Hypertension

1281

5178

1.41

26.59

2.0

1.9

185.82

209.40

pmol/l

13.71

1213

4974

Metabolic disorders

1405

6250

1.38

26.55

2.0

1.9

187.51

203.58

pmol/l

7.14

1317

5964

Malaise and fatigue

616

3096

1.61

26.53

2.0

1.8

191.66

193.21

pmol/l

0.13

575

2922

Vasomotor and allergic rhinitis

530

3158

1.66

26.45

2.1

1.8

197.78

190.50

pmol/l

0.87

509

3030

Visual disturbances and blindness

606

3802

1.61

26.44

2.0

1.8

188.72

191.79

pmol/l

0.29

574

3598

ILD medications: prednisolone, methylprednisolone, prednisone

1644

6859

1.35

26.40

2.0

1.9

195.52

195.02

pmol/l

0.06

1559

6523

Bipolar affective disorders

315

1651

1.94

26.24

2.2

1.8

179.10

195.06

pmol/l

1.89

295

1595

Diseases of the skin and subcutaneous tissue

1544

5708

1.36

26.22

2.0

1.9

189.06

200.56

pmol/l

3.47

1469

5431

GASTRO-related operations

1264

4520

1.41

26.22

2.0

1.8

188.99

196.56

pmol/l

1.53

1209

4329

Any gastric operation

1264

4520

1.41

26.22

2.0

1.8

188.99

196.56

pmol/l

1.53

1209

4329

Osteoporosis

179

698

2.42

26.21

1.8

1.9

176.40

196.14

pmol/l

1.73

169

656

Type 2 diabetes, strict (exclude DM1)

1355

5781

1.38

25.95

1.9

164.36

204.08

pmol/l

32.59

1273

5514

Asthma

1149

4240

1.43

25.88

2.1

1.8

190.45

197.01

pmol/l

1.22

1087

4062

Other disorders of penis

267

1336

2.07

25.88

1.9

1.8

203.57

211.84

pmol/l

0.75

260

1266

Type 2 diabetes, definitions combined

1352

5771

1.38

25.81

1.9

164.39

204.14

pmol/l

32.48

1269

5505

Panic disorder

244

1183

2.10

25.38

2.1

1.8

172.91

188.00

pmol/l

1.35

228

1136

Injuries to the knee and lower leg

1672

6979

1.34

25.35

1.9

194.56

194.49

pmol/l

0.01

1584

6633

Somatoform disorder

214

990

2.19

25.09

2.0

1.8

176.39

196.59

pmol/l

1.83

202

944

Impingement syndrome of shoulder

339

1846

1.86

25.05

2.0

1.8

200.04

200.41

pmol/l

0.02

315

1747

Substance abuse, excluding more controls

946

5604

1.45

25.04

2.0

1.8

196.65

202.45

pmol/l

0.80

873

5361

Other reaction to severe stress, and adjustment disorders

533

3298

1.63

24.80

1.9

1.8

194.37

195.20

pmol/l

0.06

501

3177

Injuries to the head

1586

7328

1.34

24.64

1.9

201.77

193.23

pmol/l

2.15

1501

6967

Disorders of adult personality and behaviour

500

3059

1.66

24.48

2.1

1.9

182.43

191.52

pmol/l

0.91

469

2932

Excluding asthma or asthma-COPD overlap

1198

4294

1.41

24.41

2.0

1.8

197.18

pmol/l

0.00

1136

4112

Use of pramipexole

246

1214

2.05

24.31

2.1

1.8

194.28

199.11

pmol/l

0.27

237

1137

Asthma (mode)

1123

4270

1.42

24.24

2.1

1.8

191.10

196.73

pmol/l

0.96

1065

4091

Other arthrosis

746

3424

1.52

24.23

2.1

1.8

199.25

202.81

pmol/l

0.44

695

3272

Benign neoplasm of colon, rectum, anus and anal canal

722

4157

1.52

24.19

1.9

185.56

197.50

pmol/l

2.58

662

3912

Injury of muscle and tendon at shoulder and upper arm level

608

3920

1.57

23.93

2.0

1.9

206.82

200.95

pmol/l

0.77

576

3715

Diabetes medication

1496

6641

1.34

23.77

1.9

168.49

203.73

pmol/l

28.06

1395

6349

Other extrapyramidal and movement disorders in other diseases

276

1431

1.95

23.72

2.2

1.9

184.09

196.58

pmol/l

1.03

263

1336

ILD differential diagnosis

1186

4270

1.40

23.56

2.0

1.8

197.71

196.73

pmol/l

0.11

1125

4091

Excessive, frequent and irregular menstruation

108

183

3.24

23.54

1.2

1.3

16.22

18.82

pmol/l

0.96

102

164

Cervicalgia

250

1257

2.01

23.47

2.0

1.8

190.49

197.86

pmol/l

0.46

238

1191

Other enthesopathies

359

2031

1.79

23.34

2.1

1.8

193.84

197.97

pmol/l

0.36

342

1934

Diseases of the ear and mastoid process

1739

6667

1.32

23.30

1.9

193.22

196.18

pmol/l

0.51

1651

6352

COPD differential diagnosis

1185

4275

1.40

23.28

2.0

1.8

197.86

196.68

pmol/l

0.13

1124

4096

Certain infectious and parasitic diseases

1062

3758

1.42

23.27

1.9

1.8

195.91

197.38

pmol/l

0.16

1005

3577

Other (not insulin) diabetes medications

1358

5969

1.36

23.14

2.0

1.9

164.03

203.56

pmol/l

32.75

1266

5696

Diarrhoea and gastroenteritis of presumed infectious origin

1069

6940

1.40

23.14

2.0

1.9

197.16

195.61

pmol/l

0.17

1007

6627

Migraine with aura

232

1145

2.04

22.87

1.7

165.50

167.10

pmol/l

0.07

226

1084

Other/unspecified dorsalgia

447

2679

1.67

22.77

2.1

1.8

193.92

193.71

pmol/l

0.01

421

2547

Diseases of the eye and adnexa

1418

5286

1.35

22.77

2.0

1.9

194.46

197.04

pmol/l

0.35

1349

5054

Any reimbursement code in KELA

1014

3578

1.43

22.74

2.0

1.7

187.66

202.98

pmol/l

3.71

970

3443

Personality disorders

465

2856

1.65

22.48

2.1

1.9

176.66

192.15

pmol/l

2.10

435

2742

Psychotic depression

289

3.18

22.36

1.9

1.7

184.94

198.03

pmol/l

0.44

283

Pain in limb

1079

5205

1.39

22.25

2.0

1.8

181.78

192.77

pmol/l

2.69

1011

4972

Pain in thoracic spine

209

1008

2.10

22.08

1.9

1.8

186.60

200.10

pmol/l

1.19

199

958

Autoimmune diseases

1737

6813

1.30

21.78

1.9

194.81

196.55

pmol/l

0.26

1648

6484

Diseases of oesophagus, stomach and duodenum

1508

6851

1.32

21.74

1.9

196.11

197.01

pmol/l

0.12

1428

6515

Migraine without aura

191

894

2.16

21.72

1.8

1.6

154.81

165.22

pmol/l

0.52

180

845

Specific personality disorders

393

2339

1.70

21.49

2.1

1.9

175.20

188.54

pmol/l

1.38

370

2236

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1627

6786

1.31

21.43

2.0

1.8

189.18

198.77

pmol/l

3.09

1523

6488

Benign neoplasm: Colon

589

3686

1.54

21.22

1.9

1.8

181.06

196.55

pmol/l

3.50

540

3456

Enthesopathies of lower limb, excluding foot

300

1661

1.83

21.09

1.9

1.8

204.48

199.78

pmol/l

0.33

283

1585

Disorders of lacrimal system

373

2200

1.70

20.70

2.2

1.8

199.72

187.51

pmol/l

1.23

356

2069

Finngen Rheumatological endpoints

1464

6352

1.32

20.38

2.0

1.9

198.10

195.70

pmol/l

0.34

1369

6078

Postprocedural endocrine and metabolic disorders, not elsewhere classified

123

490

2.54

20.38

2.3

1.7

176.88

199.36

pmol/l

1.10

114

461

Other diseases of hard tissues of teeth

807

2880

1.46

20.36

2.0

1.8

205.17

203.38

pmol/l

0.16

762

2760

Redundant prepuce, phimosis and paraphimosis

598

3957

1.53

20.30

2.1

1.9

207.94

216.72

pmol/l

1.32

577

3780

Glucagon-like peptide-1 (GLP-1) analogues

466

2945

1.60

20.11

2.0

1.9

169.63

206.42

pmol/l

13.57

438

2807

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

466

2945

1.60

20.11

2.0

1.9

169.63

206.42

pmol/l

13.57

438

2807

Tinnitus

313

1784

1.78

20.01

1.8

197.37

199.60

pmol/l

0.13

291

1675

Deforming dorsopathies

319

1827

1.76

19.97

2.1

1.8

188.11

193.15

pmol/l

0.43

299

1741

Biguanides

1309

6021

1.33

19.91

2.0

1.9

165.06

203.59

pmol/l

30.21

1223

5741

Disorders of lipoprotein metabolism and other lipidaemias

1203

5557

1.35

19.91

2.0

1.9

187.13

206.96

pmol/l

10.49

1133

5295

Diseases of the respiratory system

815

2841

1.45

19.52

2.0

1.8

195.00

192.24

pmol/l

0.27

767

2707

Other disorders of lacrimal gland

316

1819

1.75

19.41

2.2

1.8

197.84

189.72

pmol/l

0.58

299

1712

Pain and other conditions associated with female genital organs and menstrual cycle

177

3.49

19.31

1.1

1.3

16.67

19.01

pmol/l

0.67

161

Other and unspecified tonsillitis

737

4336

1.45

19.05

2.0

1.9

200.53

196.91

pmol/l

0.37

698

4182

Dental operations

855

3102

1.42

19.02

2.0

1.8

197.25

203.20

pmol/l

0.77

800

2962

Disorders of thyroid, IBD co-morbidities

181

598

2.15

19.01

2.0

1.6

179.75

190.60

pmol/l

0.56

159

570

Artificial joint operation, meniscal resection

1273

6266

1.33

19.01

2.0

1.9

200.10

202.49

pmol/l

0.39

1201

5952

Extrapyramidal and movement disorders

384

2344

1.65

18.98

2.0

1.8

186.16

194.84

pmol/l

0.87

365

2178

Subjective visual disturbances

283

1593

1.80

18.87

1.8

191.24

195.22

pmol/l

0.25

266

1502

Symptoms and signs involving the nervous and musculoskeletal systems

659

4536

1.46

18.81

2.1

1.8

185.37

191.59

pmol/l

0.70

618

4279

Temporomandibular joint disorders, including avohilmo

432

2680

1.60

18.78

2.1

1.8

174.75

169.87

pmol/l

0.35

409

2540

Phobic anxiety disorders

234

1246

1.91

18.71

2.1

1.8

186.27

194.26

pmol/l

0.51

227

1199

Anaemias

319

1193

1.76

18.56

2.3

1.7

187.77

204.69

pmol/l

2.15

305

1163

Cervicobrachial syndrome

254

1392

1.84

18.51

2.2

1.8

177.26

197.36

pmol/l

2.09

238

1323

Umbilical hernia

490

3197

1.55

18.47

2.1

1.9

195.98

199.92

pmol/l

0.35

467

3024

Dermatophytosis

919

6726

1.37

18.45

1.9

197.28

199.50

pmol/l

0.27

873

6388

Other metabolic disorders

135

590

2.32

18.29

2.2

1.7

177.79

199.02

pmol/l

1.16

125

558

Cough

417

2475

1.60

18.28

2.0

1.8

191.10

191.01

pmol/l

0.01

398

2345

Gonarthrosis [arthrosis of knee](FG)

1030

4415

1.36

18.23

2.1

1.9

195.07

202.02

pmol/l

1.39

961

4204

Other heart diseases, wide

1376

6480

1.31

18.18

2.0

1.9

194.98

199.73

pmol/l

0.95

1305

6198

Orchitis and epididymitis

226

1209

1.92

18.12

2.0

1.9

213.54

212.38

pmol/l

0.06

217

1136

591

3992

1.48

17.93

2.1

1.8

192.12

194.86

pmol/l

0.24

557

3818

Other heart diseases

800

3720

1.42

17.92

2.0

1.9

200.42

209.60

pmol/l

1.65

756

3596

Dental pulpitis, including avohilmo

1421

7163

1.29

17.82

2.0

1.9

193.24

196.48

pmol/l

0.49

1340

6847

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

573

3771

1.49

17.78

2.0

1.8

192.71

188.59

pmol/l

0.40

549

3603

Spondylolisthesis/Spondylolysis

216

1143

1.91

17.63

2.1

1.8

188.92

203.06

pmol/l

1.43

202

1085

Diaphragmatic hernia

349

2129

1.65

17.35

1.9

1.8

193.33

196.59

pmol/l

0.25

323

1987

Medical treatment for female infertility

343

2.68

17.19

1.2

15.90

16.52

pmol/l

0.18

314

Disturbances of skin sensation

350

2146

1.65

17.12

1.9

188.36

189.31

pmol/l

0.06

336

2034

Allergic conjunctivitis

597

4001

1.46

17.12

2.0

1.8

192.79

188.78

pmol/l

0.40

573

3814

Haemorrhoids and perianal venous thrombosis

342

2083

1.65

16.97

2.0

1.8

196.40

198.82

pmol/l

0.17

325

1955

Gingivitis and periodontal diseases

1425

5721

1.29

16.90

1.9

191.95

199.40

pmol/l

1.72

1347

5461

Influenza and pneumonia

1477

7377

1.28

16.85

1.9

191.96

196.37

pmol/l

0.78

1393

7036

Allergic asthma (mode)

314

1841

1.68

16.75

2.0

1.8

193.22

192.19

pmol/l

0.06

302

1769

Other and unspecified polyneuropathies, also in other diseases

260

1483

1.78

16.72

1.8

1.9

174.56

199.90

pmol/l

3.90

240

1385

Social phobias

167

827

2.06

16.69

2.2

1.8

198.52

201.31

pmol/l

0.12

161

801

Diseases of oral cavity, salivary glands and jaws

786

2882

1.41

16.68

2.0

1.8

199.69

203.35

pmol/l

0.36

734

2761

Allergic asthma (mode), excluding more controls

314

1844

1.68

16.64

2.0

1.8

193.22

191.56

pmol/l

0.10

302

1772

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1102

5044

1.33

16.63

2.0

1.8

188.67

193.14

pmol/l

0.62

1045

4792

1102

5044

1.33

16.63

2.0

1.8

188.67

193.14

pmol/l

0.62

1045

4792

Infections with a predominantly sexual mode of transmission

549

3483

1.48

16.57

1.9

202.32

184.31

pmol/l

2.29

516

3341

Dentofacial anomalies [including malocclusion]

899

5342

1.36

16.46

2.0

1.9

191.16

194.11

pmol/l

0.32

856

5102

Inflammatory bowel disease treatment related agents

1634

7272

1.26

16.41

2.0

1.9

195.93

195.19

pmol/l

0.10

1553

6915

Gastrointestinal diseases

883

3225

1.38

16.35

2.0

1.8

193.75

193.13

pmol/l

0.05

843

3082

Excessive attrition of teeth

751

5437

1.39

16.31

2.0

1.9

193.33

192.57

pmol/l

0.07

707

5176

Polyneuropathies and other disorders of the peripheral nervous system

293

1743

1.70

16.20

1.8

1.9

178.63

198.29

pmol/l

2.86

272

1633

Asthma (only as main-diagnosis), excluding more controls

967

4116

1.35

16.10

2.1

1.8

193.83

197.40

pmol/l

0.45

918

3946

Symptoms and signs involving the skin and subcutaneous tissue

802

5748

1.37

16.09

1.9

188.49

191.26

pmol/l

0.32

754

5444

Osteopathies and chondropathies

629

4123

1.43

15.92

2.0

1.9

185.47

196.64

pmol/l

2.14

600

3910

Pure hypercholesterolaemia

1013

4990

1.33

15.77

1.9

188.05

206.09

pmol/l

7.39

947

4750

Diverticular disease of intestine

852

3998

1.37

15.72

1.9

1.8

191.35

201.01

pmol/l

2.15

786

3784

Fall on same level

1649

7207

1.25

15.68

1.9

197.23

194.87

pmol/l

0.37

1555

6864

Voice disturbances

236

1333

1.79

15.63

1.8

175.94

191.13

pmol/l

1.43

215

1248

Mental and behavioural disorders due to sedatives or hypnotics

162

816

2.04

15.62

2.4

1.9

198.77

214.97

pmol/l

0.97

152

779

Asthma, including avohilmo

1643

7404

1.25

15.38

2.0

1.8

192.08

195.64

pmol/l

0.68

1556

7043

Asthma, hospital admission 2, infections

713

5063

1.39

15.27

2.1

1.9

190.92

194.60

pmol/l

0.39

669

4817

Asthma-related infections

713

5063

1.39

15.27

2.1

1.9

190.92

194.60

pmol/l

0.39

669

4817

Substance use, excluding alcohol

393

2554

1.56

15.24

2.2

1.9

194.72

207.15

pmol/l

1.15

368

2449

Emergency coronary revascularization (for ACS)

1155

5428

1.30

14.96

2.0

1.9

195.88

205.50

pmol/l

2.38

1101

5153

Complications of medical and surgical care

799

5439

1.36

14.87

2.0

1.9

184.79

191.58

pmol/l

1.07

751

5132

Asthma (only as main-diagnosis)

971

4240

1.33

14.86

2.1

1.8

193.53

197.01

pmol/l

0.44

922

4062

Lateral epicondylitis

186

997

1.89

14.74

2.2

1.8

196.83

202.42

pmol/l

0.35

179

948

Dermatitis

693

5020

1.38

14.67

2.0

1.9

187.13

192.58

pmol/l

0.63

652

4735

Cervicocranial syndrome

113

505

2.27

14.64

2.3

1.7

175.69

201.57

pmol/l

1.82

108

480

Percutaneous Coronary Intervention

1104

5222

1.30

14.55

2.0

1.9

195.43

205.82

pmol/l

2.89

1053

4967

Other and unspecified dermatitis

560

3941

1.43

14.38

2.0

1.9

187.07

191.08

pmol/l

0.35

526

3723

Secondary polycythaemia

238

2.96

14.36

2.8

1.9

189.94

213.72

pmol/l

0.92

225

Coronary revascularization (ANGIO or CABG)

1104

5228

1.30

14.30

2.0

1.9

197.12

205.84

pmol/l

1.93

1053

4973

Hernia of abdominal wall, postoperative

257

1528

1.70

14.30

2.1

1.8

183.91

204.05

pmol/l

2.43

247

1440

Other disorders of patella

239

1397

1.73

14.17

2.1

1.8

201.34

197.04

pmol/l

0.24

223

1344

Other shoulder lesions

136

664

2.08

14.16

1.8

189.25

205.15

pmol/l

0.89

121

630

Certain infectious and parasitic diseases

1342

5315

1.27

14.00

1.9

1.8

190.02

195.27

pmol/l

0.89

1267

5059

Haemorrhage from respiratory passages

387

2293

1.53

13.92

2.0

1.8

190.92

200.49

pmol/l

0.99

364

2157

Carpal tunnel syndrome

656

4194

1.39

13.89

2.1

1.8

185.52

195.60

pmol/l

1.79

612

3983

Other symptoms and signs involving cognitive functions and awareness

475

2967

1.47

13.83

2.0

1.8

189.15

196.12

pmol/l

0.67

444

2785

Other external causes of accidental injury

1075

4151

1.30

13.73

1.9

1.8

197.34

191.94

pmol/l

0.75

1018

3954

Symptoms and signs involving speech and voice

292

1812

1.62

13.68

1.8

1.9

176.93

192.48

pmol/l

1.67

267

1690

Accidents

1074

4151

1.30

13.63

1.9

1.8

198.53

191.94

pmol/l

0.98

1020

3954

Complications of procedures, not elsewhere classified

981

6260

1.30

13.61

2.0

1.9

188.86

194.92

pmol/l

1.01

926

5933

Acromegaly and pituitary gigantism

5.81

13.56

3.2

1.4

173.77

259.36

pmol/l

2.15

1366

5622

1.26

13.48

1.9

1.8

191.90

pmol/l

0.00

1287

5332

Infections of the skin and subcutaneous tissue

931

7109

1.31

13.33

2.0

1.9

189.00

201.45

pmol/l

2.80

895

6768

Fever of other and unknown origin

691

4532

1.36

13.32

2.1

1.8

188.18

196.64

pmol/l

1.48

655

4308

Candidiasis

264

1610

1.65

13.29

1.9

1.8

176.54

179.91

pmol/l

0.18

257

1521

Hernia of abdominal wall

634

4638

1.38

13.08

2.1

1.9

193.05

199.31

pmol/l

0.80

603

4384

Viral infections characterized by skin and mucous membrane lesions

1109

7480

1.27

12.92

2.0

1.8

197.67

193.21

pmol/l

0.63

1069

7096

Anogenital herpesviral [herpes simplex] infection

144

744

1.96

12.82

1.9

1.8

185.63

175.41

pmol/l

0.39

134

707

Nasal polyp

284

1788

1.61

12.69

1.8

1.9

194.75

199.42

pmol/l

0.38

274

1700

Other symptoms and signs involving the nervous and musculoskeletal systems

457

3175

1.45

12.67

2.2

1.8

185.17

190.50

pmol/l

0.51

434

3005

Triptan medication for migraine, min. 3 purchases

553

3014

1.41

12.62

1.9

1.8

170.32

175.21

pmol/l

0.47

528

2874

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

632

4585

1.37

12.56

2.0

1.9

184.99

190.99

pmol/l

0.76

593

4313

Dysphagia

249

1520

1.65

12.54

2.0

1.8

188.41

199.95

pmol/l

0.98

235

1422

Poisoning by drugs, medicaments and biological substances

372

2494

1.51

12.50

2.1

1.9

175.66

194.89

pmol/l

2.19

353

2385

Ischemic heart diseases

1138

5400

1.27

12.49

2.0

1.9

197.56

205.72

pmol/l

1.82

1083

5134

Vocal cord dysfunction

152

722

1.91

12.32

1.8

1.7

188.98

209.68

pmol/l

1.56

140

689

Infections with a predominantly sexual mode of transmission

388

2628

1.49

12.26

1.8

1.9

201.25

184.66

pmol/l

1.66

361

2514

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

497

3536

1.42

12.23

2.0

1.9

207.00

204.89

pmol/l

0.18

472

3375

Anomalies of dental arch relationship, including avohilmo

257

1432

1.63

12.19

2.2

1.8

190.77

185.29

pmol/l

0.31

247

1362

Other functional intestinal disorders

415

2641

1.47

12.19

2.1

1.8

179.52

190.53

pmol/l

1.20

395

2482

Soft tissue disorders related to use, overuse and pressure

298

1914

1.57

12.17

2.0

1.8

186.02

200.30

pmol/l

1.72

283

1820

Fissure and fistula of anal and rectal regions

329

2165

1.53

12.08

2.0

1.8

196.67

200.41

pmol/l

0.25

305

2051

Diseases of appendix

1055

7534

1.27

12.03

2.0

1.9

196.04

197.36

pmol/l

0.17

1001

7165

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

577

4215

1.37

11.89

2.0

1.9

186.21

190.91

pmol/l

0.50

541

3962

Fenamates

122

403

2.07

11.84

1.8

1.6

184.25

168.35

pmol/l

0.63

112

385

Appendicitis, broad definition

1049

7529

1.27

11.83

2.0

1.9

195.83

197.34

pmol/l

0.20

995

7160

Hypothyroidism, strict autoimmune

698

3429

1.34

11.79

1.9

1.7

172.66

183.24

pmol/l

1.55

656

3222

Gonarthrosis,primary

1010

4883

1.28

11.76

2.1

1.8

192.19

198.93

pmol/l

1.34

943

4619

Migraine, single triptan purchase ok & required. ICD-code if available is included

1017

5425

1.28

11.71

2.0

1.9

186.71

197.86

pmol/l

2.76

983

5191

Triptan medication for migraine, single purchase ok

1017

5425

1.28

11.71

2.0

1.9

186.71

197.86

pmol/l

2.76

983

5191

Symptoms and signs involving cognition, perception, emotional state and behaviour

1228

6740

1.25

11.68

1.9

190.84

195.36

pmol/l

0.74

1151

6410

Sequelae of injuries, of poisoning and of other consequences of external causes

388

2666

1.47

11.60

2.0

1.9

199.70

202.64

pmol/l

0.19

364

2548

Major coronary heart disease event

1126

5417

1.26

11.53

2.0

1.9

196.99

205.51

pmol/l

1.93

1071

5148

Allergic rhinitis

404

2768

1.45

11.44

2.1

1.8

193.85

189.82

pmol/l

0.32

391

2644

Emotionally unstable personality disorder

171

969

1.79

11.44

2.2

1.8

147.61

184.31

pmol/l

3.51

160

918

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

190

1117

1.75

11.38

2.4

1.9

204.78

216.71

pmol/l

0.53

178

1070

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

344

2308

1.50

11.28

2.0

1.7

169.64

191.18

pmol/l

2.37

328

2225

Dyspnoea

1059

6238

1.26

11.16

2.1

1.8

185.82

194.56

pmol/l

1.99

992

5915

External causes of morbidity and mortality

830

3192

1.31

11.08

1.9

1.8

198.91

190.22

pmol/l

1.15

788

3034

Non-invasive ventilation

284

1643

1.56

11.03

1.9

1.8

187.21

209.52

pmol/l

4.10

270

1585

Abnormal findings on examination of blood, without diagnosis

618

4244

1.35

10.99

1.9

188.22

195.78

pmol/l

0.91

583

3980

Blepharochalasis

187

1098

1.71

10.95

1.8

205.42

192.70

pmol/l

0.85

170

1019

Acute appendicitis

996

7419

1.26

10.92

2.0

1.9

195.13

197.56

pmol/l

0.34

944

7061

Implicit viral Sepsis

311

2066

1.52

10.92

2.1

1.8

182.31

197.19

pmol/l

1.79

294

1936

Hard cardiovascular diseases

1144

5482

1.25

10.92

2.0

1.9

199.30

205.32

pmol/l

1.14

1092

5218

Infections, IBD-co-morbidities

168

675

1.79

10.82

1.9

1.7

197.94

217.78

pmol/l

1.69

161

645

Hypothyroidism, drug reimbursement

139

523

1.89

10.60

1.8

1.6

185.20

202.64

pmol/l

1.10

129

506

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

1638

0.47

10.60

1.8

151.97

196.12

pmol/l

3.59

1535

All pneumoniae

1358

7463

1.22

10.60

1.9

191.26

197.68

pmol/l

1.24

1282

7112

Obsessive-compulsive disorder

110

556

2.01

10.57

2.3

1.7

180.07

197.79

pmol/l

0.75

105

533

Post-traumatic stress disorder

474

2.09

10.56

2.2

1.6

165.82

167.91

pmol/l

0.05

454

Disorders of synovium and tendon

615

4048

1.34

10.52

2.0

1.8

197.29

193.97

pmol/l

0.29

579

3859

Migraine without aura and triptan purchases

137

744

1.86

10.51

1.9

1.7

156.71

156.74

pmol/l

0.00

129

699

Other and unspecified mood [affective] disorders

112

571

1.99

10.50

2.0

1.9

182.47

200.04

pmol/l

0.83

104

547

Poisoning by medicine

327

2223

1.49

10.36

2.1

1.9

176.87

194.99

pmol/l

1.70

310

2125

Other viral diseases

540

3976

1.36

10.29

2.0

1.9

195.25

193.03

pmol/l

0.17

521

3812

Other and unspecified nerve root and plexus disorders, also in other diseases

281

1859

1.53

10.19

2.0

1.9

194.91

201.40

pmol/l

0.48

263

1774

Diseases of external ear

398

2815

1.42

10.17

1.9

194.07

194.54

pmol/l

0.03

369

2657

Symptoms and signs concerning food and fluid intake

113

583

1.96

10.14

2.6

1.8

198.14

198.95

pmol/l

0.02

106

553

Oedema, not elsewhere classified

303

2008

1.50

10.10

1.9

1.8

178.25

194.55

pmol/l

1.74

279

1883

Congenital malformations, deformations and chromosomal abnormalities

877

6406

1.27

10.09

2.0

1.9

191.93

195.62

pmol/l

0.40

835

6119

Diseases of salivary glands

331

2266

1.47

10.07

2.0

1.9

194.33

193.63

pmol/l

0.04

311

2145

Small fibre neuropathy

201

2.72

10.07

2.1

1.9

163.96

210.75

pmol/l

2.11

187

Disorders of ocular muscles, binocular movement, accommodation and refraction

555

4123

1.34

9.89

1.8

1.9

187.25

189.62

pmol/l

0.20

535

3920

Abnormal involuntary movements

159

922

1.74

9.88

2.1

1.9

189.97

198.97

pmol/l

0.30

149

872

Care involving use of rehabilitation procedures

795

5747

1.28

9.81

2.0

1.9

183.87

198.05

pmol/l

3.77

738

5456

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1267

6280

1.22

9.75

1.9

180.62

207.77

pmol/l

15.63

1180

6005

Disorders of vestibular function (Vertigo)

383

2666

1.42

9.70

2.0

1.9

187.60

192.69

pmol/l

0.49

359

2499

Persons with potential health hazards related to communicable diseases

520

3841

1.35

9.66

2.0

1.9

198.60

187.88

pmol/l

1.22

496

3676

Conjunctivitis

867

5764

1.26

9.51

2.0

1.9

192.38

193.65

pmol/l

0.13

825

5509

Pneumonias (Asthma/COPD co-morbidities)

1339

7466

1.21

9.50

1.9

191.16

197.78

pmol/l

1.29

1263

7115

Other specified and unspecified personality disorders

149

862

1.76

9.42

2.0

1.9

178.90

205.63

pmol/l

1.98

140

813

Other viral diseases, not elsewhere classified

359

2519

1.43

9.36

1.9

195.17

191.92

pmol/l

0.21

346

2406

Thyroiditis, ILD-related definition

470

2.02

9.29

2.3

1.8

175.54

181.87

pmol/l

0.21

439

Viral warts

293

1994

1.48

9.29

2.1

1.9

206.49

195.10

pmol/l

0.76

283

1905

Early lumbar disc prolapse, operated

210

1337

1.60

9.19

2.0

1.9

189.68

206.01

pmol/l

1.73

200

1289

Other viral hepatitis

152

895

1.74

9.15

2.4

1.9

187.53

213.60

pmol/l

1.98

146

855

Adenomyosis (Endometriosis of uterus)

5.01

9.08

1.5

1.3

22.53

14.16

pmol/l

0.66

Diseases of pulp and periapical tissues, including avohilmo

1358

5854

1.21

9.06

1.9

1.8

186.70

196.48

pmol/l

2.45

1263

5597

Constipation

940

5242

1.25

9.05

2.1

1.8

185.96

192.73

pmol/l

1.13

872

4958

Other disorders of ear

1099

5891

1.23

9.04

1.9

189.88

197.52

pmol/l

1.70

1045

5590

Chronic lower respiratory diseases

1629

7344

1.18

9.02

2.0

1.8

191.80

195.78

pmol/l

0.79

1545

6984

Other arrhythmias

758

4507

1.27

8.97

2.0

1.9

194.65

196.89

pmol/l

0.26

717

4290

COPD/asthma related infections

1221

5046

1.22

8.84

1.9

1.8

190.35

193.10

pmol/l

0.33

1161

4793

COPD/asthma/ILD related infections

1221

5046

1.22

8.84

1.9

1.8

190.35

193.10

pmol/l

0.33

1161

4793

Achilles tendinitis

140

811

1.75

8.81

1.9

1.8

198.56

208.12

pmol/l

0.59

135

770

Viral hepatitis

159

957

1.70

8.81

2.4

1.9

185.21

213.49

pmol/l

2.38

153

913

Adhesive capsulitis of shoulder

161

968

1.68

8.79

2.0

1.8

204.11

198.79

pmol/l

0.27

149

918

Asthma, hospital admissions , main diagnosis only

983

7071

1.23

8.77

2.1

1.8

194.13

193.61

pmol/l

0.05

934

6716

Acne

161

969

1.68

8.76

2.2

1.9

163.42

192.96

pmol/l

1.95

155

925

Benign neoplasm: Sigmoid colon

198

1255

1.59

8.75

1.8

1.9

180.59

200.98

pmol/l

2.23

181

1180

Chronic viral hepatitis

139

810

1.76

8.74

2.4

1.9

186.43

215.38

pmol/l

2.14

134

774

Disorders of sclera, cornea, iris and ciliary body

697

5496

1.27

8.59

2.1

1.9

190.98

199.08

pmol/l

1.37

674

5227

Seminoma of testis, including Hilmo

198

2.70

8.57

2.5

1.9

208.16

243.44

pmol/l

1.26

190

Seminoma of testis

163

2.90

8.56

2.4

1.8

205.51

253.66

pmol/l

1.72

155

Benign neoplasm: Ascending colon

136

788

1.74

8.54

2.2

1.9

186.92

196.29

pmol/l

0.44

122

739

Colonic or urogenital fistula

336

2386

1.42

8.51

2.0

1.9

195.95

197.65

pmol/l

0.10

311

2253

Abnormal serum enzyme levels

437

3158

1.36

8.49

1.9

1.8

190.05

195.18

pmol/l

0.39

409

2933

Benign paroxysmal vertigo

218

1421

1.54

8.49

2.0

1.8

194.08

196.05

pmol/l

0.11

207

1322

Other disorders of eyelid

309

2057

1.44

8.40

1.9

1.8

194.78

189.64

pmol/l

0.36

286

1910

Oral corticosteroids

1395

6973

1.19

8.37

2.0

1.9

194.49

195.50

pmol/l

0.13

1320

6633

Mixed and other personality disorders

143

848

1.72

8.35

2.4

1.9

184.67

209.45

pmol/l

1.85

133

805

Hydrocele

201

1298

1.57

8.29

1.8

213.79

209.24

pmol/l

0.27

193

1210

Asthma-related pneumonia

343

2449

1.40

8.28

1.9

1.8

190.95

195.53

pmol/l

0.30

319

2295

Dislocation, sprain and strain of joints and ligaments at neck level

208

1354

1.55

8.24

2.2

1.9

199.80

195.18

pmol/l

0.26

195

1285

Asthma, hospital admissions 3, pneumonia

343

2455

1.40

8.17

1.9

1.8

190.95

195.70

pmol/l

0.31

319

2301

Asthma-related pneumonia or sepsis

343

2455

1.40

8.17

1.9

1.8

190.95

195.70

pmol/l

0.31

319

2301

Dental caries, including avohilmo

917

3795

1.24

8.16

2.0

1.8

199.83

199.16

pmol/l

0.06

850

3638

Functional dyspepsia

239

1604

1.50

8.14

1.8

194.99

194.94

pmol/l

0.00

225

1509

Other and unspecified disorders of vitreous body

290

1993

1.44

8.10

1.9

1.8

197.10

192.53

pmol/l

0.26

263

1865

Disorders of vitreous body and globe

407

2887

1.36

8.04

1.9

1.8

193.58

195.10

pmol/l

0.10

368

2695

Other symptoms and signs involving the urinary system

144

864

1.69

8.03

2.0

1.9

181.36

203.81

pmol/l

1.79

135

810

Benign neoplasm: Rectum, anus and anal canal

200

1298

1.55

8.01

1.9

191.02

199.61

pmol/l

0.60

185

1215

Malignant neoplasm of digestive organs

193

2330

0.65

8.00

1.7

1.9

192.03

198.17

pmol/l

0.43

181

2184

Non-allergic asthma (mode), excluding more controls

186

1176

1.58

7.98

2.2

1.8

193.23

188.70

pmol/l

0.23

179

1112

Asthma and allergy

155

935

1.65

7.97

2.0

1.8

194.04

188.87

pmol/l

0.23

147

903

Undetermined asthma, excluding more controls

129

751

1.73

7.96

2.2

1.8

182.55

191.11

pmol/l

0.46

121

711

Non-allergic asthma (mode)

186

1177

1.58

7.95

2.2

1.7

193.23

189.88

pmol/l

0.16

179

1113

Ptosis of eyelid

512

1.89

7.95

1.9

197.32

197.44

pmol/l

0.00

479

Retinal breaks without detachment

169

1058

1.61

7.93

1.9

202.85

196.46

pmol/l

0.31

160

1001

Undetermined asthma

129

752

1.73

7.93

2.2

1.8

182.55

193.75

pmol/l

0.65

121

713

Abrasion of teeth

315

2243

1.41

7.86

2.0

1.9

195.24

192.94

pmol/l

0.13

298

2121

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

416

3102

1.35

7.85

1.9

201.21

196.73

pmol/l

0.35

401

2977

Nontoxic multinodular goitre

368

2.05

7.84

1.8

1.7

173.39

178.66

pmol/l

0.15

340

Pain associated with micturition

106

586

1.83

7.84

2.1

1.9

201.56

197.43

pmol/l

0.16

101

548

Chronic apical periodontitis

1461

7077

1.18

7.83

2.0

1.8

192.09

196.21

pmol/l

0.74

1364

6755

Urticaria and erythema

349

2530

1.39

7.82

2.0

1.8

180.18

186.45

pmol/l

0.53

325

2405

Asthma and allergy, excluding more controls

155

940

1.64

7.82

2.0

1.8

194.04

188.22

pmol/l

0.27

147

909

Heartburn

132

780

1.71

7.78

1.8

1.9

197.53

201.31

pmol/l

0.16

122

737

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

662

4694

1.27

7.74

1.9

185.05

196.27

pmol/l

2.23

606

4430

Benign neoplasm: Rectum

186

1198

1.57

7.74

1.9

188.23

200.08

pmol/l

0.92

172

1125

Dizziness and giddiness

756

4816

1.25

7.69

1.9

1.8

189.32

191.20

pmol/l

0.18

706

4552

Disorders of vitreous body

391

2794

1.36

7.67

1.9

1.8

193.39

195.03

pmol/l

0.10

353

2611

Diseases of pulp and periapical tissues and dental caries

808

3327

1.25

7.67

2.0

1.8

198.55

199.60

pmol/l

0.08

752

3192

Disorders of refraction and accommodation

312

2222

1.41

7.64

1.7

1.8

187.10

189.01

pmol/l

0.11

305

2119

Falls/tendency to fall

1485

6337

1.18

7.62

1.9

197.09

194.35

pmol/l

0.40

1413

6039

Contact with and exposure to communicable diseases

402

2982

1.35

7.61

2.0

1.8

195.80

183.90

pmol/l

1.10

386

2848

Other follicular disorders

117

677

1.76

7.51

2.0

1.8

168.23

205.93

pmol/l

3.34

112

637

Other neurological diseases

742

4690

1.25

7.51

1.9

190.24

194.98

pmol/l

0.62

706

4410

Chromosomal abnormalities, not elsewhere classified

171

2.59

7.49

2.6

1.8

182.74

213.83

pmol/l

0.93

162

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

241

1654

1.47

7.45

2.0

1.9

177.72

198.30

pmol/l

1.55

230

1578

Persons encountering health services in other circumstances

464

3522

1.32

7.44

2.1

1.8

196.85

191.87

pmol/l

0.40

429

3363

Complications of surgical and medical care, not elsewhere classified

1192

6873

1.19

7.44

2.0

1.9

188.13

196.10

pmol/l

1.79

1124

6524

Diseases of inner ear

479

3547

1.31

7.43

1.9

188.65

194.89

pmol/l

0.74

451

3334

Disorders of parathyroid gland

108

602

1.78

7.43

1.9

1.6

185.49

199.09

pmol/l

0.80

102

562

Visual field defects

490

1.88

7.37

2.3

1.9

176.23

202.08

pmol/l

1.17

460

Congenital malformations, deformations and chromosomal abnormalities

787

6099

1.23

7.35

2.0

1.9

193.47

195.48

pmol/l

0.18

752

5819

Schizophrenia

136

2188

0.61

7.35

1.6

2.0

185.81

210.18

pmol/l

2.04

129

2090

Presence of other devices

170

1081

1.57

7.33

1.7

1.9

171.87

191.89

pmol/l

2.31

157

988

Other/unspecified enthesopathies of lower limb, excluding foot

456

1.91

7.31

1.7

1.8

224.43

207.69

pmol/l

0.58

435

Herpesviral [herpes simplex] infections

230

1569

1.47

7.29

2.1

1.9

192.37

182.24

pmol/l

0.61

224

1489

Benign neoplasm of other and ill-defined parts of digestive system

147

910

1.63

7.24

1.7

1.9

187.27

195.45

pmol/l

0.34

136

851

Diseases of middle ear and mastoid

793

5282

1.23

7.24

1.9

192.84

194.16

pmol/l

0.11

754

5045

Missing teeth due to accident, extraction or parodontitis

597

4449

1.27

7.18

1.9

185.75

196.54

pmol/l

1.28

558

4185

Anogenital herpesviral [herpes simplex] infection

431

1.93

7.18

1.7

1.9

204.46

184.48

pmol/l

0.71

404

Injury, poisoning and certain other consequences of external causes

630

2485

1.28

7.16

1.9

1.8

195.73

189.40

pmol/l

0.63

596

2365

Other diseases of lip and oral mucosa

394

2955

1.34

7.16

2.1

1.9

199.15

192.85

pmol/l

0.50

377

2803

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

348

1.89

7.15

1.9

1.8

192.19

219.63

pmol/l

1.93

325

Injuries to the ankle and foot

966

7149

1.21

7.11

1.9

188.82

196.44

pmol/l

1.39

931

6819

Acute appendicitis, no complications

807

6588

1.22

7.07

2.0

1.9

194.35

198.90

pmol/l

0.71

764

6286

Asthma (diagnoses ohter than nonallergic)

994

6889

1.20

6.97

2.1

1.8

188.06

192.02

pmol/l

0.59

939

6535

Autoimmune diseases excluding thyroid diseases

1449

6791

1.17

6.91

1.9

198.60

196.80

pmol/l

0.26

1375

6462

Mental and behavioural disorders due to psychoactive substance use

978

7591

1.20

6.84

2.0

1.9

196.65

202.26

pmol/l

0.81

905

7251

Diabetes, insulin treatment (Kela reimbursement)

1308

6746

1.17

6.84

1.9

180.78

205.12

pmol/l

13.31

1218

6450

Sensorineural hearing loss

781

4325

1.23

6.84

1.9

189.42

196.94

pmol/l

1.44

737

4072

Atherosclerosis, excluding cerebral and coronary sclerosis

192

2250

0.67

6.83

1.7

1.8

171.73

193.99

pmol/l

2.74

171

2064

COPD, early/later onset

251

2976

0.71

6.79

2.1

1.8

190.95

193.99

pmol/l

0.16

224

2763

Procreative management

525

3437

1.28

6.71

1.9

192.07

205.77

pmol/l

1.98

506

3298

Metatarsalgia

391

1.93

6.71

1.6

1.8

196.87

194.34

pmol/l

0.08

373

Acute nasopharyngitis (common cold)

308

2244

1.38

6.68

2.0

1.9

205.42

210.27

pmol/l

0.48

299

2157

Other disorders of bone

262

1866

1.42

6.66

2.1

1.9

193.41

198.13

pmol/l

0.33

252

1770

Autoimmune diseases related-to ILD

1069

7728

1.19

6.65

1.9

195.75

196.17

pmol/l

0.04

1018

7349

Radiculopathy

141

885

1.60

6.61

1.9

1.8

195.81

203.11

pmol/l

0.30

134

837

Trigger finger

133

825

1.62

6.55

2.0

1.8

191.50

199.88

pmol/l

0.47

121

781

Viral and other specified intestinal infections

417

3084

1.31

6.53

1.9

188.26

195.97

pmol/l

0.67

397

2963

Coxarthrosis

515

2660

1.28

6.52

2.0

1.8

191.50

198.93

pmol/l

0.94

473

2524

Hypothyroidism, strict autoimmune, 3 medication purchases required

696

3807

1.24

6.52

1.9

1.8

171.44

180.29

pmol/l

1.19

654

3582

Erosion of teeth , including avohilmo

319

2356

1.36

6.51

2.0

1.9

187.63

193.04

pmol/l

0.36

304

2246

Spermatocele

132

822

1.63

6.49

1.9

1.8

214.31

210.28

pmol/l

0.16

124

762

Other predominantly sexually transmitted diseases, not elsewhere classified

253

1799

1.42

6.49

1.9

1.8

202.25

183.97

pmol/l

1.17

233

1723

Caries of enamel

1183

7280

1.18

6.46

2.0

1.9

194.63

197.23

pmol/l

0.33

1130

6939

Urolithiasis

406

3109

1.31

6.46

1.8

1.9

186.78

199.54

pmol/l

2.21

377

2919

Mycoses

290

2112

1.38

6.45

1.9

194.70

196.54

pmol/l

0.10

278

1988

Caries of dentine

312

2237

1.37

6.43

2.1

1.9

188.31

206.46

pmol/l

2.18

289

2152

Otitis externa

255

1821

1.41

6.39

2.0

1.9

187.54

196.39

pmol/l

0.60

237

1716

Acute laryngitis and tracheitis

189

1256

1.49

6.39

1.9

1.8

188.51

203.74

pmol/l

1.16

179

1207

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1274

7457

1.17

6.38

1.9

191.71

198.19

pmol/l

1.19

1202

7104

COPD, hospital admissions

250

2942

0.71

6.38

2.1

1.8

191.01

193.89

pmol/l

0.15

223

2732

Benign lipomatous neoplasm

307

2261

1.37

6.37

2.1

1.9

190.62

197.94

pmol/l

0.66

282

2135

Acne vulgaris

130

811

1.62

6.33

2.3

1.8

170.16

197.41

pmol/l

1.45

125

775

Persons encountering health services in circumstances related to reproduction

1002

5693

1.19

6.27

1.9

205.73

205.64

pmol/l

0.01

966

5472

Paroxysmal tachycardia

261

1565

1.40

6.26

2.3

1.8

198.33

204.29

pmol/l

0.47

241

1499

Benign neoplasm: Colon, unspecified

234

1652

1.43

6.26

1.8

1.9

177.26

195.86

pmol/l

2.69

209

1541

Caries of dentine, including avohilmo

958

4093

1.20

6.25

1.9

1.8

196.63

198.54

pmol/l

0.19

890

3922

Ethmoidectomy

182

1228

1.50

6.23

2.0

1.9

205.64

200.61

pmol/l

0.24

175

1162

FESS (DNB20)

176

1181

1.51

6.20

2.0

1.9

205.83

199.66

pmol/l

0.30

169

1116

Superficial injury of lower leg

267

1932

1.39

6.19

1.9

193.47

193.16

pmol/l

0.02

250

1842

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

125

777

1.63

6.19

2.3

1.9

204.86

205.54

pmol/l

0.02

118

747

Conductive and sensorineural hearing loss

843

4729

1.21

6.14

1.9

190.27

198.01

pmol/l

1.59

799

4464

Disorders of conjunctiva

948

6409

1.19

6.14

2.0

1.9

191.76

193.99

pmol/l

0.27

899

6109

Injuries to the abdomen, lower back, lumbar spine and pelvis

444

3427

1.29

6.11

1.9

201.98

195.17

pmol/l

0.58

419

3242

Disorders of muscles

126

787

1.62

6.10

2.1

1.9

203.13

204.46

pmol/l

0.04

119

750

Lichen ruber planus, wide definition including periferal and oral lichen planus

185

1256

1.48

6.10

1.7

1.9

189.07

199.87

pmol/l

0.80

177

1186

Actinic keratosis

220

1425

1.43

6.10

1.9

1.8

187.11

188.37

pmol/l

0.07

199

1298

Primary adrenocortical insufficiency

3.46

6.08

2.2

1.8

155.90

237.19

pmol/l

1.80

Injuries to the neck

303

2246

1.36

6.08

2.1

1.9

197.93

194.48

pmol/l

0.22

281

2140

Other keratitis

154

1014

1.53

5.95

2.0

200.01

201.45

pmol/l

0.05

148

958

COPD, hospital admissions 1, only main diagnosis

161

2047

0.67

5.94

2.2

1.8

190.68

194.00

pmol/l

0.13

140

1884

Other diseases of anus and rectum

270

1967

1.38

5.93

1.9

1.8

184.33

199.53

pmol/l

1.66

251

1843

Hyperaldosteronism

148

2.48

5.92

2.6

1.6

191.77

218.96

pmol/l

0.90

133

Syncope and collapse

471

3176

1.27

5.91

1.9

1.8

191.33

194.93

pmol/l

0.28

431

2995

Calculus of kidney and ureter

378

2906

1.31

5.89

1.8

1.9

187.82

200.07

pmol/l

1.96

351

2730

Chronic laryngitis and laryngotracheitis

118

731

1.63

5.89

1.9

1.8

194.62

195.73

pmol/l

0.04

112

692

Conjunctivitis (acute, non atopic)

313

2335

1.34

5.86

1.9

1.8

193.41

191.43

pmol/l

0.12

294

2228

Dental caries

345

2518

1.33

5.86

2.1

1.8

190.01

206.51

pmol/l

2.09

320

2426

Other gastritis (incl. Duodenitis)

222

1574

1.42

5.83

2.0

1.9

182.68

200.04

pmol/l

2.30

211

1469

Other enthesopathy of foot (+metatarsalgia)

447

1.80

5.82

1.6

1.8

197.49

195.94

pmol/l

0.05

427

Skin changes due to chronic exposure to nonionizing radiation

224

1463

1.42

5.82

1.9

1.8

187.95

188.44

pmol/l

0.03

203

1333

Oxycodone

347

2383

1.32

5.81

2.1

1.8

182.27

199.09

pmol/l

2.05

328

2240

COPD, hospital admission 2, with asthma infections

157

1998

0.67

5.80

2.0

1.8

192.64

194.92

pmol/l

0.08

134

1852

Implicit viral Sepsis

208

1460

1.43

5.79

2.0

1.8

183.01

200.04

pmol/l

1.52

199

1370

Pollen allergy

229

1614

1.41

5.79

2.3

1.8

193.73

192.16

pmol/l

0.07

222

1538

Asthma, unspecified (mode), excluding more controls

562

3382

1.25

5.79

2.1

1.8

182.84

194.57

pmol/l

1.85

526

3230

Keratitis

442

3476

1.28

5.77

2.0

1.9

193.47

199.52

pmol/l

0.61

425

3309

Other disorders of the musculoskeletal system and connective tissue

155

1030

1.52

5.73

2.1

1.9

200.11

202.30

pmol/l

0.09

148

971

Atrial fibrillation and flutter

489

2511

1.27

5.70

1.9

201.05

216.72

pmol/l

3.11

466

2425

Viral infections characterized by skin and mucous membrane lesions

529

4251

1.25

5.70

2.0

1.9

197.59

196.77

pmol/l

0.06

509

4055

Injury of muscle and tendon at hip and thigh level

141

922

1.55

5.66

2.1

1.9

212.17

204.02

pmol/l

0.35

133

873

Sacrococcygeal disorders, not elsewhere classified

121

2.60

5.65

2.6

1.6

152.23

208.77

pmol/l

1.80

112

Viral Sepsis

208

1467

1.43

5.65

2.0

1.8

183.01

200.05

pmol/l

1.52

199

1377

Heart failure, strict

379

3444

0.77

5.61

1.8

1.9

180.80

197.89

pmol/l

2.43

351

3213

Autoimmune diseases excluding thyroid diseases, strict definition

1373

6544

1.15

5.59

1.9

1.8

199.66

197.37

pmol/l

0.34

1303

6236

Substance abuse

946

7569

1.18

5.59

2.0

1.9

196.65

202.45

pmol/l

0.82

873

7235

Cellulitis

300

2252

1.34

5.58

2.1

1.9

192.23

204.73

pmol/l

0.95

286

2141

Mental disorders, not otherwise specified

110

681

1.63

5.57

1.9

1.8

175.57

203.02

pmol/l

1.84

102

642

Sequelae of external causes of morbidity and mortality

251

1837

1.37

5.49

2.2

1.9

187.29

198.82

pmol/l

0.97

240

1720

Gout

303

2004

1.34

5.48

1.9

1.8

184.81

200.48

pmol/l

1.77

269

1887

Disorders of eyelid, lacrimal system and orbit

841

5378

1.19

5.46

2.0

1.9

194.85

189.91

pmol/l

0.64

785

5082

Peripheral artery disease

237

2580

0.73

5.45

1.8

172.94

195.30

pmol/l

3.09

212

2381

Fracture at wrist and hand level

564

4586

1.23

5.44

2.0

1.9

203.26

204.70

pmol/l

0.11

537

4397

Zoster [herpes zoster]

396

3047

1.28

5.41

1.9

1.8

191.47

191.18

pmol/l

0.02

378

2853

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

570

2916

1.24

5.40

2.0

1.8

186.30

206.21

pmol/l

5.11

545

2806

Other CVD

151

1011

1.50

5.38

1.9

1.8

182.89

199.41

pmol/l

1.28

141

934

Asthma, unspecified (mode)

563

3442

1.24

5.37

2.1

1.8

182.50

193.94

pmol/l

1.77

527

3287

Condition for Implicit Sepsis (Organ dysfunction codes)

1134

6750

1.16

5.36

1.9

187.33

198.69

pmol/l

3.07

1064

6433

Enlarged lymph nodes

180

1250

1.45

5.35

1.8

184.76

202.23

pmol/l

1.38

170

1180

Unspecified haematuria

478

3167

1.26

5.35

1.9

181.56

199.00

pmol/l

3.17

445

2966

Tonsillectomy and adenotomy

818

4793

1.19

5.32

1.9

193.22

195.62

pmol/l

0.24

783

4606

Covid-19 confirmed case

361

2798

1.30

5.31

1.8

185.48

191.44

pmol/l

0.46

337

2635

Striking against or struck by other objects

559

4562

1.23

5.29

2.0

1.9

205.83

203.84

pmol/l

0.17

534

4369

Provisional assignment of new diseases of uncertain etiology

566

4617

1.23

5.28

1.8

1.9

184.16

189.93

pmol/l

0.64

537

4368

Codes for special purposes

566

4620

1.23

5.25

1.8

1.9

184.16

189.90

pmol/l

0.64

537

4371

Lichen planus, including avohilmo

157

1066

1.48

5.25

1.7

1.9

184.53

200.87

pmol/l

1.36

149

1006

Sequelae of injuries of upper limb

151

1022

1.50

5.19

2.1

2.0

205.60

207.60

pmol/l

0.06

144

968

140

932

1.51

5.17

2.1

1.9

172.72

195.38

pmol/l

1.69

132

885

Cutaneous abscess, furuncle and carbuncle

368

2874

1.29

5.16

2.0

1.9

186.43

202.18

pmol/l

1.60

355

2735

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

548

1.68

5.15

1.8

1.9

166.25

197.16

pmol/l

1.61

513

Flat foot [pes planus] (acquired)

384

1.81

5.14

1.9

1.8

157.80

197.43

pmol/l

2.66

368

COPD, hospital admissions 3, with asthma pneumonia sepsis

114

1502

0.65

5.14

2.0

1.8

192.40

195.61

pmol/l

0.09

1379

Other benign neoplasms of skin

303

2305

1.32

5.14

2.0

1.9

192.53

192.74

pmol/l

0.01

279

2159

Other disorders of veins

291

2189

1.33

5.11

2.0

1.9

186.07

191.62

pmol/l

0.43

273

2052

All-cause Heart Failure

371

3340

0.78

5.11

1.8

1.9

179.67

198.02

pmol/l

2.67

343

3110

Persons encountering health services for specific procedures and health care

1397

7355

1.14

5.11

2.0

1.9

188.67

197.20

pmol/l

2.28

1314

7010

Type 2 diabetes, wide definition

958

5244

1.17

5.10

2.0

1.9

173.44

209.08

pmol/l

26.20

891

4995

Abnormal results of function studies

111

705

1.59

5.10

1.9

170.33

201.27

pmol/l

2.39

666

Other diseases of oesophagus

104

650

1.61

5.09

1.9

209.73

207.46

pmol/l

0.08

614

Postprocedural musculoskeletal disorders, not elsewhere classified

364

1.83

5.09

1.9

196.15

201.06

pmol/l

0.14

343

Early lumbar disc prolapse operation

215

1560

1.40

5.09

2.1

2.0

190.82

204.57

pmol/l

1.38

205

1492

Disorders of tooth development and eruption

200

1153

1.41

5.05

1.9

1.8

191.02

204.83

pmol/l

1.13

193

1115

Disorders of puberty

2.80

4.99

1.8

1.5

113.58

217.02

pmol/l

3.04

Mental and behavioural disorders due to use of other stimulants, including caffeine

498

1.72

4.93

2.4

1.9

195.90

219.56

pmol/l

0.57

475

Noninfective enteritis and colitis

559

4593

1.22

4.92

1.9

198.25

198.48

pmol/l

0.02

534

4373

Seborrhoeic keratosis

162

1122

1.45

4.91

2.0

1.8

209.56

195.40

pmol/l

0.62

153

1044

Assault

274

2077

1.33

4.89

1.9

205.71

207.90

pmol/l

0.11

260

1988

Other diseases of liver

206

1492

1.39

4.88

2.1

1.9

193.67

205.71

pmol/l

0.85

192

1411

Vasomotor rhinitis (mode)

414

1.76

4.85

2.1

1.8

204.64

200.54

pmol/l

0.12

391

Excessive earwax

571

4600

1.22

4.83

2.0

1.9

191.58

196.67

pmol/l

0.55

541

4331

Heart failure,strict

366

3273

0.79

4.82

1.8

1.9

180.24

200.58

pmol/l

3.16

342

3071

Inguinal hernia

1082

6281

1.16

4.82

1.9

209.99

206.86

pmol/l

0.52

1028

5984

Melanocytic naevi

284

2165

1.32

4.79

1.8

1.9

181.04

189.38

pmol/l

0.66

270

2047

Other diseases of blood and blood-forming organs, wide

218

1599

1.37

4.78

2.3

1.9

184.58

200.43

pmol/l

1.53

210

1506

Chronic periodontitis, including avohilmo

1206

7076

1.14

4.74

1.9

187.51

201.54

pmol/l

4.86

1126

6743

Benign neoplasm: Caecum

538

1.65

4.73

1.9

181.19

194.40

pmol/l

0.62

499

Other chronic obstructive pulmonary disease

251

2739

0.75

4.72

2.1

1.8

190.95

194.74

pmol/l

0.20

224

2538

Macular pucker

103

655

1.58

4.70

2.0

1.8

196.96

189.00

pmol/l

0.19

602

Urticaria

272

2067

1.32

4.69

2.1

1.8

179.96

185.76

pmol/l

0.40

254

1965

Other CVD (FINNGEN)

113

565

1.56

4.68

1.9

1.8

188.47

204.80

pmol/l

0.96

105

538

Problems related to lifestyle

170

1203

1.43

4.67

1.9

186.30

204.47

pmol/l

0.93

159

1148

Other disorders of skin and subcutaneous tissue

632

4692

1.20

4.66

1.9

1.8

182.68

192.42

pmol/l

1.29

593

4410

Chronic gastritis

188

1351

1.40

4.65

2.2

1.8

185.01

197.42

pmol/l

1.06

169

1249

Injuries to the thorax

595

4954

1.21

4.64

1.9

197.62

201.36

pmol/l

0.37

558

4698

Any dementia

1020

0.63

4.62

1.5

1.8

163.16

188.32

pmol/l

2.36

927

Unknown and unspecified causes of morbidity

443

1.71

4.61

2.3

1.9

178.37

204.46

pmol/l

1.56

419

Malignant neoplasm of prostate

312

2399

0.77

4.60

1.8

1.9

178.31

198.75

pmol/l

2.10

286

2253

240

1646

1.34

4.56

1.9

1.8

186.11

189.45

pmol/l

0.22

218

1509

Acute bronchitis

420

3316

1.25

4.55

1.9

186.82

196.70

pmol/l

1.21

392

3144

Thyrotoxicosis, other and/or unspecified

125

836

1.50

4.55

1.9

1.8

178.71

186.75

pmol/l

0.33

107

788

Other disorders of eye and adnexa

130

879

1.49

4.51

1.7

1.9

190.85

193.63

pmol/l

0.10

125

824

Benign neoplasm: Transverse colon

105

679

1.56

4.50

2.1

1.9

179.44

200.80

pmol/l

1.46

637

Primary gonarthrosis, bilateral

387

2645

1.26

4.47

2.2

1.8

189.55

194.10

pmol/l

0.42

358

2466

Other chronic obstructive pulmonary disease, including avohilmo

356

3697

0.79

4.46

2.1

1.9

191.69

195.08

pmol/l

0.25

320

3462

Other viral diseases

397

3179

1.25

4.46

2.1

1.9

198.10

195.00

pmol/l

0.23

384

3043

Retinal detachments and breaks

324

2540

1.28

4.45

1.8

1.9

201.91

195.46

pmol/l

0.55

305

2365

COPD

273

2896

0.77

4.45

2.1

1.8

190.87

195.33

pmol/l

0.25

245

2688

Pneumonia, organism unspecified

1147

7054

1.14

4.42

2.0

1.9

193.07

199.70

pmol/l

1.13

1080

6725

Nontoxic goitre/thyroid nodule

114

753

1.52

4.40

1.8

163.72

179.76

pmol/l

0.80

106

699

Adverse effects, not elsewhere classified

177

1275

1.40

4.37

1.9

1.8

176.89

186.89

pmol/l

0.51

166

1206

COPD related to multimorbidity

211

2387

0.74

4.36

2.2

1.8

182.43

193.67

pmol/l

0.90

188

2206

Malignant neoplasm of prostate, including Hilmo

345

2585

0.79

4.36

1.8

1.9

182.80

199.51

pmol/l

1.73

319

2437

Gestational diabetes (for exclusion)

113

513

1.54

4.35

1.2

16.26

18.56

pmol/l

1.22

106

472

Other systemic involvement of connective tissue (FG)

142

970

1.45

4.35

1.9

1.8

182.81

182.79

pmol/l

0.00

133

910

Solid cancers, helper endpoint

805

5534

0.86

4.32

1.9

199.98

199.52

pmol/l

0.04

763

5275

Acute pharyngitis

250

1889

1.32

4.32

2.0

1.9

189.01

192.44

pmol/l

0.19

241

1809

Periodontitis

1202

7085

1.14

4.31

1.9

187.59

201.41

pmol/l

4.72

1123

6752

Panniculitis affecting regions of neck and back

212

2.01

4.29

2.5

1.6

191.19

213.18

pmol/l

0.61

202

Thyrotoxicosis

147

1028

1.44

4.28

2.0

1.8

182.20

183.46

pmol/l

0.04

128

968

Other specified/unspecified arthritis

244

1853

1.32

4.28

1.8

186.57

192.55

pmol/l

0.45

226

1768

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

242

1814

1.32

4.27

1.9

1.8

168.43

167.74

pmol/l

0.03

231

1720

Recurrent dislocation and subluxation of joint

108

713

1.53

4.26

2.4

1.9

210.35

207.09

pmol/l

0.12

103

686

Unspecified mental disorder

559

4674

1.20

4.23

2.0

1.9

179.50

202.42

pmol/l

5.47

519

4481

Weight loss

547

1.60

4.23

2.5

1.8

197.20

199.30

pmol/l

0.05

513

Disorders of puberty, all

115

2.40

4.21

2.0

1.6

118.52

196.54

pmol/l

2.37

107

Other predominantly sexually transmitted diseases, not elsewhere classified

188

1378

1.37

4.20

1.8

1.9

188.24

188.22

pmol/l

0.00

172

1319

Hypotension

122

827

1.48

4.19

1.9

185.65

196.30

pmol/l

0.57

113

762

Malignant neoplasm

836

5728

0.86

4.19

1.9

201.60

200.04

pmol/l

0.15

790

5461

Heart failure and bmi 25plus

243

2147

0.76

4.19

1.9

2.0

175.12

193.93

pmol/l

2.09

227

2008

Olecranon bursitis

103

678

1.54

4.15

2.0

1.9

189.00

212.54

pmol/l

2.34

649

Otitis externa, unspecified

127

871

1.47

4.15

2.2

1.9

188.62

197.88

pmol/l

0.39

118

819

Abnormal weight loss

511

1.62

4.14

2.6

1.9

203.13

199.10

pmol/l

0.11

479

Ganglion

180

1315

1.38

4.10

2.1

1.8

192.63

191.38

pmol/l

0.05

171

1251

Complications of internal orthopaedic prosthetic devices, implants and grafts

161

1155

1.40

4.09

2.3

1.8

184.41

196.60

pmol/l

0.87

152

1072

Brachial plexus disorders

632

1.55

4.06

2.6

1.8

186.40

196.93

pmol/l

0.43

597

Convergence insufficiency and excess

2.82

4.06

2.2

1.7

180.53

199.00

pmol/l

0.25

Dermatitis and eczema

1382

7641

1.12

4.05

1.9

190.42

196.35

pmol/l

1.13

1312

7264

Other and unspecified drugs and medicaments

515

1.61

4.03

1.9

166.78

199.81

pmol/l

1.60

488

Misadventures to patients during surgical and medical care

125

860

1.46

4.02

2.3

1.9

195.09

199.09

pmol/l

0.16

120

806

Other viral diseases, not elsewhere classified

226

1712

1.32

4.01

1.9

199.34

196.17

pmol/l

0.17

217

1626

Stroke, including SAH

446

3926

0.82

4.00

1.8

1.9

193.90

199.48

pmol/l

0.51

407

3697

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

344

2756

1.25

4.00

2.0

1.9

169.64

186.22

pmol/l

1.58

328

2629

965

7446

1.15

4.00

2.0

1.9

197.07

202.25

pmol/l

0.82

896

7105

Gonarthrosis, primary, with knee surgery

433

2821

1.23

3.99

2.2

1.8

186.38

193.63

pmol/l

0.90

402

2627

Torsion of testis

367

1.75

3.97

1.9

1.8

202.53

232.26

pmol/l

2.01

346

Appendectomy

802

6642

1.16

3.94

2.0

1.9

192.42

197.56

pmol/l

0.78

760

6345

Suicide or other Intentional self-harm

324

2585

1.26

3.93

2.0

1.9

179.01

197.17

pmol/l

1.78

309

2469

Papulosquamous disorders

415

3403

1.22

3.89

1.8

1.9

190.50

198.70

pmol/l

0.87

387

3229

Hyperlipidaemia, other/unspecified

394

2956

1.23

3.87

2.0

1.8

181.51

202.82

pmol/l

5.73

367

2789

Stroke, excluding SAH

408

3632

0.82

3.87

1.8

1.9

193.10

198.38

pmol/l

0.55

368

3414

Cardiac murmurs and other cardiac sounds

445

1.63

3.85

2.0

1.7

201.42

190.71

pmol/l

0.17

426

Superficial injury of thorax

188

1400

1.35

3.85

1.9

192.28

204.87

pmol/l

1.04

177

1330

Fall on same level involving ice and snow

588

4984

1.18

3.84

1.9

195.53

195.87

pmol/l

0.03

548

4742

Open wound of wrist and hand

747

6309

1.16

3.84

1.9

196.70

202.68

pmol/l

0.92

714

6031

Nonalcoholic fatty liver disease

127

888

1.44

3.80

2.0

196.46

208.88

pmol/l

0.57

115

843

Spondylopathies (FG)

180

1335

1.36

3.79

2.0

1.9

202.60

204.48

pmol/l

0.09

174

1277

Other acute lower respiratory infections

629

5113

1.18

3.79

1.9

193.28

197.60

pmol/l

0.49

591

4874

Alcohol withdrawal state with delirium

959

0.60

3.78

1.7

2.0

196.58

208.63

pmol/l

0.51

910

Cholecystectomy

537

3897

1.19

3.75

1.9

1.8

180.92

187.11

pmol/l

0.71

501

3657

Carbimazole or st.post thyroidectomy, condition for graves disease

131

922

1.43

3.75

1.7

1.8

169.63

184.23

pmol/l

0.79

119

868

Other inflammation of eyelid

111

758

1.47

3.74

1.6

1.8

206.64

199.59

pmol/l

0.25

104

712

Recurrent aphthous stomatitis , including avohilmo

124

867

1.44

3.70

2.0

1.9

195.03

192.25

pmol/l

0.09

118

814

Lesion of ulnar nerve

183

1367

1.35

3.69

2.2

1.8

196.60

202.47

pmol/l

0.39

171

1299

Organic, including symptomatic, mental disorders

255

2318

0.78

3.69

1.8

177.96

195.16

pmol/l

2.53

222

2146

Special screening examination for other diseases and disorders

112

768

1.47

3.69

2.0

1.8

198.65

195.36

pmol/l

0.11

106

726

Other bursopathies

127

894

1.43

3.66

2.2

1.8

191.79

202.67

pmol/l

0.76

117

848

Intracranial injury

689

5616

1.16

3.65

1.9

200.97

195.47

pmol/l

0.58

654

5337

Polyarthrosis

548

1.53

3.63

2.0

1.7

207.63

197.49

pmol/l

0.33

518

Glaucoma, exfoliation

261

1.81

3.63

1.9

1.8

189.32

205.90

pmol/l

0.42

244

Carcinoma in situ of skin

313

1.74

3.62

1.8

241.90

196.81

pmol/l

0.82

291

Peritonsillar abscess

280

2220

1.27

3.62

1.8

1.9

196.60

196.68

pmol/l

0.00

270

2132

Cyst of kidney

437

1.62

3.58

1.6

1.9

213.91

200.42

pmol/l

0.25

408

Other and unspecified effects of external causes

306

2455

1.25

3.57

2.0

1.8

197.18

192.06

pmol/l

0.27

292

2335

Sequelae of injuries of lower limb

128

909

1.42

3.55

2.2

2.0

205.82

204.48

pmol/l

0.05

119

859

Coxarthrosis, primary

477

3381

1.20

3.55

1.9

190.19

194.30

pmol/l

0.44

438

3157

Atrial fibrillation and flutter with reimbursement

338

1736

1.24

3.51

1.8

193.87

214.78

pmol/l

3.90

318

1670

Other arthritis (FG)

291

2326

1.26

3.50

1.8

186.06

192.78

pmol/l

0.57

271

2213

Heart failure and coronary heart disease

263

2353

0.79

3.50

1.9

1.8

182.27

199.37

pmol/l

1.67

245

2187

Motorcycle rider injured in other and unspecified transport accidents

132

950

1.41

3.45

1.9

2.0

216.18

213.00

pmol/l

0.12

125

904

Certain disorders involving the immune mechanism

216

1669

1.30

3.45

2.0

1.9

192.56

203.37

pmol/l

0.87

198

1582

Disorders of mineral metabolism

570

1.52

3.40

2.2

1.8

203.17

210.55

pmol/l

0.22

544

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

481

4038

1.19

3.40

1.9

194.24

194.59

pmol/l

0.02

459

3864

Thoracic aortic aneurysm

187

1422

1.33

3.39

1.8

201.66

202.57

pmol/l

0.04

178

1328

Superficial injury of wrist and hand

247

1947

1.28

3.38

1.9

192.54

193.89

pmol/l

0.08

233

1868

Sequelae with surgical and medical care as external cause

176

1326

1.33

3.37

2.4

1.8

187.49

199.96

pmol/l

0.82

168

1239

Other systemic involvement of connective tissue

149

1094

1.37

3.36

1.9

1.8

184.35

184.77

pmol/l

0.02

139

1022

Dementia, including avohilmo

155

1433

0.74

3.33

1.7

1.8

173.82

188.35

pmol/l

1.21

133

1307

Dementia

139

1307

0.73

3.32

1.7

1.8

176.45

188.80

pmol/l

0.96

119

1194

Diabetes mellitus in pregnancy

103

449

1.47

3.30

1.3

1.2

17.74

18.02

pmol/l

0.06

411

Fasciculation

2.40

3.30

1.6

1.9

216.33

217.58

pmol/l

0.01

Neuromuscular dysfunction of bladder

648

1.48

3.28

1.9

216.78

203.51

pmol/l

0.54

613

Coxarthrosis [arthrosis of hip](FG)

518

3092

1.18

3.28

2.0

1.9

191.35

198.45

pmol/l

0.90

476

2922

Congenital malformations and deformations of the musculoskeletal system

115

809

1.42

3.27

2.1

1.9

178.90

194.43

pmol/l

0.64

104

768

In situ neoplasms

183

1392

1.32

3.27

1.6

1.8

173.12

170.35

pmol/l

0.09

164

1284

Prepatellar bursitis

529

1.54

3.26

2.1

1.9

202.45

213.58

pmol/l

0.38

506

Erectile dysfunction

103

716

1.45

3.25

1.8

1.9

229.15

200.40

pmol/l

1.23

667

Diplopia

122

873

1.41

3.25

2.2

1.8

195.75

201.30

pmol/l

0.24

117

818

Later onset COPD

943

0.67

3.24

2.0

1.7

178.86

186.99

pmol/l

0.28

849

Other/unspecified synovitis and tenosynovitis

105

732

1.44

3.24

1.9

1.8

196.14

198.18

pmol/l

0.06

695

Dermatophytosis

155

1155

1.35

3.24

1.9

189.84

204.62

pmol/l

1.10

148

1085

Abnormal findings on diagnostic imaging of lung

427

3432

1.20

3.22

1.8

1.9

187.38

196.85

pmol/l

1.34

390

3209

Overexertion and strenuous or repetitive movements

145

1073

1.36

3.19

2.0

1.9

193.82

206.05

pmol/l

0.67

139

1019

Other otitis externa (chronic)

436

1.57

3.15

2.1

1.9

200.70

199.34

pmol/l

0.03

416

Inflammatory bowel disease

412

3456

1.20

3.15

2.0

1.9

198.24

201.30

pmol/l

0.24

397

3294

Other congenital malformations

119

853

1.40

3.14

1.8

1.9

164.79

195.96

pmol/l

2.74

112

802

Persons encountering health services for specific procedures, not carried out

113

805

1.42

3.13

1.9

203.40

204.83

pmol/l

0.03

106

761

Any event in cancer register

920

6098

0.89

3.12

1.9

197.92

195.40

pmol/l

0.27

871

5809

Car occupant injured in other and unspecified transport accidents

228

1801

1.27

3.10

2.1

1.9

196.47

194.78

pmol/l

0.06

212

1719

Other bacterial intestinal infections

205

1598

1.29

3.09

2.0

1.9

197.74

199.74

pmol/l

0.10

195

1512

Other congenital malformations

550

1.50

3.09

1.9

169.26

193.40

pmol/l

1.30

518

Spondyloarthritis

210

1643

1.28

3.08

2.0

1.9

202.08

203.42

pmol/l

0.07

204

1562

Malignant neoplasm of stomach

286

0.35

3.08

1.5

1.8

172.20

209.42

pmol/l

—

265

Benign neoplasm of mouth and pharynx

108

766

1.42

3.06

1.8

1.9

183.74

201.36

pmol/l

0.93

100

724

Systemic connective tissue disorders

205

1601

1.28

3.04

1.9

1.8

185.91

185.64

pmol/l

0.01

191

1490

Primary amenorrhea

5.95

3.04

1.1

1.0

11.00

21.25

pmol/l

—

Fibroblastic disorders

194

1507

1.29

3.01

2.0

1.8

206.30

195.81

pmol/l

0.53

180

1417

Epileptic seizures related to alcohol

0.00

3.01

0.0

1.9

—

246.22

—

Degenerative diseases of the nervous system

986

0.70

2.99

1.5

1.8

164.36

190.60

pmol/l

2.63

898

Coxarthrosis, primary, with hip surgery

335

2590

1.21

2.98

2.0

1.9

191.26

193.51

pmol/l

0.16

311

2413

Other bacterial diseases

1261

7241

1.11

2.97

2.0

1.9

188.07

201.14

pmol/l

3.90

1184

6905

Other disorders of bladder

127

933

1.37

2.94

2.5

1.9

196.61

200.64

pmol/l

0.16

113

875

Other medical care

263

2915

0.81

2.94

2.0

1.8

183.99

195.03

pmol/l

0.92

249

2713

Traumatic subdural haemorrhage

668

1.43

2.93

1.7

215.42

214.25

pmol/l

0.02

624

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

140

1045

1.35

2.92

2.1

1.9

189.03

199.82

pmol/l

0.59

131

992

Primary coxarthrosis, bilateral

192

1496

1.29

2.92

2.0

1.9

193.89

196.31

pmol/l

0.12

178

1397

Lichen planus

648

1.44

2.91

1.5

1.9

180.40

203.60

pmol/l

1.50

612

Open wound of forearm

130

961

1.36

2.91

1.9

2.0

188.62

206.00

pmol/l

0.69

124

908

Ischaemic Stroke, excluding all haemorrhages

376

3334

0.84

2.91

1.8

1.9

195.49

197.21

pmol/l

0.13

342

3120

Need for other prophylactic measures

486

1.52

2.90

1.8

1.9

199.10

213.23

pmol/l

0.63

462

Fracture of rib(s), sternum and thoracic spine

361

3018

1.20

2.90

2.0

1.9

198.60

201.36

pmol/l

0.17

335

2856

Phlebitis and thrombophlebitis (not including DVT)

203

1597

1.28

2.88

2.1

1.9

189.93

200.59

pmol/l

0.72

194

1497

Deep bite

114

722

1.39

2.88

1.9

1.8

189.51

188.27

pmol/l

0.04

108

688

Injury of muscle and tendon at forearm level

223

1.79

2.87

2.2

1.9

200.44

216.23

pmol/l

0.20

215

Other spirochaetal diseases

272

2213

1.23

2.87

1.9

206.69

197.00

pmol/l

0.82

256

2080

Retention of urine

340

2316

1.21

2.87

1.9

177.98

195.44

pmol/l

2.35

311

2147

Nail disorders

102

726

1.42

2.87

1.8

1.9

196.43

210.30

pmol/l

0.53

690

Nausea and vomiting

203

1565

1.27

2.85

1.7

1.8

173.21

191.16

pmol/l

1.58

189

1479

Transient ischemic attack

432

2966

1.18

2.84

1.8

189.17

195.45

pmol/l

0.67

409

2763

Superficial injury of abdomen, lower back and pelvis

171

1319

1.30

2.84

1.8

1.9

197.72

199.64

pmol/l

0.07

163

1247

Infection of intervertebral disc (pyogenic)

2.28

2.84

2.1

1.6

177.35

237.61

pmol/l

1.67

Psoriatic arthropathies

113

820

1.39

2.83

1.8

205.67

206.46

pmol/l

0.02

103

782

Atopic dermatitis, strict definition with reimbursement

325

2605

1.21

2.80

1.9

1.8

192.20

184.90

pmol/l

0.50

303

2482

D07AA Corticosteroids, weak (group I)

154

1172

1.32

2.79

1.8

1.9

177.08

190.05

pmol/l

0.87

138

1112

Any dementia, excluding more controls

896

0.70

2.79

1.6

1.7

163.23

191.95

pmol/l

2.79

828

Ischaemic heart disease, wide definition

922

5103

1.12

2.79

1.9

195.55

204.48

pmol/l

1.75

871

4849

Assault by bodily force

153

1169

1.32

2.78

2.1

2.0

206.84

211.10

pmol/l

0.14

147

1120

Arthropod-borne viral fevers and viral haemorrhagic fevers

197

1552

1.28

2.78

1.9

183.43

201.73

pmol/l

1.87

185

1460

Emotional disorders starting during childhood or adolecense, excluding more controls

263

1.68

2.76

2.3

1.5

122.64

178.19

pmol/l

1.95

251

Failure and rejection of transplanted organs and tissues

139

2.00

2.75

1.6

2.0

201.37

230.47

pmol/l

0.81

131

Thyroiditis

255

1.70

2.74

2.4

1.8

154.62

185.05

pmol/l

1.01

237

Viral warts

110

800

1.38

2.74

2.1

1.9

216.74

200.10

pmol/l

0.52

105

752

Psoriasis

322

2680

1.21

2.74

1.9

195.35

200.05

pmol/l

0.33

301

2545

Use of disulfiram, acamprosate or naltrexone

176

1374

1.29

2.74

1.9

2.0

192.78

210.47

pmol/l

1.95

169

1314

Sulfonylureas

164

1685

0.77

2.73

1.9

1.8

169.44

198.46

pmol/l

3.15

147

1554

Polyarthropathies

750

4332

1.13

2.73

1.9

1.8

190.55

196.35

pmol/l

0.77

682

4153

Epilepsy

287

2355

1.22

2.72

2.0

1.8

184.69

204.10

pmol/l

2.73

270

2231

Other skin changes

138

1040

1.33

2.72

1.7

1.8

188.58

195.41

pmol/l

0.37

128

971

Cerebrovascular diseases

597

4795

0.87

2.71

1.8

1.9

192.76

198.87

pmol/l

0.77

557

4523

Other and unspecified mononeuropathies of upper limb

242

1.72

2.70

1.6

1.8

225.83

207.29

pmol/l

0.37

229

Other specified/unspecified spondylopathies

2.20

2.68

2.1

1.6

205.35

218.71

pmol/l

0.14

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

112

1511

0.74

2.66

1.8

1.9

188.93

203.72

pmol/l

0.93

107

1426

Strabismus

257

2093

1.23

2.66

1.8

1.9

184.25

193.58

pmol/l

0.69

242

1990

Oral lichen planus, including avohilmo , including avohilmo

273

1.66

2.65

2.0

1.9

213.60

205.63

pmol/l

0.20

257

Other spirochaetal diseases

266

2183

1.22

2.62

1.9

205.80

197.32

pmol/l

0.68

250

2052

Implicit Sepsis

944

6208

1.11

2.60

2.0

1.9

183.62

198.71

pmol/l

4.88

874

5908

Other strabismus

216

1730

1.25

2.59

1.8

1.9

184.31

191.24

pmol/l

0.40

204

1646

Stomatitis and related lesions

186

1470

1.27

2.59

2.1

1.9

194.63

197.94

pmol/l

0.15

176

1398

All kidney diseases

1126

6986

1.10

2.58

1.8

1.9

182.58

193.78

pmol/l

2.95

1057

6652

Event of undetermined intent

717

1.40

2.57

2.2

1.9

186.01

212.45

pmol/l

1.89

681

Glucosamine medication

245

1590

1.23

2.55

2.0

1.8

195.46

192.85

pmol/l

0.16

227

1463

Alcohol use disorder, Swedish definition

872

7186

1.12

2.55

2.0

1.9

198.67

203.25

pmol/l

0.64

808

6852

Venous thromboembolism

465

3878

1.16

2.55

2.1

1.9

186.55

195.97

pmol/l

1.23

438

3631

Lyme disease

262

2155

1.22

2.54

1.9

206.00

197.12

pmol/l

0.72

246

2026

Pruritus

443

1.50

2.54

2.0

1.8

172.86

182.67

pmol/l

0.32

413

Early onset COPD

172

2176

0.79

2.53

2.2

1.8

195.78

199.60

pmol/l

0.16

160

2045

Disorders of psychological development

159

1146

1.29

2.52

2.1

1.8

177.29

208.27

pmol/l

2.08

151

1098

Other disorders of binocular movement

129

1.96

2.52

1.9

1.7

186.48

192.09

pmol/l

0.09

119

Pilonidal cyst

178

1409

1.28

2.50

2.1

2.0

185.82

212.32

pmol/l

2.60

169

1345

Heterophoria

494

1.47

2.50

1.8

180.66

189.07

pmol/l

0.19

463

Uterine polyps

3.47

2.48

1.4

29.33

15.00

pmol/l

—

Localized swelling, mass and lump of skin and subcutaneous tissue

290

2416

1.20

2.47

1.9

192.77

194.17

pmol/l

0.08

269

2277

Injury of eye and orbit

239

1958

1.23

2.46

1.8

1.9

203.57

204.55

pmol/l

0.06

223

1873

Endometriosis of pelvic peritoneum

2.07

2.46

1.0

1.3

20.90

17.99

pmol/l

0.19

Myocardial infarction

426

3478

0.86

2.45

1.8

1.9

192.85

203.06

pmol/l

1.36

405

3281

Kela-code for behavioural disturbances in mental retardation

0.00

2.45

0.0

1.7

—

251.79

—

Atopic dermatitis

659

4787

1.13

2.43

1.9

193.69

193.05

pmol/l

0.04

631

4572

Residual foreign body in soft tissue

524

1.45

2.41

2.0

1.9

209.48

209.93

pmol/l

0.01

502

Psoriasis vulgaris

227

1854

1.23

2.40

1.8

1.9

187.88

202.97

pmol/l

1.48

213

1756

All influenza

311

2617

1.19

2.39

2.0

1.9

196.81

201.20

pmol/l

0.30

289

2485

Injury of muscle and tendon at lower leg level

226

1849

1.23

2.37

1.8

1.9

202.79

206.60

pmol/l

0.26

219

1761

Diseases of the digestive system

425

3653

1.16

2.36

1.8

1.9

194.55

194.20

pmol/l

0.02

392

3432

Viral haemorrhagic fevers, not elsewhere classified/unspecified

169

1337

1.27

2.36

1.8

1.9

181.96

200.90

pmol/l

1.72

159

1261

Spirochaetal infections, other/unspecified

262

2175

1.21

2.34

1.9

206.00

196.97

pmol/l

0.74

246

2045

AV-block

140

947

1.30

2.34

1.7

1.8

180.28

202.60

pmol/l

2.12

130

878

Budesonide

149

1163

1.29

2.34

1.8

1.9

200.07

200.26

pmol/l

0.01

143

1094

Viral meningitis

316

1.57

2.32

2.8

1.8

207.29

211.14

pmol/l

0.08

299

Gout, FINNGEN

303

2546

1.19

2.31

1.9

1.8

184.81

196.82

pmol/l

1.21

269

2378

Fracture of lumbar spine and pelvis

167

1321

1.27

2.31

1.8

1.9

191.03

198.89

pmol/l

0.40

155

1234

Immunodeficiencies

285

1.59

2.29

2.1

1.9

186.89

209.11

pmol/l

0.72

271

Malignant neoplasm, wide definition for exclusion

936

6051

0.91

2.29

1.9

203.64

199.72

pmol/l

0.50

888

5770

Intestinal malabsorption

358

1.52

2.26

1.5

1.9

235.93

205.96

pmol/l

0.66

342

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

631

1.39

2.26

2.1

1.9

167.40

197.27

pmol/l

1.85

591

Myocardial infarction, unclassifiable

1122

0.74

2.26

1.7

1.8

174.17

195.38

pmol/l

1.57

1027

Schizophrenia or delusion, excluding more controls

383

3265

1.16

2.25

1.9

1.8

183.82

208.95

pmol/l

3.29

356

3157

Inflammatory diseases of female pelvic organs

110

604

1.34

2.25

1.1

1.2

16.26

18.82

pmol/l

0.84

102

558

Disorders of calcium metabolism

334

1.54

2.25

2.2

1.7

196.71

204.93

pmol/l

0.20

317

Kela-code for severe mental illness

492

4315

1.14

2.25

2.0

1.9

179.69

204.51

pmol/l

5.51

455

4140

Other peripheral vertigo

415

1.48

2.24

1.7

2.0

189.02

195.12

pmol/l

0.18

393

Peripheral artery operations in Hilmo

856

0.69

2.22

2.2

1.9

174.75

202.38

pmol/l

1.09

795

Stenosis and insufficiency of lacrimal passages

359

1.51

2.22

2.6

1.8

211.57

196.27

pmol/l

0.49

336

Hallux valgus (acquired)

152

856

1.28

2.22

1.8

1.7

184.52

186.37

pmol/l

0.07

140

806

Secondary hypertension

677

1.37

2.20

1.9

1.8

183.80

215.23

pmol/l

2.52

643

Other disorders of optic [2nd] nerve and visual pathways

393

1.49

2.19

2.2

1.9

173.32

201.63

pmol/l

1.18

373

Diabetic nephropathy, excluding more controls

115

1234

0.76

2.19

1.7

2.0

179.12

171.69

pmol/l

0.35

110

1156

Central nervous system disorder causing precocious puberty

4.48

2.18

2.8

1.1

91.83

184.50

pmol/l

—

Non-ischemic cardiomyopathy

176

1757

0.80

2.18

1.8

1.9

172.48

200.21

pmol/l

4.27

163

1629

Effects of foreign body entering through natural orifice

394

3414

1.16

2.17

1.9

199.47

205.50

pmol/l

0.54

373

3256

Personal history of certain other diseases

101

2.01

2.17

1.8

1.6

186.95

178.13

pmol/l

0.13

5-aminosalicylic acid

281

2369

1.19

2.17

2.0

1.9

205.15

199.80

pmol/l

0.35

269

2252

Sarcoidosis

143

1124

1.28

2.15

2.1

1.9

192.15

205.57

pmol/l

0.84

132

1066

Peripheral arterial reconstruction

967

0.71

2.14

1.8

1.9

170.24

196.56

pmol/l

1.36

883

Diagnoses used for exclusion with ILD

245

2042

1.20

2.14

2.1

1.9

191.46

200.98

pmol/l

0.80

225

1917

Ankylosing spondylitis

116

889

1.31

2.13

1.9

1.8

207.12

209.71

pmol/l

0.10

111

848

Other diseases of stomach and duodenum

347

1.51

2.12

1.8

1.9

183.74

205.36

pmol/l

0.88

328

Melanocytic naevi of trunk

113

863

1.32

2.12

1.8

1.9

187.73

198.24

pmol/l

0.48

106

810

Other and unspecified urticaria

159

1268

1.26

2.12

2.1

1.9

178.15

188.66

pmol/l

0.67

147

1195

Suppurative and unspecified otitis media

482

3755

1.14

2.11

1.8

1.9

192.55

193.78

pmol/l

0.08

456

3600

Pediculosis, acariasis and other infestations

200

1638

1.23

2.10

1.9

188.79

196.07

pmol/l

0.50

193

1557

Carcinoma in situ of skin of other and unspecified parts of face

236

1.62

2.10

1.9

1.8

228.79

196.03

pmol/l

0.32

218

Childhood asthma (age<16), excluding more controls

185

1180

1.24

2.10

1.9

1.8

186.85

190.01

pmol/l

0.13

179

1144

Childhood asthma (age<16)

185

1181

1.24

2.10

1.9

1.8

186.85

190.34

pmol/l

0.15

179

1145

Cardiodefibrillation

349

2997

1.17

2.09

1.9

1.8

196.01

197.38

pmol/l

0.10

319

2796

Acute pancreatitis

230

1912

1.21

2.08

1.9

195.39

202.67

pmol/l

0.53

215

1806

Aortic aneurysm

249

2045

1.20

2.08

1.9

198.31

198.01

pmol/l

0.02

239

1886

Psoriatic and enteropathic arthropathies

132

1033

1.28

2.07

1.8

1.9

205.87

205.59

pmol/l

0.01

121

984

Primary open-angle glaucoma

167

1297

1.25

2.07

1.8

193.84

193.52

pmol/l

0.01

150

1200

Polypectomy (DHB20)

720

1.35

2.07

1.9

192.66

205.79

pmol/l

0.65

682

Other bursitis of knee

132

1.86

2.07

1.7

1.8

182.62

211.12

pmol/l

0.71

126

Abnormal spermatozoa

165

1328

1.25

2.07

2.5

1.8

196.36

200.59

pmol/l

0.22

159

1227

Medical abortion

520

0.71

2.06

1.3

1.2

14.67

19.36

pmol/l

2.57

482

Ulcerative colitis

308

2632

1.17

2.04

1.9

198.87

201.69

pmol/l

0.20

299

2509

Diseases of the myoneural junction and muscle

119

921

1.30

2.04

1.9

219.89

203.03

pmol/l

0.51

110

875

Early syphilis

209

1.67

2.03

1.9

228.76

221.82

pmol/l

0.13

198

Other disorders of kidney and ureter

121

939

1.30

2.03

1.6

1.9

196.62

202.16

pmol/l

0.16

114

886

Other infective otitis externa

400

1.46

2.03

1.9

1.8

176.09

205.39

pmol/l

1.09

380

Colorectal cancer

119

1493

0.78

2.03

1.7

1.8

195.68

196.45

pmol/l

0.03

112

1397

Necrosis of pulp, including avohilmo

745

6723

1.11

2.02

2.0

1.9

191.11

198.98

pmol/l

1.34

712

6415

Adenocarcinoma and ductal carcinoma of pancreas

145

0.34

2.02

1.4

2.0

214.40

208.29

pmol/l

—

136

Oral lichen planus

2.02

2.01

1.4

2.0

223.44

223.21

pmol/l

0.00

ILD medications: azathioprine

174

1413

1.24

2.00

1.9

190.78

201.19

pmol/l

0.84

162

1336

Gout, unspecified

215

1784

1.21

2.00

2.0

1.8

180.97

199.35

pmol/l

2.13

189

1664

Inguinal or femoral hernia, bilateral

144

1146

1.26

2.00

1.7

1.9

210.95

205.25

pmol/l

0.29

133

1071

Benign lipomatous neoplasm of other sites/unspecified

485

1.41

1.99

2.1

1.9

178.08

202.28

pmol/l

1.20

461

Acute suppurative otitis media

372

3016

1.15

1.98

1.8

1.9

195.21

194.44

pmol/l

0.04

354

2897

Scabies

171

1389

1.24

1.97

1.9

188.67

196.87

pmol/l

0.54

165

1317

Atopic dermatitis, strict definition

298

2496

1.17

1.96

1.8

191.16

180.93

pmol/l

0.74

278

2386

Fracture of lower leg, including ankle

598

5304

1.12

1.96

1.9

186.99

201.14

pmol/l

2.82

560

5065

Orthopaedic devices associated with adverse incidents

2.21

1.95

2.3

1.8

168.79

210.05

pmol/l

0.90

Precocious puberty

4.63

1.95

1.0

1.1

23.00

166.64

pmol/l

—

Fall on and from ladder

109

841

1.31

1.95

2.1

1.9

195.04

207.60

pmol/l

0.63

101

794

Inguinal hernia, bilateral

143

1141

1.26

1.95

1.7

1.9

211.23

205.27

pmol/l

0.30

132

1066

Galactorrhea

4.59

1.94

1.0

1.2

22.20

18.36

pmol/l

—

Myocardial infarction, strict

407

3307

0.87

1.93

1.7

1.9

192.11

202.93

pmol/l

1.55

387

3115

Conduction disorders

258

1766

1.19

1.93

1.9

1.8

183.11

200.86

pmol/l

2.42

240

1639

895

7402

1.09

1.92

1.9

197.56

202.37

pmol/l

0.68

828

7064

Acute tubulo-interstitial nephritis

450

3421

1.14

1.92

1.8

166.52

178.15

pmol/l

1.40

420

3191

Acute pancreatitis (for exclusion)

230

1930

1.20

1.91

1.9

195.39

203.02

pmol/l

0.56

215

1831

Maxillary retrognathism

143

1.77

1.91

2.3

1.8

190.88

208.05

pmol/l

0.36

136

Premature rupture of membranes

375

0.63

1.91

1.2

16.18

18.22

pmol/l

0.56

346

Implicit Sepsis

827

5683

1.10

1.90

2.0

1.9

181.17

198.19

pmol/l

5.29

768

5395

Other maternal disorders predominantly related to pregnancy

107

512

1.31

1.90

1.3

1.2

18.20

18.32

pmol/l

0.02

102

468

Early syphilis

190

1.68

1.90

1.8

1.9

239.81

221.83

pmol/l

0.38

182

Fracture of skull and facial bones

316

2726

1.16

1.89

1.8

1.9

203.89

205.23

pmol/l

0.08

303

2609

Abnormalities of gait and mobility

661

1.34

1.89

1.7

1.8

170.23

196.14

pmol/l

1.71

619

Chondropathies

177

1451

1.23

1.89

2.1

1.9

201.54

200.67

pmol/l

0.04

171

1375

Fitting and adjustment of other devices

249

1900

1.19

1.87

1.8

190.41

193.87

pmol/l

0.25

230

1753

Fall on and from stairs and steps

238

2008

1.19

1.86

1.9

182.62

197.29

pmol/l

1.41

220

1903

Coronary atherosclerosis

737

4226

1.11

1.86

1.9

197.00

205.04

pmol/l

1.25

696

4006

Procedures for purposes other than remedying health state

1.99

1.85

1.3

2.0

172.24

197.24

pmol/l

0.37

Disorder of lipoprotein metabolism, unspecified

119

935

1.28

1.85

1.7

1.8

173.76

207.95

pmol/l

2.68

111

877

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

523

1.35

1.83

1.2

17.68

17.85

pmol/l

0.05

481

Arthropod-borne viral fevers and viral haemorrhagic fevers

121

955

1.28

1.83

1.9

185.62

204.93

pmol/l

1.54

116

907

Combinations of oral blood glucose lowering drugs

329

2855

1.16

1.83

1.9

1.8

177.00

205.68

pmol/l

6.51

301

2703

Amblyopia ex anopsia

238

1.57

1.82

1.9

1.8

193.11

198.42

pmol/l

0.08

228

Burns and corrosions confined to eye and internal organs

328

1.49

1.82

1.6

2.0

196.12

213.25

pmol/l

0.52

312

Status post-ami

173

1602

0.82

1.81

1.7

1.8

184.57

199.38

pmol/l

1.25

167

1473

Condition for Implicit Sepsis (Organ dysfunction codes)

996

6472

1.09

1.81

2.0

1.9

186.94

198.96

pmol/l

3.03

927

6166

Other diseases of intestine

123

974

1.27

1.80

2.0

1.8

185.30

203.57

pmol/l

1.28

112

913

Azathioprine

174

1434

1.22

1.78

1.9

190.78

202.39

pmol/l

0.98

162

1356

Lipomatosis, not elsewhere classified

3.47

1.77

1.0

2.6

154.67

243.44

pmol/l

—

ILD medications: immunosuppressive drugs

739

6259

1.10

1.75

1.9

196.77

197.89

pmol/l

0.11

706

5954

Colorectal adenocarcinoma

1255

0.78

1.74

1.8

197.33

198.26

pmol/l

0.03

1174

Presence of other functional implants

449

2760

1.13

1.74

2.0

1.9

190.12

193.93

pmol/l

0.29

428

2553

Myocardial infarction, with ST-elevation

112

1413

0.79

1.73

1.7

1.9

195.87

199.97

pmol/l

0.19

103

1304

Angina pectoris

586

3516

1.11

1.72

1.9

190.70

202.62

pmol/l

1.82

555

3317

Vestibular neuronitis

585

1.34

1.72

2.5

1.9

204.25

202.50

pmol/l

0.06

550

Ulcerative proctitis

551

1.35

1.72

1.9

206.97

202.93

pmol/l

0.11

518

Benign neoplasm: Lip

118

1.80

1.71

2.4

1.8

191.10

224.54

pmol/l

0.67

111

Viral and other specified intestinal infections

289

2439

1.16

1.71

2.0

1.9

196.63

196.86

pmol/l

0.01

274

2347

Acute alcohol intoxication, ICD10

238

2785

0.85

1.70

1.9

191.98

203.04

pmol/l

0.99

220

2660

Dialysis, with operation codes

105

1330

0.79

1.69

1.5

1.9

181.35

208.66

pmol/l

2.35

1253

Superficial injury of head

235

2000

1.18

1.69

2.0

1.9

196.16

198.24

pmol/l

0.11

219

1899

Bilateral cryptorchidism (undescended testicles)

2.97

1.69

4.9

1.6

191.43

241.68

pmol/l

—

Diseases of liver

367

3229

1.14

1.69

1.9

192.46

201.20

pmol/l

0.89

343

3058

Abnormal blood-pressure reading, without diagnosis

243

1.53

1.68

2.1

1.7

228.38

210.10

pmol/l

0.52

231

Separation of retinal layers (serosa)

477

1.38

1.68

1.8

1.9

196.78

210.94

pmol/l

0.76

453

Superficial injury of forearm

105

824

1.28

1.68

2.0

1.9

175.69

197.08

pmol/l

1.49

784

Scissor bite

155

1.68

1.67

2.3

1.7

181.73

169.70

pmol/l

0.25

148

Emotional disorders and disorders of social functioning with onset specific to childhood

336

1.44

1.66

2.2

1.6

127.02

176.54

pmol/l

1.86

320

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

212

1.57

1.66

1.9

1.8

182.48

198.65

pmol/l

0.37

198

Injuries to the elbow and forearm

715

5738

1.10

1.66

1.9

197.06

194.76

pmol/l

0.21

670

5471

Cluster headache, strict

277

1.49

1.65

1.9

1.7

180.34

217.65

pmol/l

1.38

263

Other complications of surgical and medical care, not elsewhere classified

573

1.33

1.63

1.9

181.00

194.09

pmol/l

0.41

537

Gout, idiopatic and unspecified

257

2212

1.17

1.63

2.0

1.9

186.48

197.92

pmol/l

1.03

227

2061

Maternal care related to the fetus and amniotic cavity and possible delivery problems

476

0.73

1.62

1.2

14.93

18.90

pmol/l

2.37

439

Nonsuppurative otitis media

262

1952

1.16

1.62

2.0

1.8

194.67

186.14

pmol/l

0.46

249

1858

Iridocyclitis

225

1917

1.18

1.62

2.1

1.9

192.38

199.90

pmol/l

0.49

217

1816

Cholecystitis

104

822

1.27

1.58

2.1

1.9

188.79

198.05

pmol/l

0.43

766

525

1.33

1.57

1.8

189.75

182.25

pmol/l

0.28

477

Other and unspecified iron deficiency

210

1784

1.18

1.56

2.1

1.8

184.95

185.14

pmol/l

0.01

200

1650

Effects of other deprivation

3.46

1.54

4.0

2.5

242.80

274.40

pmol/l

—

Supervision of normal pregnancy

264

0.65

1.54

1.1

1.3

15.00

21.43

pmol/l

2.51

241

Convulsions, not elsewhere classified

290

2499

1.15

1.54

2.0

1.8

197.46

199.28

pmol/l

0.09

279

2379

Bell's palsy

109

871

1.26

1.53

1.7

1.9

201.25

201.40

pmol/l

0.01

102

825

Iron deficiency anaemia

273

2338

1.15

1.52

2.3

1.8

188.15

185.68

pmol/l

0.15

260

2171

Adenocarcinoma and papillary adenocarcinoma of stomach

144

0.41

1.52

1.2

2.1

192.83

223.16

pmol/l

—

134

STROKE

628

3890

1.10

1.51

1.9

195.36

206.38

pmol/l

1.77

593

3704

Congenital malformations of the urinary system

452

1.36

1.50

1.5

1.9

175.02

202.56

pmol/l

1.21

426

Other blood glucose lowering drugs, excl. Insulins

126

1026

1.23

1.50

1.9

174.91

203.46

pmol/l

2.48

117

971

Other disorders of conjunctiva

103

820

1.26

1.49

1.9

186.83

199.60

pmol/l

0.73

774

Corns and callosities

444

1.36

1.49

2.2

1.9

178.09

201.93

pmol/l

1.22

419

Ulcerative colitis (strict definition, all Crohn cases excluded)

191

1621

1.18

1.48

1.9

199.02

203.54

pmol/l

0.26

185

1541

Mild mental retardation

229

0.52

1.48

3.0

1.8

142.08

219.34

pmol/l

2.07

216

Burn and corrosion confined to eye and adnexa

285

1.46

1.48

1.6

1.9

196.17

213.31

pmol/l

0.44

271

Bacterial, viral and other infectious agents

147

1220

1.21

1.47

1.9

2.0

208.93

207.26

pmol/l

0.07

141

1167

Arthropathic psoriasis

122

993

1.23

1.47

1.8

1.9

205.89

204.55

pmol/l

0.04

112

938

Other disorders of Eustachian tube

171

1.59

1.47

2.6

1.7

163.00

207.95

pmol/l

1.85

162

Maternal care for cervical incompetence

2.38

1.45

1.6

1.1

17.44

15.87

pmol/l

—

Dilated cardiomyopathy

1158

0.79

1.45

1.6

1.9

202.55

207.33

pmol/l

0.23

1086

COPD-related respiratory insufficiency

672

0.73

1.44

2.1

1.8

159.82

196.55

pmol/l

1.78

624

Ventral hernia

187

1589

1.18

1.43

2.1

1.8

185.19

197.94

pmol/l

0.89

174

1483

Sequelae of injuries of head

614

1.30

1.42

2.1

1.9

192.22

210.50

pmol/l

0.80

586

Other hearing loss

165

1357

1.19

1.42

2.0

1.8

186.16

196.33

pmol/l

0.68

157

1256

Glaucoma suspect

226

1951

1.16

1.41

1.8

179.77

194.25

pmol/l

1.54

206

1822

Acute alcohol intoxication

289

3281

0.88

1.41

1.8

1.9

190.20

203.64

pmol/l

1.44

266

3122

Pregnancy hypertension

509

1.30

1.41

1.3

1.2

17.40

17.93

pmol/l

0.15

470

Injuries to the hip and thigh

430

3503

1.11

1.40

2.0

1.9

203.74

197.00

pmol/l

0.51

410

3298

Disorders of optic nerve and visual pathways

597

1.30

1.40

2.1

1.9

168.32

196.75

pmol/l

1.58

558

Congenital malformations and deformations of the musculoskeletal system

638

1.28

1.39

2.2

1.9

176.36

194.00

pmol/l

0.52

604

Benign neoplasm of bone and articular cartilage

678

1.28

1.38

2.0

1.9

195.81

204.69

pmol/l

0.33

640

Asymptomatic human immunodeficiency virus [HIV] infection status

113

1.75

1.37

2.5

1.8

235.37

223.30

pmol/l

0.26

107

Anxious personality disorder

199

1.53

1.36

2.1

1.8

191.87

227.57

pmol/l

1.07

191

Use of riluzole

0.00

1.36

0.0

1.7

—

255.09

—

Injury of nerves at shoulder and upper arm level

1.81

1.35

1.6

2.0

236.06

222.53

pmol/l

0.15

Primary open-angle glaucoma, strict

130

1073

1.21

1.34

1.9

1.8

184.99

195.01

pmol/l

0.50

117

992

Sequelae of other and unspecified infectious and parasitic diseases

602

1.29

1.34

2.2

1.9

208.31

209.67

pmol/l

0.03

569

Seropositive rheumatoid arthritis, wide

101

1246

0.81

1.34

2.0

1.8

198.55

195.42

pmol/l

0.13

1171

Erectile dysfunction, exclusion

0.00

1.33

0.0

1.6

—

242.89

—

Other/unspecified seropositive rheumatoid arthritis

1223

0.81

1.33

2.0

1.8

199.09

195.25

pmol/l

0.16

1150

Insulin, fast-acting

447

4046

1.11

1.32

1.7

1.9

193.21

202.79

pmol/l

1.10

413

3844

Acute and subacute iridocyclitis

194

1667

1.17

1.32

2.1

1.9

189.99

203.39

pmol/l

0.96

187

1577

L02BB Anti-androgens

592

0.72

1.32

1.8

104.91

196.30

pmol/l

4.97

542

Cluster headache, strict, including avohilmo

463

1.33

1.32

1.8

1.9

184.25

205.08

pmol/l

0.90

440

Use of levodopa decarboxylase inhibitor

647

1.27

1.31

1.6

1.9

195.75

195.69

pmol/l

0.00

594

COPD (mode)

206

1872

0.86

1.31

2.2

1.8

187.45

196.45

pmol/l

0.51

182

1758

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

453

1.32

1.30

1.7

1.9

198.62

192.68

pmol/l

0.21

411

Alzheimer disease

618

0.77

1.30

1.5

1.8

165.46

188.66

pmol/l

1.60

556

IBD patients in KELA-register

305

2708

1.13

1.30

1.9

203.10

201.80

pmol/l

0.08

293

2585

Amputation of foot

172

0.52

1.30

3.4

2.0

158.44

215.81

pmol/l

—

162

All dysplastic lesions of the cervix uteri, vagina or vulva

439

1.33

1.30

1.2

18.33

17.72

pmol/l

0.13

403

Constitutional tall stature

2.82

1.29

1.0

1.4

99.40

217.33

pmol/l

—

Endometriosis of rectovaginal septum and vagina

2.36

1.29

1.3

29.13

14.07

pmol/l

—

Pedal cyclist injured in transport accident

266

2344

1.14

1.28

2.0

1.9

200.86

200.53

pmol/l

0.02

252

2236

Supervision of high-risk pregnancy

245

1.35

1.28

1.3

15.30

21.56

pmol/l

2.65

223

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

213

1849

1.16

1.28

1.9

203.67

202.53

pmol/l

0.06

206

1759

Sequelae of infectious and parasitic diseases

659

1.27

1.28

2.2

1.9

204.69

207.99

pmol/l

0.09

625

Diseases of arteries, arterioles and capillaries (FINNGEN)

307

1884

1.13

1.28

1.9

1.8

196.30

215.39

pmol/l

2.71

291

1816

L04AX Other immunosuppressants

556

5095

1.09

1.28

2.0

1.9

196.67

195.92

pmol/l

0.06

528

4840

Type of accident

317

2826

1.12

1.27

1.9

205.00

196.31

pmol/l

0.67

308

2694

Schizoaffective disorder

750

1.25

1.26

1.8

2.0

170.71

210.06

pmol/l

2.32

706

Bacterial, viral and other infectious agents

140

1178

1.20

1.26

2.0

209.90

207.73

pmol/l

0.09

134

1127

Injuries to unspecified part of trunk, limb or body region

786

1.24

1.26

1.9

177.91

200.94

pmol/l

1.31

741

Other noninfective gastroenteritis and colitis

204

1767

1.16

1.25

1.9

192.20

197.99

pmol/l

0.34

194

1676

Foreign body on external eye

292

2599

1.13

1.23

1.8

1.9

201.58

207.24

pmol/l

0.51

278

2488

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

1211

0.82

1.23

2.0

1.8

199.09

194.26

pmol/l

0.20

1138

Palmar fascial fibromatosis [Dupuytren]

126

1051

1.20

1.23

2.0

1.8

218.44

198.52

pmol/l

0.77

114

986

Diabetic nephropathy

115

1366

0.83

1.23

1.7

1.9

179.12

172.70

pmol/l

0.29

110

1267

Thiazolidinediones

101

825

1.23

1.22

2.2

1.9

168.32

204.71

pmol/l

3.06

781

Polycythaemia vera

188

1.50

1.22

2.1

1.9

193.14

213.16

pmol/l

0.36

176

Pacemaker

217

1814

1.15

1.22

1.8

188.39

194.40

pmol/l

0.44

198

1677

Second line medication for Crohn's disease

580

5341

1.09

1.21

2.0

1.9

196.31

196.75

pmol/l

0.04

551

5079

Cholangitis (primary sclerosing, PSC)

426

1.32

1.21

2.0

1.9

201.73

207.76

pmol/l

0.20

401

Acute posthaemorrhagic anaemia

141

0.49

1.21

2.1

2.0

212.00

200.17

pmol/l

—

132

Cerebrovascular diseases (FINNGEN)

366

2330

1.11

1.20

1.9

1.8

199.47

212.52

pmol/l

1.40

344

2243

Open wound of head

715

6403

1.08

1.20

1.9

205.08

203.40

pmol/l

0.14

683

6087

Neovascular glaucoma

238

0.58

1.20

2.0

1.9

187.21

214.02

pmol/l

0.60

225

Recurrent dislocation of patella

315

1.37

1.18

2.2

1.7

204.30

172.94

pmol/l

1.40

297

Glaucoma secondary to other eye disorders

237

0.59

1.18

2.0

1.9

187.21

214.09

pmol/l

0.60

222

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

233

2051

1.14

1.17

1.9

207.09

202.09

pmol/l

0.28

225

1953

Hair colour and hair shaft abnormalities

0.00

1.17

0.0

1.5

—

207.12

—

Other psoriatic arthropathies

109

903

1.21

1.17

1.8

1.9

205.39

204.85

pmol/l

0.02

849

Other and unspecified myopathies

668

1.25

1.17

2.0

1.9

216.49

204.31

pmol/l

0.26

630

Insulin, fast-acting or short human

447

4079

1.10

1.16

1.7

1.9

193.21

201.83

pmol/l

0.94

413

3877

Psoriatic arthropathies, ICD10

111

922

1.21

1.16

1.8

1.9

206.98

203.72

pmol/l

0.10

101

867

Herpesviral keratitis and keratoconjunctivitis

274

1.40

1.16

2.4

1.8

159.68

208.59

pmol/l

2.09

257

Anterior Iridocyclitis

200

1744

1.15

1.16

2.1

1.9

189.60

202.53

pmol/l

0.95

193

1650

Unspecific neurodegenerative disorder

132

1069

0.84

1.15

1.7

1.8

175.86

188.70

pmol/l

1.02

113

969

Other diseases of the digestive system

281

2505

1.12

1.15

1.9

187.51

197.95

pmol/l

0.98

260

2338

Divergent concomitant strabismus

589

1.26

1.15

1.6

1.9

190.44

200.82

pmol/l

0.46

556

Alzheimer disease, including avohilmo

770

0.81

1.14

1.8

166.25

186.36

pmol/l

1.71

695

Inflammatory bowel disease, strict (require KELA)

305

2735

1.12

1.14

1.9

203.10

201.34

pmol/l

0.11

293

2610

Other bacterial intestinal infections

139

1180

1.18

1.14

2.0

1.9

193.07

202.32

pmol/l

0.50

131

1107

Familial erythrocytosis

2.02

1.13

1.5

1.7

159.30

253.28

pmol/l

—

Osteomalacia

1.93

1.13

1.7

189.09

243.02

pmol/l

0.79

Heart failure, not strict

683

4988

0.93

1.13

1.9

176.08

202.45

pmol/l

9.80

640

4733

Other/unspecified cytomegaloviral diseases

151

1.54

1.13

1.4

1.8

197.87

228.50

pmol/l

0.97

142

Nontraumatic intracranial haemmorrhage

103

1240

0.83

1.12

1.7

1.9

195.90

200.58

pmol/l

0.11

1151

Mucosal proctocolitis

168

1451

1.16

1.12

1.9

199.42

205.60

pmol/l

0.36

163

1377

DVT of lower extremities and pulmonary embolism

328

2943

1.11

1.12

2.1

1.9

186.42

196.62

pmol/l

1.05

312

2750

Superficial injury of shoulder and upper arm

114

954

1.20

1.11

2.2

1.9

199.65

206.99

pmol/l

0.31

104

901

Cholesteatoma of middle ear

328

1.35

1.11

1.4

1.8

189.42

202.62

pmol/l

0.63

310

Pedestrian injured in other and unspecified transport accidents

1.75

1.10

2.2

1.6

196.79

251.52

pmol/l

0.74

Contact with machinery

190

1661

1.15

1.10

2.0

1.9

190.15

208.65

pmol/l

2.23

179

1577

Evidence of alcohol involvement determined by blood alcohol level

165

0.54

1.09

2.7

1.8

153.78

225.42

pmol/l

—

157

Primary_lymphoid and hematopoietic malignant neoplasms

196

1715

1.15

1.09

2.0

1.9

197.03

198.05

pmol/l

0.04

188

1602

Cytomegalovirus infection, IBD co-morbidity

177

1.48

1.09

1.4

1.9

192.62

217.33

pmol/l

0.74

166

Benign neoplasm: Choroid

286

1.37

1.09

1.8

198.62

201.77

pmol/l

0.06

270

Benign neoplasm: Skin of eyelid, including canthus

747

1.22

1.08

2.1

1.9

196.50

197.27

pmol/l

0.02

708

Ulcerative colitis (strict definition, require KELA)

217

1915

1.14

1.08

1.9

204.18

202.44

pmol/l

0.09

209

1821

Atopic conjunctivitis

278

1.37

1.08

1.7

1.8

197.32

203.50

pmol/l

0.11

265

Episcleritis

347

1.33

1.08

2.0

1.8

181.02

202.95

pmol/l

0.84

328

Injury of muscle and tendon at wrist and hand level

195

1710

1.14

1.07

2.1

1.9

206.41

204.21

pmol/l

0.08

179

1638

Emotional disorders starting during childhood or adolescence

336

1.33

1.06

2.3

1.7

122.64

177.89

pmol/l

2.04

322

Nutritional anaemias

312

2711

1.11

1.06

2.2

1.8

186.75

186.13

pmol/l

0.04

297

2516

Other lesions of median nerve

113

1.60

1.06

2.2

1.8

177.28

208.28

pmol/l

0.81

107

Pleural effusion

947

0.81

1.06

2.2

1.9

199.96

197.93

pmol/l

0.05

880

Cardiomyopathy (excluding other)

105

1252

0.84

1.05

1.7

1.9

203.90

204.36

pmol/l

0.02

1170

Intracerebral haemorrhage

669

0.78

1.05

1.9

185.11

206.29

pmol/l

0.80

628

Malignant neoplasm of skin

323

2449

0.90

1.04

1.7

1.9

200.72

195.21

pmol/l

0.45

289

2295

Unspecified fall

496

4508

1.09

1.04

1.9

199.48

196.23

pmol/l

0.29

463

4282

Malignant neoplasm of rectosigmoid junction, including Hilmo

147

0.54

1.04

3.9

1.9

209.38

214.35

pmol/l

—

137

malignant neoplasm of male genital organs

402

2680

0.91

1.04

1.9

184.52

201.18

pmol/l

2.01

374

2526

Fracture of femur

121

1292

0.85

1.04

1.7

1.8

185.58

200.37

pmol/l

0.95

113

1199

Sulfasalazine

272

2440

1.12

1.03

1.9

201.13

194.42

pmol/l

0.52

259

2310

Vitamin D deficiency

114

1.59

1.03

2.6

1.9

145.16

224.11

pmol/l

2.42

109

Covid-19 suspected case

211

1865

1.13

1.03

1.7

1.9

178.95

189.63

pmol/l

0.88

205

1778

Disorders in reading

163

1.49

1.03

2.0

1.9

221.75

223.00

pmol/l

0.01

156

Toxic effect of carbon monoxide

163

1.49

1.03

2.8

1.8

209.33

223.74

pmol/l

0.23

155

Other maltreatment syndromes

475

1.28

1.02

1.7

1.9

186.47

216.90

pmol/l

1.45

455

Type 1 diabetes, strict (exclude DM2)

108

1275

0.84

1.01

1.7

2.0

216.97

213.91

pmol/l

0.10

100

1218

Injury of unspecified body region

546

1.25

1.01

1.9

180.24

201.47

pmol/l

0.82

519

Pulmonary embolism

216

1915

1.13

1.00

2.1

1.9

183.78

197.30

pmol/l

1.11

207

1783

Coronary artery bypass grafting

187

1583

0.88

0.99

1.6

1.8

193.09

197.86

pmol/l

0.18

166

1454

Familial hypercholesterolemia

116

985

1.18

0.98

2.0

1.8

183.80

204.27

pmol/l

1.49

104

922

Benign neoplasm of ovary

1.71

0.98

1.1

1.2

20.23

14.55

pmol/l

0.72

Nephropathy related operations

107

1263

0.84

0.98

1.6

1.9

184.87

207.18

pmol/l

1.60

1191

Diabetic neuropathy

111

935

1.19

0.98

1.8

170.22

180.93

pmol/l

0.55

103

871

Complications predominantly related to the puerperium

370

1.30

0.98

1.1

1.2

22.07

16.91

pmol/l

0.59

340

Other diseases of pleura

320

3086

0.91

0.97

2.1

1.8

191.59

195.55

pmol/l

0.28

293

2871

Degeneration of macula and posterior pole

261

1863

1.12

0.97

2.0

1.8

191.90

190.33

pmol/l

0.07

236

1710

Fracture of foot, except ankle

266

2394

1.11

0.97

1.8

1.9

187.15

198.53

pmol/l

1.11

254

2285

Pulmonary heart disease

216

1920

1.13

0.97

2.1

1.9

183.78

197.08

pmol/l

1.09

207

1786

Type 1 diabetes, wide definition, subgroup 1

283

2554

1.11

0.97

1.8

2.0

200.06

210.74

pmol/l

0.96

263

2453

Gastric ulcer

122

1043

1.17

0.96

1.9

1.8

194.98

201.63

pmol/l

0.26

115

965

Volume depletion

505

1.25

0.96

1.9

1.8

178.48

214.58

pmol/l

1.66

478

Intentional self-harm by unspecified means

133

1.52

0.95

1.6

1.8

153.65

214.10

pmol/l

1.21

127

Other protozoal intestinal diseases

1.66

0.95

1.9

1.6

198.29

234.10

pmol/l

0.46

Acute gastritis

488

1.25

0.95

2.2

1.9

176.48

205.83

pmol/l

1.96

457

Benign neoplasm: Skin, unspecified

225

1.39

0.95

1.7

1.9

210.35

211.65

pmol/l

0.01

211

Deep bite that required surgery

109

1.58

0.94

1.9

204.29

223.49

pmol/l

0.29

103

Other specified and unspecified disorders of eyelid

1.63

0.94

2.8

1.7

216.47

215.88

pmol/l

0.01

GI-bleeding

280

2532

1.11

0.94

1.9

187.17

198.31

pmol/l

1.08

258

2364

Follicular cysts of skin and subcutaneous tissue

194

1720

1.13

0.93

1.9

189.57

205.19

pmol/l

1.35

180

1628

Rheumatoid arthritis, including avohilmo

186

2101

0.88

0.93

1.8

194.96

191.10

pmol/l

0.21

171

1964

Other obstetric conditions, not elsewhere classified

516

1.20

0.93

1.4

1.2

16.10

18.84

pmol/l

1.42

480

Other diseases of pancreas

608

1.22

0.91

2.0

1.9

192.16

205.14

pmol/l

0.49

571

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

516

1.19

0.91

1.4

1.2

15.85

18.84

pmol/l

1.65

480

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

563

1.23

0.91

2.1

1.9

207.09

207.78

pmol/l

0.02

532

Occupant of heavy transport vehicle injured in other and unspecified transport accidents

105

0.46

0.91

1.4

2.0

197.40

235.61

pmol/l

—

Type 1 diabetes, definitions combined

110

1281

0.85

0.91

1.6

2.0

217.42

214.10

pmol/l

0.11

102

1224

Purpura and other haemorrhagic conditions

115

985

1.17

0.90

1.7

1.9

188.19

199.03

pmol/l

0.45

107

925

Unspecified urinary incontinence

210

1.38

0.90

1.5

1.8

135.29

191.90

pmol/l

1.59

200

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

102

0.49

0.90

1.2

1.9

220.60

222.38

pmol/l

—

Other specified congenital malformation syndromes affecting multiple systems

135

1.50

0.90

1.8

1.6

179.90

223.34

pmol/l

0.81

130

Major coronary heart disease event excluding revascularizations

570

4066

0.93

0.90

1.8

1.9

194.57

203.61

pmol/l

1.39

543

3847

Mental and behavioural disorders due to alcohol

784

7115

1.06

0.89

2.0

1.9

197.88

202.81

pmol/l

0.64

722

6801

Respiratory insufficiency

381

0.73

0.89

2.7

1.8

160.95

198.06

pmol/l

1.04

354

Benign neoplasm: Peripheral nerves and autonomic nervous system

111

1.55

0.88

3.1

1.8

179.88

226.38

pmol/l

1.28

105

Chronic pancreatitis

155

1361

1.14

0.88

1.7

1.9

204.27

207.42

pmol/l

0.16

147

1285

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

502

1.24

0.88

1.9

204.55

203.06

pmol/l

0.04

476

Diabetic retinopathy, strict definition

146

1471

0.87

0.88

1.8

1.9

187.53

167.88

pmol/l

1.37

137

1371

Toxic effect of ethanol

471

0.76

0.88

1.8

1.9

198.25

210.09

pmol/l

0.34

448

Diabetic maculopathy, excluding more controls

128

1110

1.16

0.87

1.7

1.9

191.57

213.55

pmol/l

1.70

117

1054

Ankylosing spondylitis, ICD10

113

971

1.17

0.87

1.9

209.42

209.59

pmol/l

0.01

108

921

Erysipelas

885

6401

1.06

0.87

2.0

1.9

183.25

205.87

pmol/l

7.81

830

6093

Other and specified injuries of hip and thigh

136

1.48

0.87

1.8

1.9

215.15

226.28

pmol/l

0.18

128

All influenza (not pneumonia)

197

1758

1.12

0.87

2.0

1.9

209.12

204.60

pmol/l

0.23

185

1674

Bacterial intestinal infections, IBD co-morbidities

137

1196

1.15

0.85

2.0

1.9

195.73

201.26

pmol/l

0.26

129

1122

Urethritis and urethral syndrome

137

1.47

0.84

1.8

170.60

210.96

pmol/l

1.26

128

Other and unspecified psoriasis

497

1.23

0.83

1.9

2.0

183.29

206.81

pmol/l

1.07

469

Alzheimer’s disease, strict definition

506

0.80

0.83

1.5

1.7

176.40

189.65

pmol/l

0.58

449

Benign neoplasm: Tongue

171

1.41

0.83

1.8

1.9

169.58

214.62

pmol/l

1.37

159

Crohn's disease of small intestine

652

1.20

0.83

2.0

1.9

192.73

208.34

pmol/l

0.86

614

Contact with sharp glass

471

1.24

0.83

2.0

1.9

190.43

209.49

pmol/l

0.69

446

Cytomegaloviral disease

197

1.38

0.83

1.4

1.8

190.15

219.00

pmol/l

0.98

185

Non-small cell lung cancer, adenocarcinoma

273

0.69

0.83

1.7

1.8

160.16

200.13

pmol/l

1.68

253

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

102

1187

0.86

0.82

1.7

1.9

193.60

198.82

pmol/l

0.19

1120

Gastrojejunal ulcer

1.66

0.82

1.9

1.8

215.83

220.57

pmol/l

0.07

Type 1 diabetes, strict definition

1097

0.85

0.82

1.5

2.0

216.72

215.92

pmol/l

0.02

1050

Cardiomyopathies, Primary/intrinsic

103

1197

0.86

0.82

1.6

1.9

204.22

206.73

pmol/l

0.11

1118

Other diseases of urinary system

915

5409

0.95

0.80

1.9

1.8

173.38

188.92

pmol/l

4.17

856

5105

Other demyelinating diseases of the central nervous system

259

0.69

0.80

1.4

1.8

218.00

205.23

pmol/l

0.18

247

Pulmonary heart disease, diseases of pulmonary circulation

227

2053

1.11

0.80

2.1

1.8

181.50

196.59

pmol/l

1.37

216

1910

Acidosis

150

0.60

0.79

2.8

1.9

137.78

226.81

pmol/l

—

140

Benign neoplasm: Skin of lip

1.68

0.79

2.4

1.6

207.27

249.69

pmol/l

0.85

Viral pneumonia

130

1139

1.14

0.79

1.9

182.46

205.76

pmol/l

1.75

123

1081

Dipeptidyl peptidase 4 (DPP-4) inhibitors

505

3782

1.07

0.79

1.9

1.8

166.06

204.57

pmol/l

18.59

462

3582

Scleritis and episcleritis

402

1.25

0.78

1.9

1.8

181.62

204.77

pmol/l

0.96

378

Vitreous haemorrhage

768

1.18

0.77

1.7

1.9

189.46

205.83

pmol/l

0.92

725

Motor disorders

1.56

0.77

1.4

1.7

125.43

207.90

pmol/l

1.43

Speech therapy

150

1690

0.89

0.77

1.8

1.9

186.58

198.16

pmol/l

0.84

134

1592

Type 1 diabetes, wide definition

288

2640

1.09

0.77

1.8

2.0

200.24

210.47

pmol/l

0.92

266

2531

Ankylosis of teeth

2.21

0.77

1.6

2.0

292.40

211.22

pmol/l

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

537

1.18

0.76

1.2

17.52

17.91

pmol/l

0.10

497

Burns and corrosions

183

1643

1.12

0.76

1.8

1.9

195.09

203.80

pmol/l

0.52

173

1561

Biological medication for rheuma

196

1766

1.11

0.76

1.8

1.9

195.87

202.33

pmol/l

0.40

187

1682

Infliximab

218

1.34

0.76

2.2

1.9

200.59

226.95

pmol/l

0.90

209

Superficial injury of ankle and foot

126

1106

1.14

0.75

1.8

1.9

175.26

198.55

pmol/l

1.11

121

1047

Other fall from one level to another

262

2397

1.09

0.75

1.8

1.9

193.26

197.55

pmol/l

0.22

245

2277

ILD, hospital admissions 1, main diag only

762

1.17

0.74

2.0

1.9

199.42

199.68

pmol/l

0.01

708

Benign neoplasm: Skin of other and unspecified parts of face

523

1.21

0.74

2.1

1.9

197.15

197.61

pmol/l

0.01

498

Spasmodic torticollis

133

1.44

0.74

1.5

1.7

196.06

205.30

pmol/l

0.15

124

Non-small cell lung cancer, adenocarcinoma, helper endpoint

266

0.71

0.73

1.7

1.8

160.16

200.12

pmol/l

1.67

245

Accidental poisoning by and exposure to alcohol

195

0.66

0.73

1.8

1.7

219.92

212.72

pmol/l

0.08

185

Rheumatic valve diseases

106

0.56

0.73

1.0

2.1

220.67

232.39

pmol/l

—

100

Other abnormal findings of blood chemistry

290

1.28

0.72

1.9

1.8

199.43

201.67

pmol/l

0.05

274

Leisure time condition

171

1535

1.12

0.72

1.8

1.9

187.93

199.89

pmol/l

0.76

165

1457

Specific developmental disorder of motor function

1.53

0.72

1.4

1.6

125.43

212.74

pmol/l

1.57

Enterobiasis

117

1.46

0.72

2.0

1.7

205.29

201.46

pmol/l

0.04

108

Other localized connective tissue disorders

1.63

0.72

3.3

2.0

164.27

210.92

pmol/l

0.31

Malignant neoplasm of colon, including Hilmo

1117

0.87

0.71

1.8

198.98

198.53

pmol/l

0.01

1050

Pleural plaque

507

1.21

0.71

1.8

175.26

194.54

pmol/l

1.00

457

Seropositive rheumatoid arthritis

101

1156

0.87

0.71

2.0

1.8

198.55

192.83

pmol/l

0.25

1081

Impacted teeth

227

1840

1.10

0.71

1.6

1.8

172.13

184.13

pmol/l

0.79

217

1762

Malignant neoplasm of oral cavity

252

0.71

1.6

1.9

211.17

211.37

pmol/l

0.00

235

Viral infections of central nervous system, not elsewhere classified/unspecified

101

1.50

0.71

1.8

1.9

249.47

227.93

pmol/l

0.16

Other superficial mycoses

186

1.35

0.70

2.0

1.8

223.56

220.56

pmol/l

0.03

176

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

1.73

0.70

1.7

1.5

251.14

236.11

pmol/l

—

Pleural plaque without asbestos

143

1.40

0.70

1.5

1.9

160.35

208.89

pmol/l

1.24

132

Reimbursement for rheumatic diseases

461

4307

1.07

0.70

2.0

1.9

196.95

193.08

pmol/l

0.36

434

4079

Tumor necrosis factor alpha inhibitors

174

1568

1.11

0.69

1.8

1.9

194.20

202.21

pmol/l

0.49

167

1488

106

805

1.15

0.69

1.9

1.8

185.62

182.71

pmol/l

0.12

731

Melanoma in situ of trunk

1.54

0.69

1.8

205.38

217.67

pmol/l

0.28

Foreign body entering into or through eye or natural orifice

116

1021

1.14

0.69

1.9

2.0

219.23

209.08

pmol/l

0.40

109

970

Diabetic retinopathy

278

1882

0.92

0.69

1.9

181.35

170.67

pmol/l

0.98

257

1752

Renal agenesis and other reduction defects of kidney

1.69

0.69

1.9

2.1

176.14

221.54

pmol/l

—

Drug-induced osteoporosis

1.61

0.69

1.8

178.91

231.49

pmol/l

1.33

Pregnancy with abortive outcome

534

0.86

0.68

1.2

17.09

19.30

pmol/l

0.89

495

Anoxic brain damage

0.54

0.67

3.6

1.8

234.00

231.13

pmol/l

—

Rash and other nonspecific skin eruption

502

1.20

0.67

2.5

1.8

173.64

193.63

pmol/l

0.85

472

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1049

6550

1.04

0.67

1.8

1.9

187.38

193.03

pmol/l

0.98

1010

6202

Unspecified acute lower respiratory infection

197

1792

1.10

0.67

2.0

1.9

204.80

204.07

pmol/l

0.03

189

1707

Tooth agenesis EXCLUDE clefts and syndromes

260

0.73

0.66

1.4

1.8

136.37

178.43

pmol/l

0.89

247

Other and unspecified nonorganic psychotic disorders

266

2454

1.09

0.66

1.9

2.0

177.81

206.44

pmol/l

2.82

248

2349

Insulin, intermediate and long-acting

649

5990

1.05

0.66

1.8

1.9

183.67

202.26

pmol/l

4.95

604

5686

Exclusion endpoint for clefts

162

1.37

0.66

1.8

1.6

164.32

221.92

pmol/l

1.26

155

Chronic myeloid leukaemia, including Hilmo

1.59

0.66

2.8

1.7

174.91

252.02

pmol/l

1.86

Retinal detachment with retinal break

114

1006

1.14

0.66

1.8

1.9

202.75

198.77

pmol/l

0.18

106

950

Wet age-related macular degeneration

417

1.21

0.65

1.7

180.81

184.42

pmol/l

0.12

374

Tuberculosis, wide

316

0.76

0.65

1.5

1.8

198.25

205.40

pmol/l

0.18

296

Amiodarone users

754

0.85

0.65

1.7

1.9

193.63

203.52

pmol/l

0.28

706

Other and unspecified injuries of head

532

1.19

0.64

2.1

1.9

185.40

200.08

pmol/l

0.45

509

Melanocytic naevi of scalp and neck

163

1.36

0.64

2.0

1.9

154.45

208.78

pmol/l

0.94

153

Alcohol abuse, main dg, excluding more controls

194

1768

1.10

0.64

1.8

188.20

207.12

pmol/l

1.86

176

1703

Paralytic ileus and intestinal obstruction

184

1673

1.10

0.63

2.3

1.8

197.02

202.85

pmol/l

0.34

179

1565

Supplementary factors related to causes of morbidity and mortality classified elsewhere

338

3156

1.07

0.62

1.9

204.60

196.54

pmol/l

0.64

327

3008

Foreign body or object entering through skin

767

1.15

0.62

2.0

1.9

210.18

209.58

pmol/l

0.02

734

Diabetic retinopathy, excluding more controls

239

1456

0.92

0.62

1.9

2.0

187.06

169.85

pmol/l

1.70

220

1364

Infections of genitourinary tract in pregnancy

138

1.38

0.62

1.1

1.2

16.89

17.33

pmol/l

0.05

125

Other disorders of breast

104

1.44

0.62

1.1

1.2

16.27

15.91

pmol/l

0.04

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

184

1626

1.10

0.62

1.7

2.0

187.53

200.12

pmol/l

0.94

176

1546

Retinal vascular occlusion

544

1.18

0.61

1.6

1.9

194.85

191.70

pmol/l

0.10

509

Zoster [herpes zoster]

110

974

1.13

0.61

1.9

1.8

173.29

198.05

pmol/l

2.05

105

915

Coagulation defects, purpura and other haemorrhagic conditions

154

1391

1.11

0.61

2.0

1.9

190.99

197.78

pmol/l

0.28

146

1311

Type 1 diabetes, strict definition, subgroup 2

0.00

0.61

0.0

1.5

—

305.45

—

Unspecified kidney failure

591

1.17

0.61

2.1

1.9

170.64

209.60

pmol/l

2.26

553

Hypospadias with an incomplete glans penis

0.00

0.61

0.0

1.9

—

204.81

—

Pyoderma gangrenosum

1.58

0.61

2.9

1.6

184.25

234.43

pmol/l

—

Retinal vascular disorders

554

1.18

0.61

1.6

1.9

195.98

191.55

pmol/l

0.15

517

Benign neoplasm of middle ear and respiratory system

620

1.16

0.60

2.1

1.9

218.70

204.82

pmol/l

0.54

586

Contraceptive management

576

3835

1.05

0.60

1.9

200.11

200.30

pmol/l

0.02

555

3680

Sequelae of cerebrovascular disease

229

2142

0.92

0.60

1.8

1.9

186.44

195.58

pmol/l

0.94

214

1990

Other interstitial pulmonary diseases

100

882

1.14

0.60

1.9

196.57

198.83

pmol/l

0.09

820

Urticaria due to cold and heat

1.55

0.60

1.9

1.5

188.38

241.98

pmol/l

—

Chronic myeloid leukaemia [CML], BCR/ABL-positive

1.55

0.60

2.8

1.8

174.91

240.92

pmol/l

1.56

Tuberculosis, IBD comorbidity

311

0.77

0.59

1.5

1.8

198.25

205.08

pmol/l

0.17

291

Unstable angina pectoris

310

2279

1.07

0.59

1.8

190.05

197.53

pmol/l

0.67

289

2119

Other cataract

349

2472

1.07

0.59

1.9

1.8

188.07

196.45

pmol/l

0.69

326

2307

Distal bite

182

1.31

0.59

2.2

1.7

165.58

169.86

pmol/l

0.07

175

Interstitial lung disease endpoints

100

883

1.13

0.59

1.9

196.57

198.73

pmol/l

0.09

821

Interstitial lung disease

100

883

1.13

0.59

1.9

196.57

198.73

pmol/l

0.09

821

Embedded and impacted teeth

314

2418

1.07

0.59

1.7

1.8

176.16

186.01

pmol/l

0.78

300

2315

Unspecified privation

101

893

1.13

0.59

1.6

2.0

199.95

202.03

pmol/l

0.07

840

ILD, hospital admissions

874

1.13

0.59

1.9

1.8

195.97

199.17

pmol/l

0.13

813

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

140

1.36

0.58

2.4

1.8

192.84

217.11

pmol/l

0.45

132

Viral infections of central nervous system, not elsewhere classified/unspecified

123

1.39

0.58

1.9

252.71

231.97

pmol/l

0.18

116

Maternal care for known or suspected fetal abnormality and damage

324

0.80

0.58

1.2

22.00

18.45

pmol/l

0.24

296

Other and unspecified bullous disorders

1.49

0.57

1.1

1.7

174.00

214.70

pmol/l

—

Other secondary gonarthrosis

328

1.22

0.57

2.3

1.9

203.76

204.11

pmol/l

0.01

312

Non-Hodgkin lymphoma, all, including Hilmo

106

943

1.13

0.56

1.9

203.09

202.24

pmol/l

0.02

101

885

Early onset COPD, excluding more controls

172

1879

0.91

0.56

2.2

1.8

195.78

198.51

pmol/l

0.11

160

1779

Heart failure and antihypertensive medication

240

1452

1.08

0.56

2.0

1.8

188.68

218.87

pmol/l

3.75

228

1401

Unspecified threat to breathing

1.55

0.56

2.0

1.6

197.80

219.42

pmol/l

—

Type 1 diabetes

328

3072

1.07

0.56

1.8

1.9

196.04

209.51

pmol/l

1.58

301

2942

Fracture of forearm

423

3662

1.06

0.55

1.9

1.8

203.81

194.35

pmol/l

1.00

398

3490

Disorders of choroid and retina

810

5525

1.04

0.55

1.9

196.73

198.68

pmol/l

0.20

755

5232

Infective dermatitis

880

1.13

0.54

1.8

1.9

209.46

199.12

pmol/l

0.48

823

Other bullous disorders

151

1.33

0.54

1.7

1.8

193.65

205.80

pmol/l

0.24

143

L01XX Other antineoplastic agents

276

1.24

0.54

1.6

1.9

176.03

205.77

pmol/l

0.74

259

Type 1 diabetes, strict definition, subgroup 1

1033

0.89

0.53

1.5

2.0

216.65

216.77

pmol/l

0.00

991

Presence of cardiac and vascular implants and grafts

381

3000

0.94

0.53

1.8

1.9

190.54

198.98

pmol/l

0.74

363

2793

Other congenital malformations of nervous system

1.55

0.53

2.0

1.3

170.67

200.51

pmol/l

—

Alcohol induced polyneuropathy

0.62

0.53

1.2

1.7

159.83

226.93

pmol/l

—

Bicuspidal aortic valve syndrome

479

0.83

0.52

1.7

1.9

217.90

217.49

pmol/l

0.01

453

Bacterial pneumonia, not elsewhere classified

323

3024

0.94

0.52

1.8

1.9

182.41

197.79

pmol/l

1.66

306

2854

Atrophic disorders of skin

536

1.16

0.51

1.4

1.9

168.33

196.23

pmol/l

1.31

501

Family history of malignant neoplasm

471

1.17

0.51

1.8

176.36

188.46

pmol/l

0.33

438

L01XE Protein kinase inhibitors

270

0.78

0.51

1.9

196.43

212.46

pmol/l

0.39

252

Pedal cyclist injured in noncollision transport accidents

130

1180

1.10

0.51

2.3

2.0

202.76

204.44

pmol/l

0.07

122

1114

Congenital malformations of the circulatory system

152

1348

1.10

0.51

2.0

1.9

200.36

199.63

pmol/l

0.03

147

1275

Molar incisor enamel hypoplasia

173

0.72

0.51

1.7

1.6

209.00

174.96

pmol/l

0.48

166

Bleeding

908

6227

1.04

0.50

1.9

194.37

201.07

pmol/l

1.09

850

5908

Epidural haemorrhage

1.51

0.50

3.2

1.5

194.60

265.08

pmol/l

—

Burn and corrosion of ankle and foot

144

0.69

0.49

1.6

1.8

190.00

227.78

pmol/l

—

134

Multiple myeloma

101

1.39

0.49

1.6

1.8

187.86

217.95

pmol/l

0.40

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

101

1.39

0.49

1.6

1.8

187.86

217.95

pmol/l

0.40

Spontaneous abortion

460

0.86

0.49

1.1

1.2

16.87

19.15

pmol/l

0.60

426

Crohn disease

145

1326

1.10

0.49

2.0

1.9

195.11

203.35

pmol/l

0.51

136

1258

Other meningitis

110

1.37

0.49

2.7

1.9

196.47

226.82

pmol/l

0.48

102

Typhoid and paratyphoid fevers

1.54

0.48

1.4

2.0

187.71

260.08

pmol/l

—

Bacterial pneumoniae

353

3289

0.95

0.48

1.8

1.9

182.36

197.85

pmol/l

1.86

335

3104

Chronic iridocyclitis

317

1.20

0.48

2.2

1.8

187.03

208.08

pmol/l

0.64

300

Alcohol use disorder, ICD-based

632

6067

1.04

0.48

2.0

1.9

198.28

204.34

pmol/l

0.74

580

5789

Alzheimer’s disease (Late onset)

409

0.84

0.48

1.5

1.6

178.34

185.61

pmol/l

0.24

360

Other degenerative diseases of the nervous system

141

961

1.10

0.48

1.5

1.7

193.98

199.42

pmol/l

0.25

127

897

Disorders of porphyrin and bilirubin metabolism

102

1.38

0.48

1.3

1.9

213.57

232.69

pmol/l

0.41

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

280

1.22

0.48

1.7

1.9

209.06

214.68

pmol/l

0.09

266

Ectopic testis

1.48

0.47

2.9

1.6

222.29

256.81

pmol/l

—

Gastroduodenal ulcer

186

1718

1.08

0.47

1.9

194.43

198.69

pmol/l

0.22

176

1601

Fracture of shoulder and upper arm

319

3008

1.06

0.47

1.9

197.62

201.49

pmol/l

0.31

302

2865

Systemic sclerosis (FG)

1.48

0.47

2.4

1.7

159.40

201.35

pmol/l

—

Acute nephritic syndrome

176

0.73

0.46

1.6

1.9

169.46

215.29

pmol/l

1.45

167

Effects of other external causes

384

1.18

0.46

2.9

1.9

220.11

219.88

pmol/l

0.00

365

Tuberculosis

254

0.79

0.45

1.4

1.8

200.25

209.09

pmol/l

0.21

237

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

270

2008

1.06

0.45

2.0

1.7

143.93

152.11

pmol/l

0.54

254

1858

L04AC Interleukin inhibitors

629

1.13

0.44

1.8

1.9

214.91

209.92

pmol/l

0.17

598

Entropion and trichiasis of eyelid

297

0.81

0.44

2.0

1.8

187.75

205.27

pmol/l

0.35

275

Other conjunctival vascular disorders and cysts

121

1.33

0.44

1.2

1.9

156.13

218.50

pmol/l

1.62

112

Cardiomyopathy

152

1646

0.92

0.44

1.7

1.9

210.34

203.36

pmol/l

0.36

143

1545

Other disorders of urethra and urinary system

384

2914

0.95

0.44

1.8

168.63

174.16

pmol/l

0.43

354

2704

Use of rivastigmine

338

1.18

0.44

1.6

1.7

167.65

197.03

pmol/l

1.18

306

Respiratory distress of newborn

1.60

0.43

1.2

1.9

139.20

149.52

pmol/l

—

Malignant neoplasm of rectosigmoid junction

0.66

0.42

4.0

1.9

182.67

216.44

pmol/l

—

Legal intervention

0.00

0.42

0.0

1.9

—

253.20

—

Macular cyst

122

1.32

0.42

1.4

1.9

191.94

219.29

pmol/l

0.45

112

Shigellosis

1.44

0.42

1.4

1.9

173.00

234.75

pmol/l

—

Inflammatory disorders of breast

0.64

0.42

1.8

1.2

15.83

15.99

pmol/l

—

Other injuries of lower limb, level unspecified

1.44

0.42

1.9

1.7

183.80

223.05

pmol/l

—

Underdevelopment of the second kidney

0.00

0.42

0.0

1.8

—

176.60

—

Problems related to social environment

149

1.28

0.42

2.9

1.9

155.32

207.71

pmol/l

1.14

141

Renal tubulo-interstitial diseases

786

5658

1.03

0.41

1.9

1.8

175.57

189.26

pmol/l

3.17

735

5350

Squamous cell neoplasms and carcinomas of the skin

267

1.20

0.41

1.6

1.8

184.65

200.91

pmol/l

0.58

243

Other acantholytic disorders

0.00

0.41

0.0

1.5

—

213.60

—

Gout, strict definition

170

1581

1.08

0.41

2.1

1.8

178.16

200.25

pmol/l

1.97

147

1475

Congenital malformations of larynx

0.00

0.41

0.0

1.7

—

175.53

—

Hypoplasia of dental enamel, prenatal , including avohilmo

0.00

0.41

0.0

1.1

—

158.00

—

Asthma/COPD (KELA code 203)

1096

7303

1.03

0.41

2.0

1.8

194.39

195.68

pmol/l

0.15

1042

6944

Later onset COPD, excluding more controls

664

0.89

0.41

2.0

1.7

179.21

188.13

pmol/l

0.31

598

Exposure to other specified electric current

268

1.20

0.41

2.5

1.8

223.06

217.64

pmol/l

0.09

258

Drug-induced cataract

168

1.26

0.40

1.7

1.9

191.52

218.16

pmol/l

0.60

158

Basal cell carcinoma

260

1905

0.94

0.40

1.8

198.31

195.30

pmol/l

0.19

230

1776

ILD, hospital admissions 3, with pneumonia sepsis

427

1.15

0.40

2.0

202.00

203.90

pmol/l

0.04

400

Exposure to other and unspecified inanimate mechanical forces

816

1.11

0.39

2.0

205.19

208.41

pmol/l

0.11

773

Transitory disorders of carbohydrate metabolism specific to fetus and newborn

1.44

0.39

1.2

1.8

74.80

142.82

pmol/l

—

Hepatomegaly and splenomegaly, not elsewhere classified

1.42

0.39

3.1

1.7

162.60

238.31

pmol/l

—

Use of galantamine

160

0.75

0.39

2.3

1.9

153.58

210.60

pmol/l

1.65

149

Benign neoplasm: Retina

1.44

0.39

1.2

1.9

167.60

198.93

pmol/l

—

Fracture of spine, level unspecified

0.00

0.39

0.0

1.4

—

219.89

—

Parkinson's disease, including avohilmo

816

1.10

0.39

1.6

1.9

192.41

195.22

pmol/l

0.11

751

N06DA Anticholinesterases

856

0.91

0.39

1.7

1.8

181.45

186.53

pmol/l

0.24

772

Use of anticholinesterases

856

0.91

0.39

1.7

1.8

181.45

186.53

pmol/l

0.24

772

Pleural plaque with presence of asbestos

400

1.15

0.39

1.8

176.10

198.00

pmol/l

1.11

366

Somnolence

1.38

0.38

1.3

1.6

209.64

219.36

pmol/l

0.09

Malignant neoplasm of small intestine, including Hilmo

160

1.25

0.38

1.4

1.9

182.00

216.66

pmol/l

1.32

149

Transitory endocrine and metabolic disorders specific to fetus and newborn

1.40

0.38

1.2

1.7

74.80

144.66

pmol/l

—

Ulcerative colitis, NAS

151

1404

1.08

0.38

1.9

203.51

203.30

pmol/l

0.01

146

1329

Psoriasis (vulgaris), strict definition

392

1.15

0.38

1.9

190.18

218.11

pmol/l

1.46

375

Pedal cyclist injured in other and unspecified transport accidents

119

1097

1.09

0.37

1.9

199.82

205.70

pmol/l

0.30

113

1037

Varicose veins

334

2645

0.95

0.37

1.8

186.00

191.06

pmol/l

0.45

315

2456

Assault by sharp object

290

1.18

0.37

1.9

2.0

231.29

223.30

pmol/l

0.08

278

Respiratory tuberculosis, not confirmed

169

0.77

0.37

1.5

1.8

191.54

216.86

pmol/l

0.63

155

Injury of nerves at lower leg level

1.37

0.36

2.0

182.91

223.41

pmol/l

0.72

Glaucoma

361

2969

1.05

0.36

1.8

189.32

194.31

pmol/l

0.44

331

2759

Isolated proteinuria with specified morphological lesion

1.34

0.36

1.3

1.8

138.08

230.04

pmol/l

3.32

Viral agents as the cause of diseases classified to other chapters

180

1.23

0.36

2.0

1.8

190.82

206.56

pmol/l

0.28

172

Diseases of arteries, arterioles and capillaries

587

4487

0.97

0.36

1.9

191.31

198.78

pmol/l

1.06

551

4217

Malignant neoplasm of renal pelvis, including Hilmo

0.65

0.36

1.8

2.0

177.40

228.46

pmol/l

—

Migraine with aura, drug-induced

1.43

0.35

3.3

1.7

175.33

235.62

pmol/l

—

Peripheral retinal degeneration

162

1.24

0.35

2.2

1.8

162.80

199.10

pmol/l

0.71

153

Hypoplasia of dental enamel , including avohilmo

163

0.77

0.35

1.7

1.6

209.00

174.04

pmol/l

0.49

156

Retinal haemorrhage

1.32

0.35

1.5

1.8

173.69

216.39

pmol/l

0.85

Benign neoplasm of breast

0.64

0.35

1.0

1.2

12.00

14.28

pmol/l

—

Polyarteritis nodosa and related conditions

0.62

0.35

3.6

1.8

212.80

238.53

pmol/l

—

Heart failure and hypertrophic cardiomyopathy

126

0.71

0.35

1.8

2.0

228.89

220.28

pmol/l

—

116

Dermatitis due to ingested food

173

1.22

0.35

1.1

1.7

184.55

177.54

pmol/l

0.09

167

Malignant neoplasm of larynx, including Hilmo

126

0.71

0.35

1.8

1.9

238.78

223.50

pmol/l

—

117

Leiomyoma of uterus

249

1.14

0.35

1.3

18.11

15.75

pmol/l

0.37

224

L04AA Selective immunosuppressants

202

1907

1.06

0.34

1.6

1.9

200.93

200.85

pmol/l

0.00

192

1809

Methotrexate

747

1.10

0.34

2.0

1.8

190.28

193.00

pmol/l

0.09

696

Acute lymphadenitis

509

1.12

0.34

2.0

1.9

187.67

210.20

pmol/l

1.17

483

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

169

1538

1.07

0.34

1.7

1.9

190.01

201.47

pmol/l

0.77

163

1463

Other and unspecified mononeuropathies of lower limb

136

1.25

0.33

2.3

1.7

161.65

217.05

pmol/l

1.36

129

Rheumatoid arthritis

158

1511

0.94

0.33

1.8

193.16

190.83

pmol/l

0.11

147

1420

Retinoschisis and retinal cysts

118

1.28

0.33

1.5

1.8

182.33

212.17

pmol/l

0.72

110

Long labour

363

1.13

0.33

1.2

16.90

18.14

pmol/l

0.34

332

Palindromic rheumatism

1.31

0.33

2.8

1.9

161.67

210.40

pmol/l

—

Glomerular disorders in diseases classified elsewhere

102

1104

0.92

0.33

1.8

1.9

183.84

205.38

pmol/l

1.42

1040

Alcohol abuse, main dg

194

2052

0.94

0.33

1.8

1.9

188.20

202.81

pmol/l

1.26

176

1954

Alcohol-induced chronic pancreatitis

904

1.09

0.32

1.7

2.0

205.70

209.15

pmol/l

0.13

854

Cerebral palsy and other paralytic syndromes

836

1.09

0.32

1.9

2.0

188.63

202.53

pmol/l

0.49

789

Other abnormal products of conception

419

1.11

0.32

1.2

1.3

15.20

18.76

pmol/l

1.63

386

Systemic sclerosis

1.36

0.32

2.4

1.8

159.40

202.70

pmol/l

—

Hypo-osmolality and hyponatraemia

107

985

1.08

0.32

2.1

1.8

174.68

207.96

pmol/l

2.02

934

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

285

1.16

0.32

2.0

1.9

205.33

217.23

pmol/l

0.23

269

Mental and behavioural disorders due to alcohol, excluding acute intoxication

679

6564

1.03

0.32

2.0

1.9

200.28

203.88

pmol/l

0.38

622

6264

Renal agenesis and other reduction defects of kidney

1.36

0.31

1.9

2.0

176.14

226.85

pmol/l

—

Congenital malformations of trachea and bronchus

1.35

0.31

3.7

1.7

252.71

213.13

pmol/l

—

Other respiratory diseases principally affecting the interstitium

114

1060

1.08

0.31

1.9

195.29

199.08

pmol/l

0.16

102

981

Other coagulation defects

422

0.88

0.31

2.4

1.8

182.62

193.16

pmol/l

0.18

394

Other malignant neoplasms of skin (=non-melanoma skin cancer)

281

2016

0.95

0.31

1.8

199.63

195.49

pmol/l

0.28

250

1885

Delirium, not induced by alcohol and other psychoactive substances

704

0.91

0.31

2.0

1.9

161.39

207.52

pmol/l

3.50

664

Hereditary ataxia

0.73

0.31

1.0

1.9

180.57

229.81

pmol/l

—

Myositis

156

1.22

0.31

2.3

1.7

198.84

221.32

pmol/l

0.70

149

Hypertensive Heart Disease

178

1316

1.06

0.31

1.7

1.8

176.95

206.26

pmol/l

3.42

164

1236

Wegener granulomatosis

100

0.70

0.31

2.1

2.0

187.14

229.20

pmol/l

—

Lymphangioma, anys site

1.30

0.30

1.4

1.8

211.14

240.04

pmol/l

—

Senile cataract

529

3136

1.03

0.30

1.8

196.73

196.69

pmol/l

0.00

493

2940

Other misadventures during surgical and medical care

129

1.24

0.30

2.2

1.8

195.25

221.97

pmol/l

0.58

118

Giant cell arteritis with polymyalgia rheumatica

120

1.25

0.30

1.4

2.0

189.67

215.55

pmol/l

0.65

112

Pneumonia due to other infectious organisms, not elsewhere classified

231

1.17

0.30

2.6

1.9

229.33

215.28

pmol/l

0.18

216

Familial hypercholesterolemia, with ischemic heart disease

534

1.11

0.29

1.8

1.9

180.65

196.25

pmol/l

0.58

490

Bullous disorders

278

1.15

0.29

1.8

1.9

198.97

197.32

pmol/l

0.03

264

Congenital malformations of aortic and mitral valves

514

0.89

0.29

1.7

2.0

212.11

216.82

pmol/l

0.12

487

Ectropion of eyelid

130

0.77

0.29

2.3

2.0

168.10

211.34

pmol/l

—

119

Benign neoplasm: Skin of scalp and neck

148

1.22

0.29

1.7

1.9

140.94

205.47

pmol/l

1.44

138

Malignant melanoma, including Hilmo

118

1103

1.07

0.29

1.6

1.9

196.28

197.73

pmol/l

0.06

109

1038

Respiratory TBC, ICD-8 codes not specifying whether confirmed bacteriologically or histologically

106

0.75

0.29

1.5

1.9

193.50

213.48

pmol/l

—

Other and unspecified epidermal thickening

167

1.20

0.28

1.3

1.8

195.90

211.37

pmol/l

0.18

158

Burn and corrosion, body region unspecified

1.30

0.28

2.0

1.6

175.13

242.63

pmol/l

—

Third [oculomotor] nerve palsy

103

1.27

0.28

2.1

1.8

154.46

237.72

pmol/l

2.02

Hypertrophy of tongue papillae

1.32

0.28

2.3

2.0

198.50

225.10

pmol/l

—

Other diseases of appendix

1.30

0.28

1.4

1.7

235.38

230.64

pmol/l

—

ILD, hospital admission 2, with pulmonary infections

536

1.10

0.28

1.9

197.04

199.38

pmol/l

0.06

497

Meralgia paraesthetica

214

1.17

0.28

2.0

1.9

184.52

198.00

pmol/l

0.27

205

Other infestations

116

0.77

0.27

2.4

1.7

182.89

234.10

pmol/l

—

108

Exposure to other and unspecified animate mechanical forces

233

1.16

0.27

1.6

1.8

220.96

204.88

pmol/l

0.27

220

Chronic myeloproliferative disease

1.25

0.27

1.8

213.63

229.40

pmol/l

—

Laparoscopic left hemicolectomy

120

0.75

0.27

1.4

2.0

185.44

226.60

pmol/l

—

108

Oesophageal varices

332

0.87

0.27

1.9

192.10

210.18

pmol/l

0.62

308

Injury of nerves at ankle and foot level

1.22

0.27

2.9

1.9

160.63

230.28

pmol/l

—

Respiratory tuberculosis

236

0.85

0.26

1.4

1.8

200.25

213.27

pmol/l

0.33

220

Respiratory tuberculosis, confirmed and not-confirmed

236

0.85

0.26

1.4

1.8

200.25

213.27

pmol/l

0.33

220

Schizoid personality disorder

214

0.84

0.26

1.8

1.9

228.72

232.67

pmol/l

0.04

203

Complications following infusion, transfusion and therapeutic injection

1.28

0.26

2.0

1.9

169.36

216.18

pmol/l

0.60

Acute and transient psychotic disorders

119

1265

0.94

0.26

1.9

2.0

175.98

209.71

pmol/l

2.69

111

1201

Atypical virus infections of central nervous system

0.67

0.26

2.4

1.9

235.20

249.38

pmol/l

—

Chalazion

886

1.07

0.26

1.9

183.57

199.18

pmol/l

0.84

839

Acute poliomyelitis

0.66

0.26

2.6

1.8

203.40

235.13

pmol/l

—

Insulin, fast-acting (human)

161

1695

0.95

0.26

1.8

2.0

203.40

207.57

pmol/l

0.18

147

1615

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

123

1.23

0.25

2.2

1.7

180.87

223.88

pmol/l

0.79

117

Car occupant injured in noncollision transport accident

358

1.12

0.25

2.0

1.9

211.24

210.98

pmol/l

0.00

337

Spinal enthesopathy

1.25

0.25

1.2

1.6

224.89

217.94

pmol/l

—

Temporal arteritis

123

1.22

0.25

1.4

2.0

189.67

210.21

pmol/l

0.48

115

Nonhereditary hypogammaglobulinemia

1.22

0.25

1.2

1.7

223.56

232.44

pmol/l

—

Renal failure

363

3317

0.97

0.25

1.8

1.9

180.43

198.41

pmol/l

3.06

338

3094

Bacterial meningitis

308

0.87

0.24

1.9

2.0

195.15

207.83

pmol/l

0.29

290

Rheumatic fever incl heart disease

148

0.81

0.24

1.7

2.1

285.00

218.81

pmol/l

0.66

139

Lung diseases due to external agents

918

1.07

0.24

2.0

1.9

191.16

200.31

pmol/l

0.43

854

Periapical abscess

531

5172

1.03

0.24

2.0

1.9

189.67

202.18

pmol/l

1.94

497

4940

Pneumonia derived septicemia

244

0.86

0.24

2.4

1.7

168.19

216.97

pmol/l

1.64

230

Other, unspecified and serous retinal detachments

212

0.85

0.24

1.8

1.9

184.67

214.40

pmol/l

1.10

201

Disorders of lens

649

3953

1.02

0.24

1.8

1.9

194.12

198.65

pmol/l

0.48

609

3731

Other disorders of cornea

706

1.08

0.24

2.0

1.9

191.01

208.79

pmol/l

0.84

667

Obstructed labour due to maternal pelvic abnormality

0.71

0.24

1.5

1.3

16.33

16.80

pmol/l

—

Cystitis

539

3290

0.97

0.24

1.7

1.8

149.32

174.58

pmol/l

5.75

505

3065

Chronic kidney disease

229

2157

1.04

0.23

1.7

1.9

182.68

199.52

pmol/l

1.92

211

2005

Insulin medication

687

5648

1.02

0.23

1.8

1.9

182.38

207.57

pmol/l

8.70

637

5396

Schizophrenia or delusion

383

3947

0.97

0.23

1.9

2.0

183.82

205.51

pmol/l

2.60

356

3790

Disorders of gallbladder, biliary tract and pancreas

953

6124

0.98

0.23

1.9

183.22

195.73

pmol/l

3.39

896

5800

Invasive ventilation

578

0.92

0.23

2.0

1.9

180.02

204.70

pmol/l

0.99

545

Hepatocellular carcinoma, including Hilmo

190

1.16

0.23

1.6

2.0

227.09

217.36

pmol/l

0.14

179

All chronic kidney diseases

470

3947

0.97

0.23

1.8

1.9

180.03

197.33

pmol/l

3.50

437

3721

Use of other anti-dementia drugs

547

0.92

0.22

1.5

1.7

168.37

185.46

pmol/l

0.92

490

Use of memantine

547

0.92

0.22

1.5

1.7

168.37

185.46

pmol/l

0.92

490

Bacterial pneumonia (organism specified)

375

3502

0.97

0.22

1.8

1.9

184.45

196.97

pmol/l

1.35

357

3295

L02BX Other hormone antagonists and related agents

389

0.90

0.22

2.2

1.8

112.14

202.17

pmol/l

4.14

356

Other and unspecified injuries of abdomen, lower back and pelvis

116

1.21

0.22

2.6

1.9

184.50

216.48

pmol/l

0.60

109

Disorders of other digestive organs in diseases classified elsewhere

0.00

0.22

0.0

1.2

—

306.20

—

Persistent hyperplasia of thymus

0.00

0.22

0.0

1.5

—

175.60

—

Nocardiosis

0.00

0.22

0.0

1.8

—

298.82

—

Moyamoya

0.00

0.21

0.0

1.5

—

209.00

—

Amputation of ankle

0.00

0.21

0.0

1.8

—

193.60

—

Meningitis

420

1.10

0.21

2.0

1.9

196.63

201.83

pmol/l

0.13

396

Malignant neoplasm of liver and intrahepatic bile ducts

167

0.84

0.21

1.6

2.1

215.00

219.33

pmol/l

0.08

154

Acute necrotizing ulcerative gingivitis

0.00

0.21

0.0

1.4

—

206.82

—

Transepidermal elimination disorders

0.00

0.21

0.0

1.6

—

210.55

—

Other and unspecified thalassaemias

0.00

0.21

0.0

1.5

—

203.09

—

Ependymoma

0.00

0.21

0.0

1.4

—

320.73

—

Unspecified severe protein-energy malnutrition

0.00

0.21

0.0

2.2

—

189.18

—

Labour and delivery complicated by fetal stress [distress]

394

1.08

0.21

1.2

15.12

18.21

pmol/l

1.63

362

Haemorrhagic and haematological disorders of fetus and newborn

1.19

0.21

1.0

1.8

196.80

147.22

pmol/l

—

Trichomoniasis

0.00

0.21

0.0

1.2

—

159.91

—

Abnormal findings on diagnostic imaging of breast

0.00

0.21

0.0

1.6

—

110.20

—

Hypothermia

156

0.83

0.21

1.5

1.8

191.69

227.17

pmol/l

0.48

147

Serous carcinoma of ovary, including Hilmo

0.00

0.21

0.0

1.5

—

17.80

—

Other benign neoplasms of uterus

0.00

0.21

0.0

1.3

—

16.55

—

Transient acantholytic dermatosis [Grover]

0.00

0.21

0.0

1.6

—

224.75

—

Microtia (small ears)

0.00

0.21

0.0

1.3

—

283.33

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

319

2233

0.97

0.21

1.7

1.9

203.06

195.57

pmol/l

0.68

288

2086

Exposure to high-pressure jet

0.00

0.21

0.0

2.3

—

244.08

—

Malignant neoplasm of pyriform sinus

0.00

0.21

0.0

1.5

—

280.92

—

Benign neoplasm: Connective and other soft tissue of pelvis

0.00

0.21

0.0

1.0

—

245.00

—

Family history of other conditions

1.23

0.21

1.8

129.58

210.97

pmol/l

1.86

Left ventricular outflow tract obstruction, narrow definition

574

0.92

0.21

1.6

1.9

206.42

216.47

pmol/l

0.31

545

Mucocutaneous lymph node syndrome [Kawasaki]

0.00

0.21

0.0

1.4

—

281.46

—

Osteochondrodysplasia with defects of growth of tubular bones and spine

0.00

0.20

0.0

1.4

—

220.07

—

Schizophrenia, schizotypal and delusional disorders

384

3944

0.97

0.20

1.9

2.0

183.67

205.55

pmol/l

2.65

357

3787

Other and unspecified anaemias

275

2537

1.03

0.20

1.9

1.8

173.23

193.57

pmol/l

2.94

255

2349

DVT of lower extremities

136

1298

1.05

0.20

2.0

1.8

189.13

201.82

pmol/l

0.81

126

1216

Viral agents as the cause of diseases classified to other chapters

155

1.16

0.20

2.1

1.8

199.00

214.03

pmol/l

0.22

147

Corneal scars and opacities

174

1.15

0.19

1.3

1.9

204.05

224.29

pmol/l

0.40

163

severe traumatic brain injury, does not include concussion

197

1897

1.04

0.19

1.9

206.98

201.36

pmol/l

0.24

186

1773

Simple and mucopurulent chronic bronchitis

197

0.86

0.19

2.1

1.8

155.65

210.58

pmol/l

1.41

186

Other anaemias

277

2551

1.03

0.19

1.9

1.8

173.15

193.40

pmol/l

2.95

257

2363

Sixth [abducent] nerve palsy

193

1.14

0.19

1.9

191.55

216.83

pmol/l

0.68

180

Exposure to uncontrolled fire in building or structure

1.23

0.19

1.9

1.7

204.45

235.35

pmol/l

0.46

Campylobacter enteritis

222

1.13

0.19

2.2

1.9

199.80

207.63

pmol/l

0.11

209

Poor fetal growth

249

0.88

0.19

1.2

16.91

16.23

pmol/l

0.10

227

Iliotibial band syndrome

1.17

0.18

2.9

1.5

233.57

205.05

pmol/l

—

Drug-induced polyneuropathy

1.15

0.17

2.1

1.9

169.29

223.45

pmol/l

—

Other disorders of fluid, electrolyte and acid-base balance

208

1915

1.03

0.17

2.0

1.8

173.44

202.13

pmol/l

3.37

190

1800

Other diseases of spinal cord

214

1.12

0.17

2.5

1.9

207.46

224.33

pmol/l

0.24

199

Sequelae of other accidents

120

0.83

0.16

2.5

1.9

272.90

231.97

pmol/l

—

111

Hyperosmolality and hypernatraemia

1.18

0.16

1.5

1.9

183.50

237.89

pmol/l

—

Kela reimbursement Agammaglobulinemia (D80-84)

1.13

0.16

1.3

1.7

213.38

244.87

pmol/l

—

Scleritis

1.13

0.16

1.4

1.9

208.38

237.80

pmol/l

—

Other/unspecified rheumatoid arthritis

453

0.93

0.16

2.1

1.8

198.09

193.49

pmol/l

0.09

421

Injury of blood vessels at wrist and hand level

0.78

0.16

2.7

1.9

170.67

237.97

pmol/l

—

Other congenital malformations of intestine

1.10

0.16

1.3

1.9

210.62

227.46

pmol/l

—

Other and unspecified injuries of neck

0.75

0.15

2.3

2.0

173.00

205.33

pmol/l

—

Respiratory conditions due to other external agents

0.76

0.15

2.3

2.1

212.50

220.75

pmol/l

—

Cerebral palsy

161

0.87

0.15

1.8

2.0

228.71

224.52

pmol/l

0.04

154

Bullous pemphigoid

1.14

0.15

1.9

161.00

220.83

pmol/l

—

Status epilepticus

203

0.89

0.15

2.0

1.7

162.44

220.91

pmol/l

1.64

190

Chronic suppurative otitis media

472

0.93

0.15

1.5

1.8

205.38

203.81

pmol/l

0.02

450

Dermatitis herpetiformis

102

1.18

0.15

2.2

1.9

206.75

217.85

pmol/l

0.17

Adjustment and management of implanted device

114

1094

1.04

0.15

1.7

1.9

189.91

201.24

pmol/l

0.63

107

1013

Unspecified human immunodeficiency virus [HIV] disease

188

1.12

0.15

1.9

2.0

252.76

228.79

pmol/l

0.58

178

Intentional self-harm by hanging, strangulation and suffocation

0.81

0.15

3.1

1.7

148.43

246.33

pmol/l

—

Other obstetric trauma

1.10

0.15

1.0

1.2

16.67

15.48

pmol/l

—

Other specified/unspecified deforming dorsopathies

1.19

0.14

1.7

175.73

217.51

pmol/l

0.66

Congenital malformations of the nervous system

150

1.14

0.14

1.7

1.8

166.29

207.54

pmol/l

0.79

142

MS-disease / Multiple Sclerosis

479

1.07

0.14

1.6

1.8

223.57

194.48

pmol/l

0.90

446

Use of donepezil

477

1.06

0.14

1.7

190.66

194.80

pmol/l

0.14

425

Total colectomy

382

1.08

0.14

1.8

1.9

200.46

212.57

pmol/l

0.38

361

Total colectomy operation

382

1.08

0.14

1.8

1.9

200.46

212.57

pmol/l

0.38

361

Bacterial Sepsis

390

3399

0.98

0.14

2.0

1.9

177.39

198.82

pmol/l

3.96

362

3188

Other bacterial diseases

1089

7232

1.01

0.14

2.0

1.9

185.79

202.56

pmol/l

5.23

1019

6892

Myeloid leukaemia

160

1.13

0.14

2.6

1.9

175.50

225.78

pmol/l

2.21

150

Follow-up examination after treatment for conditions other than malignant neoplasms

320

2165

0.98

0.14

1.8

175.87

190.61

pmol/l

1.83

306

2054

Coarctation of the aorta

0.80

0.14

1.3

1.7

165.38

243.84

pmol/l

—

Tularaemia

0.80

0.13

2.0

1.8

163.25

226.83

pmol/l

—

Focal epilepsy

177

1822

0.97

0.13

2.0

1.9

195.01

201.31

pmol/l

0.35

166

1724

Other disorders of glucose regulation and pancreatic internal secretion

705

1.05

0.13

2.0

182.17

205.20

pmol/l

1.25

662

Haemorrhage in early pregnancy

357

0.93

0.13

1.2

17.21

17.59

pmol/l

0.08

323

Benign neoplasm: Brain, supratentorial

113

1.15

0.13

2.2

1.9

177.38

230.27

pmol/l

0.79

103

Hereditary retinal dystrophy

110

0.82

0.13

1.3

1.9

254.44

202.82

pmol/l

—

104

Implicit bacterial Sepsis

376

3185

1.02

0.13

2.0

1.8

175.24

198.86

pmol/l

4.64

348

2981

Pneumocystosis

110

0.82

0.13

2.2

1.9

171.67

222.67

pmol/l

—

103

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1018

6941

1.01

0.12

2.1

1.8

187.30

196.05

pmol/l

1.99

960

6591

Pyogenic granuloma

123

1.14

0.12

2.1

1.9

168.50

232.08

pmol/l

2.19

113

Injuries involving multiple body regions

336

1.07

0.12

1.9

233.44

210.53

pmol/l

0.27

318

116

0.86

0.12

1.5

1.8

153.50

245.03

pmol/l

—

106

Complications of cardiac and vascular prosthetic devices, implants and grafts

116

0.86

0.12

1.5

2.0

161.90

217.08

pmol/l

—

107

Central retinal artery occlusion

1.16

0.11

1.9

2.0

179.91

219.63

pmol/l

0.91

Other and unspecified intracranial injuries

261

0.92

0.11

1.8

1.9

181.71

216.37

pmol/l

0.79

249

Nystagmus and other irregular eye movements

1.16

0.11

2.0

1.9

160.00

224.38

pmol/l

1.31

Acute epiglottitis

143

1.12

0.11

1.7

180.44

210.64

pmol/l

0.53

132

Isolated proteinuria

240

0.91

0.11

1.8

1.9

168.23

221.81

pmol/l

2.11

226

Demyelinating diseases of the central nervous system

572

1.05

0.11

1.6

1.8

226.44

197.12

pmol/l

1.01

536

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

496

0.95

0.11

2.4

2.0

208.44

212.86

pmol/l

0.10

474

Chronic periodontitis, complicated

537

5394

0.99

0.11

1.9

184.61

200.89

pmol/l

3.88

489

5125

Implicit bacterial Sepsis

334

2907

1.02

0.11

2.0

1.8

174.78

198.41

pmol/l

4.17

308

2717

Valvular operations

126

1298

0.97

0.11

1.9

197.10

207.58

pmol/l

0.65

119

1214

Bacterial infection, other or unspecified

448

3944

0.99

0.11

2.0

1.9

186.11

198.17

pmol/l

1.40

411

3713

Pneumococcal septicemia

229

0.92

0.10

2.4

1.7

168.19

219.22

pmol/l

1.74

216

Other septicaemia

292

2757

1.02

0.10

2.0

1.9

174.65

198.24

pmol/l

3.45

274

2578

Basal cell carcinoma, including avohilmo

288

2021

0.98

0.10

1.7

1.8

202.95

195.38

pmol/l

0.62

256

1887

Iridocyclitis in diseases classified elsewhere

125

0.88

0.10

1.5

1.8

211.82

229.86

pmol/l

0.48

117

Vascular syndromes of brain in cerebrovascular disorders

222

1.08

0.10

1.8

181.33

206.97

pmol/l

0.73

206

Other secondary coxarthrosis

197

0.91

0.10

1.8

1.9

190.72

215.78

pmol/l

0.81

183

Explicit Sepsis

343

3153

1.02

0.09

2.0

1.8

175.30

193.67

pmol/l

2.53

323

2952

Occlusion and stenosis of arteries, not leading to stroke

1.06

0.09

1.0

1.7

168.40

247.36

pmol/l

—

Superficial injuries involving multiple body regions

217

0.92

0.09

1.6

1.8

233.90

209.33

pmol/l

0.15

206

Other retinal disorders

544

4187

1.01

0.09

1.9

192.03

197.42

pmol/l

0.53

505

3938

Cholelithiasis, broad definition with cholecystitis

679

4521

1.01

0.09

1.9

1.8

178.46

189.80

pmol/l

2.08

633

4243

Eosinophilic disease (BM)

1.14

0.09

2.2

1.8

183.45

208.53

pmol/l

0.30

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system, including Hilmo

1.11

0.09

3.8

1.7

257.00

235.83

pmol/l

—

Childhood allergy (age < 16)

141

1134

1.02

0.09

1.7

182.31

173.99

pmol/l

0.35

135

1088

Maternal care for known or suspected disproportion

1.11

0.09

1.7

1.2

9.00

14.93

pmol/l

—

Acute renal failure

166

1696

0.98

0.09

1.9

175.36

201.55

pmol/l

2.90

159

1580

Other disorders affecting eyelid function

1.05

0.08

1.5

1.8

139.67

246.22

pmol/l

—

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

1.05

0.08

2.7

1.6

145.50

211.52

pmol/l

—

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

1.04

0.08

1.5

1.8

156.50

226.15

pmol/l

—

Enterocolitis due to Clostridium difficile

542

0.96

0.08

1.5

1.8

162.19

198.51

pmol/l

2.10

510

Malignant neoplasm of nasal cavity and sinuses, including Hilmo

0.82

0.08

1.6

2.2

258.80

232.42

pmol/l

—

Malignant neoplasm of floor of mouth, including Hilmo

0.79

0.08

1.4

2.0

231.40

233.86

pmol/l

—

Dislocation of lens

0.82

0.08

2.0

1.7

208.20

219.22

pmol/l

—

Benign neoplasm: Other parts of oropharynx

0.79

0.08

1.2

1.9

99.00

226.24

pmol/l

—

Reiter disease

1.14

0.08

1.4

1.9

221.90

251.23

pmol/l

—

Congenital malformations of great arteries

141

0.90

0.08

1.4

1.8

149.46

216.11

pmol/l

1.46

133

Malignant neoplasm of small intestine

117

1.11

0.08

1.1

2.0

185.62

224.99

pmol/l

1.07

108

Streptococcus and staphylococcus as the cause of diseases classified to other chapters

1.08

0.08

1.4

1.8

162.71

253.08

pmol/l

—

Left hemicolectomy

123

0.89

0.08

2.0

1.8

187.00

227.62

pmol/l

0.65

114

Recurrent and persistent haematuria

1.05

0.08

1.4

1.7

197.29

227.48

pmol/l

—

Myocardial infarction, without ST-elevation

314

2823

1.01

0.07

1.7

1.9

192.20

194.79

pmol/l

0.17

293

2620

Congenital malformations of ovaries, fallopian tubes and broad ligaments

1.08

0.07

1.0

1.1

15.63

14.94

pmol/l

—

Liquid cancers, helper endpoint

305

2624

1.01

0.07

1.9

193.95

198.84

pmol/l

0.33

292

2461

Disorders of lacrimal system and orbit in diseases classified elsewhere

1.04

0.07

1.9

1.8

154.25

214.06

pmol/l

—

Cardiomyopathy, other and unspecified

639

1.03

0.07

1.6

1.8

201.34

212.49

pmol/l

0.40

607

Cellulitis of external ear

0.85

0.07

1.6

1.9

221.71

221.80

pmol/l

—

Neuroendocrine tumor and carcinoma of small intestine

0.83

0.07

1.1

1.9

173.29

237.82

pmol/l

—

Hypokalaemia

651

0.97

0.07

1.9

1.8

173.63

208.40

pmol/l

2.12

623

Acute myeloid leukaemia and myelodysplastic syndromes

0.83

0.07

1.9

2.0

174.29

232.71

pmol/l

—

Other and unspecified coagulation defects

304

1.05

0.07

2.3

1.8

192.44

196.97

pmol/l

0.06

282

Other diseases of peritoneum

157

1.08

0.07

1.7

1.9

161.53

196.53

pmol/l

1.05

145

Postprocedural disorders of digestive system, not elsewhere classified

163

0.92

0.07

1.2

1.9

168.87

212.05

pmol/l

0.86

152

Marginal zone B-cell lymphoma, including Hilmo

1.05

0.07

1.7

1.9

217.78

226.35

pmol/l

—

Lung transplant status

1.04

0.07

3.2

1.9

179.11

242.48

pmol/l

—

Lung transplantation

1.04

0.07

3.2

1.9

179.11

242.48

pmol/l

—

Congenital deformities of hip

1.05

0.07

1.2

1.5

338.44

185.98

pmol/l

—

Benign neoplasm: Bronchus and lung

1.04

0.07

1.4

1.7

244.78

230.66

pmol/l

—

Arthropathy in Crohn disease

1.02

0.07

1.6

1.8

235.22

235.94

pmol/l

—

Other abnormalities of plasma proteins

0.87

0.07

2.0

1.9

166.75

239.52

pmol/l

—

Other renal tubulo-interstitial diseases

0.89

0.06

1.4

1.9

143.75

210.78

pmol/l

—

Deep endometriosis

0.86

0.06

1.3

1.2

29.13

15.12

pmol/l

—

Malignant neoplasm of other and unspecified parts of tongue

1.11

0.06

1.8

1.9

227.09

223.97

pmol/l

0.05

Malignant neoplasm of larynx

100

0.90

0.06

1.8

2.0

238.78

235.27

pmol/l

—

Burns classified according to extent of body surface involved

104

0.86

0.06

1.3

1.9

182.67

235.99

pmol/l

—

Respiratory tuberculosis, bacteriologically and histologically confirmed

102

0.88

0.06

1.2

1.9

202.56

229.93

pmol/l

—

Acute appendicitis, with complications

189

1861

1.02

0.06

2.0

1.9

198.42

201.25

pmol/l

0.13

180

1763

Malignant neoplasm of other and unspecified parts of tongue, including Hilmo

148

1.08

0.06

1.7

1.9

219.37

218.82

pmol/l

0.01

138

Complications of labour and delivery

488

1.03

0.06

1.2

16.71

19.05

pmol/l

1.07

449

Secondary thrombocytopenia

1.11

0.05

2.6

1.9

171.40

229.33

pmol/l

—

Golimumab

326

1.04

0.05

1.6

1.8

202.15

211.11

pmol/l

0.21

313

Erysipelas

634

5571

1.01

0.05

2.0

1.9

181.13

203.56

pmol/l

5.18

595

5288

Pemphigoid

100

1.10

0.05

1.9

2.0

200.18

211.46

pmol/l

0.11

Malignant neoplasm of tongue

161

0.93

0.05

1.7

2.0

212.67

215.20

pmol/l

0.05

152

Primary angle-closure glaucoma

159

1.07

0.05

1.1

1.9

199.00

201.56

pmol/l

0.04

147

Portal vein thrombosis

110

1.09

0.05

1.8

1.9

152.67

231.36

pmol/l

2.63

101

Diabetic maculopathy

122

1168

0.98

0.05

1.7

1.9

191.19

165.37

pmol/l

2.10

112

1092

Complications of other internal prosthetic devices, implants and grafts

171

0.94

0.05

1.8

1.9

189.19

201.78

pmol/l

0.21

160

Other aneurysm

337

1.04

0.05

2.1

1.9

184.66

211.64

pmol/l

1.14

312

Cysts of oral region, not elsewhere classified

555

0.97

0.04

1.9

180.31

206.19

pmol/l

1.64

525

Chronic suppurative otitis media, including avohilmo

555

1.03

0.04

1.5

1.8

188.63

204.77

pmol/l

0.36

526

Measles

140

0.93

0.04

3.2

1.8

199.85

208.78

pmol/l

0.12

130

Paranoid personality disorder

140

1.07

0.04

1.5

1.7

145.13

212.95

pmol/l

1.67

132

Focal epilepsy, mode (most common among epilepsy diagnosis)

160

1579

1.01

0.04

2.0

1.9

198.83

203.70

pmol/l

0.24

150

1488

Adalimumab

963

1.02

0.04

1.7

1.9

202.53

209.84

pmol/l

0.27

911

Asymmetry of jaw

1.10

0.04

3.0

1.8

223.80

193.83

pmol/l

—

Other diseases of the respiratory system

124

1258

0.99

0.04

2.3

1.9

180.22

199.31

pmol/l

1.20

112

1164

Other respiratory disorders and diseases

124

1258

0.99

0.04

2.3

1.9

180.22

199.31

pmol/l

1.20

112

1164

Toxic liver disease

101

1.09

0.04

1.6

1.7

170.27

223.23

pmol/l

1.19

Achalasia of cardia

101

1.09

0.04

3.2

1.8

199.82

223.13

pmol/l

0.35

Tic and related disorders

119

0.92

0.04

1.4

2.0

205.09

222.09

pmol/l

0.15

114

Alcohol dependence

377

3745

1.01

0.04

1.9

193.63

205.47

pmol/l

1.39

340

3574

Malignant melanoma of skin, including Hilmo

925

1.02

0.03

1.6

1.9

194.69

198.78

pmol/l

0.17

869

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

220

1.05

0.03

2.3

1.8

211.57

201.82

pmol/l

0.13

206

Cholelithiasis

628

4307

1.00

0.03

1.9

176.29

189.00

pmol/l

2.37

586

4036

Malignant melanoma

904

0.98

0.03

1.7

1.9

198.76

198.42

pmol/l

0.01

846

Bacterial infection, other or unspecified

508

4272

1.01

0.03

2.0

1.9

187.15

198.31

pmol/l

1.42

469

4027

Idiopathic gout

777

1.02

0.03

2.0

1.9

195.37

206.65

pmol/l

0.36

727

Pustulosis palmaris et plantaris

181

1.05

0.03

2.1

1.9

153.26

203.08

pmol/l

1.67

171

Malnutrition

1.09

0.03

1.9

234.20

229.33

pmol/l

—

Abnormal findings on examination of urine, without diagnosis

320

0.97

0.03

1.8

1.9

158.10

212.33

pmol/l

2.44

301

Ulcer of lower limb, not elsewhere classified

100

1013

0.99

0.03

2.0

1.8

169.12

200.30

pmol/l

2.11

952

Hypertensive heart and/or renal disease

194

1460

0.99

0.03

1.7

1.9

179.65

206.07

pmol/l

2.99

179

1372

Diseases of spleen

128

0.94

0.02

2.2

1.9

146.67

222.82

pmol/l

1.51

120

Tooth eruption problems

126

1216

1.01

0.02

1.7

165.37

171.40

pmol/l

0.25

119

1157

Glomerular diseases

171

1724

0.99

0.02

1.7

1.9

181.67

203.79

pmol/l

2.52

162

1626

Pustular psoriasis

218

0.96

0.02

2.0

1.8

161.81

201.88

pmol/l

1.26

203

Alcohol abuse counselling and surveillance

232

1.04

0.02

1.9

189.08

224.07

pmol/l

1.83

222

Aplastic and other anaemias

296

2771

1.00

0.02

1.9

1.8

173.55

192.93

pmol/l

2.99

276

2568

Septicaemia

336

3155

1.00

0.02

2.0

1.9

175.18

197.47

pmol/l

3.62

315

2953

Intestinal stricture

217

2158

1.01

0.01

2.2

1.9

203.45

197.88

pmol/l

0.32

207

2016

Insulin, combination of fast acting with intermediate-acting or long-acting

687

6261

1.00

0.01

1.8

1.9

182.38

201.93

pmol/l

5.56

637

5945

Focal epilepsy, strict definition

167

1680

0.99

0.01

1.9

196.85

202.69

pmol/l

0.30

156

1585

Calcific aortic valvular stenosis, including rheumatic fever

165

1608

0.99

0.01

1.7

1.8

170.07

196.39

pmol/l

3.29

153

1482

Maternal care for known or suspected malpresentation of fetus

332

0.98

0.01

1.2

12.59

18.06

pmol/l

3.30

304

Scar conditions and fibrosis of skin

197

0.96

0.01

1.3

1.8

154.32

207.80

pmol/l

1.21

188

Sub-endpoint used in defining T1D endpoints

328

3237

1.00

0.01

1.8

1.9

195.35

202.42

pmol/l

0.62

302

3084

Mental and behavioural disorders due to tobacco

772

1.01

0.01

1.9

183.35

201.53

pmol/l

0.82

734

Non-rheumatic valve diseases

427

3072

1.00

0.01

2.0

1.9

187.83

202.65

pmol/l

2.65

401

2903

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1023

6541

1.00

0.01

2.0

1.9

193.30

198.24

pmol/l

0.88

970

6196

Obstructive hydrocephalus

1.06

0.01

1.8

1.6

234.70

233.60

pmol/l

—

Salpingitis and oophoritis

1.06

0.01

1.1

1.2

16.60

14.69

pmol/l

—

Other embolism and thrombosis

863

1.01

0.01

2.2

1.9

179.24

203.78

pmol/l

1.63

811

Hereditary corneal dystrophies

126

0.95

0.00

1.6

1.8

169.92

226.88

pmol/l

0.97

117

Anaemia in chronic diseases classified elsewhere

156

0.96

0.00

2.0

1.9

187.07

224.03

pmol/l

0.78

144

Other specified and unspecified retinal disorders

194

1.03

0.00

1.6

1.9

217.50

211.21

pmol/l

0.10

183

Hodgkin lymphoma, hilmo

254

1.02

0.00

1.8

1.9

202.31

214.35

pmol/l

0.17

240

Malignant neoplasm of kidney, except renal pelvis

644

1.01

0.00

1.8

1.9

221.25

203.52

pmol/l

0.62

607

Operations 2 for CAVS

165

1605

1.00

0.00

1.7

1.8

170.07

196.48

pmol/l

3.31

153

1479

Calcific aortic valvular stenosis, diagnosis (helper)

165

1605

1.00

0.00

1.7

1.8

170.07

196.48

pmol/l

3.31

153

1479

Valvular heart disease excluding rheumatic fever

429

3098

1.00

0.00

2.0

1.9

187.61

202.76

pmol/l

2.75

402

2929

Other mental disorders due to brain damage and dysfunction and to physical disease

672

1.00

0.00

2.0

1.9

188.52

204.56

pmol/l

0.82

635

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

755

1.01

0.00

1.8

1.9

221.97

202.49

pmol/l

0.67

706

Eosinophilia

105

1.05

0.00

2.2

1.9

183.45

237.98

pmol/l

0.84

Hepatocellular carcinoma

125

0.96

0.00

1.7

2.0

207.75

223.37

pmol/l

0.29

119

Acute otitis externa, noninfective

104

0.96

0.00

1.7

2.0

175.10

222.08

pmol/l

—

Moderate visual impairment, binocular

106

1.04

0.00

2.5

1.9

168.82

212.96

pmol/l

1.04

100

Myelodysplastic syndrome, including Hilmo

126

1.03

0.00

1.5

1.8

166.15

212.96

pmol/l

1.52

117

Discitis, unspecified

1.03

0.00

2.3

1.6

241.30

231.35

pmol/l

—

Idiopathic thrombocytopenic purpura

174

0.98

0.00

1.2

1.8

195.94

210.23

pmol/l

0.19

164

Other abnormal immunological findings in serum

107

1.03

0.00

2.0

1.9

165.73

214.18

pmol/l

0.93

100

Injury of muscle and tendon at ankle and foot level

226

1.02

0.00

2.7

2.0

225.30

210.93

pmol/l

0.33

215

Tularaemia

147

1.02

0.00

2.2

1.8

188.87

221.22

pmol/l

1.05

138

Other intracranial haemorrhages

132

0.98

0.00

2.2

1.9

209.92

226.56

pmol/l

0.15

122

Certolizumab pegol

109

1.01

0.00

1.2

1.7

175.09

200.06

pmol/l

0.26

Other (seronegative) rheumatoid arthritis, wide

888

1.00

0.00

1.7

1.9

185.87

194.21

pmol/l

0.32

833

Calcific aortic valvular stenosis, operated

166

1606

1.00

0.00

1.8

169.22

196.36

pmol/l

3.45

154

1480

Calcific aortic valvular stenosis

166

1606

1.00

0.00

1.8

169.22

196.36

pmol/l

3.45

154

1480

Endometriosis ASRM stages 1,2

209

1.00

0.00

1.0

1.2

20.90

17.35

pmol/l

0.25

190

Smoking dependency

776

1.01

0.00

1.9

183.35

201.14

pmol/l

0.80

739

Malignant neoplasm of urinary organs

701

1.00

0.00

1.8

1.9

216.22

201.57

pmol/l

0.52

656

Exposure to unspecified smoke, fire and flames

1.03

0.00

1.4

2.0

163.10

235.44

pmol/l

—

Contusion of ankle

343

0.99

0.00

2.1

1.9

167.03

205.86

pmol/l

0.64

327

Chronic Coagulation defects

115

0.96

0.00

3.1

1.6

133.18

205.54

pmol/l

1.21

109

Cleft lip, lip and palate or palate

153

0.98

0.00

1.5

1.7

261.33

215.28

pmol/l

1.07

146

Lymphocyte function antigen-1 [LFA-1] defect

0.00

0.0

1.9

—

210.43

—

Intussusception

0.97

0.00

4.3

1.5

226.71

247.81

pmol/l

—

Crushing injury of shoulder and upper arm

0.00

0.0

1.3

—

310.83

—

Night blindness

0.00

0.0

1.0

—

166.86

—

Pedal cyclist injured in collision with other pedal cycle or other nonmotor vehicle

0.96

0.00

2.0

1.8

231.67

234.93

pmol/l

—

Flexion deformity

0.00

0.0

1.0

—

181.50

—

Alzheimer’s disease (undefined), excluding more controls

0.00

0.0

1.4

—

283.20

—

Respiratory tuberculosis, confirmed

0.95

0.00

1.2

1.9

202.56

224.17

pmol/l

—

Chronic respiratory disease originating in the perinatal period

0.00

0.0

1.5

—

191.63

—

Leprosy [Hansen's disease]

0.00

0.0

2.6

—

252.00

—

Pemphigus foliaceus

0.00

0.0

1.6

—

209.78

—

Disorders of accommodation

0.00

0.0

1.4

—

408.00

—

Other perinatal haematological disorders

0.00

0.0

1.5

—

151.17

—

Hereditary erythropoietic porphyria

0.00

0.0

2.7

—

217.43

—

Infection due to other mycobacteria

0.88

0.00

1.4

1.9

160.57

227.58

pmol/l

—

Bartonellosis

0.00

0.0

2.2

—

160.33

—

Disorders of glossopharyngeal nerve

0.00

-0.00

0.0

2.0

—

238.87

—

Need for immunization against combinations of infectious diseases

0.00

-0.00

0.0

2.0

—

136.80

—

Chronic bullous disease of childhood

0.00

-0.00

0.0

1.8

—

218.80

—

Benign neoplasm: Urethra

0.00

-0.00

0.0

1.6

—

280.22

—

Disorders of vagus nerve

0.00

-0.00

0.0

1.6

—

257.33

—

Acquired coagulation factor deficiency

0.00

-0.00

0.0

1.6

—

223.86

—

Carcinoma in situ of other/unspecified male genital organs

0.00

-0.00

0.0

1.6

—

262.71

—

Biliary cirrhosis, NAS

0.00

-0.00

0.0

1.7

—

236.11

—

Merkel cell carcinoma of skin

0.00

-0.00

0.0

2.0

—

195.78

—

Pediculosis and phthiriasis

0.94

-0.00

2.1

1.9

208.29

247.88

pmol/l

—

Agent resistant to multiple antibiotics

0.00

-0.00

0.0

1.6

—

196.57

—

Wrist or foot drop (acquired)

0.00

-0.00

0.0

1.2

—

167.00

—

Hyperalimentation, other specified

0.00

-0.00

0.0

2.4

—

223.00

—

Hereditary factor XI deficiency

0.00

-0.00

0.0

1.6

—

215.60

—

Explicit viral Sepsis

0.00

-0.00

0.0

2.6

—

216.88

—

Gastrointestinal stromal tumor and sarcoma

0.86

-0.00

1.8

2.1

213.40

222.02

pmol/l

—

Need for immunization against other single infectious diseases

0.00

-0.00

0.0

1.3

—

230.00

—

Graves ophthalmopathy, strict

0.99

-0.00

1.9

1.8

137.57

214.48

pmol/l

—

Horner syndrome

0.95

-0.00

1.6

1.7

243.63

237.22

pmol/l

—

Other abnormal findings in urine

0.98

-0.00

1.9

1.8

125.88

214.97

pmol/l

—

Malignant neoplasm of other and unspecified female genital organs, including Hilmo

0.00

-0.00

0.0

1.5

—

13.67

—

Cystic fibrosis, other manifestations/unspecified

0.00

-0.00

0.0

1.0

—

326.50

—

Graves ophthalmopathy

0.96

-0.00

1.9

1.8

154.25

212.38

pmol/l

—

Fetus and newborn affected by other complications of labour and delivery

0.00

-0.00

0.0

1.1

—

166.33

—

Other and unspecified disorders of skin and subcutaneous tissue related to radiation

0.00

-0.00

0.0

2.0

—

197.67

—

Congenital ovarian cysts

0.95

-0.00

1.0

1.1

18.00

14.54

pmol/l

—

Classical phenylketonuria

0.00

-0.00

0.0

1.4

—

203.13

—

Surgical ablation of atrial fibrillation

0.92

-0.00

1.2

1.9

187.60

216.39

pmol/l

—

Pulmonary oedema

0.88

-0.00

1.2

1.8

235.00

224.90

pmol/l

—

Drowning and submersion in swimming-pool or bath

0.00

-0.00

0.0

1.6

—

232.00

—

Other obstructed labour

0.92

-0.00

1.4

1.3

16.43

15.84

pmol/l

—

Pedestrian injured in collision with other nonmotor vehicle

0.00

-0.00

0.0

1.3

—

162.50

—

Pedal cyclist injured in collision with pedestrian or animal

0.84

-0.00

2.0

1.8

173.60

223.68

pmol/l

—

Nephropathy induced by unspecified drug, medicament or biological substance

0.00

-0.00

0.0

1.4

—

202.20

—

Other specified and unspecified strabismus

0.92

-0.00

2.3

1.7

191.71

237.61

pmol/l

—

Lumbosacral spina bifida and hydrocephalus

0.00

-0.00

0.0

1.0

—

362.80

—

Pediculosis and phthiriasis

1.02

-0.00

2.3

1.9

202.17

263.60

pmol/l

—

Immunodeficiency with increased immunoglobulin M [IgM]

0.00

-0.00

0.0

2.6

—

300.29

—

Inflammation of lacrimal passages (acute and unspecified)

1.01

-0.00

2.3

1.8

164.50

224.28

pmol/l

—

Trichomoniasis

0.00

-0.00

0.0

1.3

—

150.67

—

Benign neoplasm: Bone and articular cartilage, unspecified

0.88

-0.00

2.6

1.8

134.20

243.25

pmol/l

—

Disorders of muscle tone of newborn

0.00

-0.00

0.0

1.1

—

205.89

—

Spondylopathies in diseases classified elsewhere

0.93

-0.00

3.4

1.7

142.60

202.27

pmol/l

—

Other migraine, drug-induced

0.00

-0.00

0.0

1.5

—

182.17

—

Acrodermatitis chronica atrophicans

0.00

-0.00

0.0

1.8

—

162.00

—

Neurological devices associated with adverse incidents

0.00

-0.00

0.0

1.6

—

223.60

—

Neonatal aspiration syndromes

0.00

-0.00

0.0

1.1

—

213.13

—

Abscess of spleen

0.00

-0.00

0.0

1.3

—

291.43

—

Occupant of railway train or railway vehicle injured in transport accident

0.00

-0.00

0.0

1.3

—

216.11

—

Carcinoma in situ of rectum

0.98

-0.00

1.4

2.2

130.38

216.39

pmol/l

—

Diphyllobothriasis and sparganosis

0.00

-0.00

0.0

1.8

—

154.20

—

Alpha thalassaemia

0.00

-0.00

0.0

1.8

—

198.63

—

Disorders of muscle in diseases classified elsewhere

0.00

-0.00

0.0

1.1

—

135.29

—

Other nutritional anaemias

0.92

-0.00

2.8

1.7

210.60

242.29

pmol/l

—

Thalassaemia trait

0.00

-0.00

0.0

1.0

—

223.83

—

Irritant contact dermatitis due to drugs in contact with skin

0.00

-0.00

0.0

1.4

—

335.60

—

Assault by unspecified chemical or noxious substance

0.00

-0.00

0.0

1.3

—

407.67

—

Streptococcus and staphylococcus as the cause of diseases classified to other chapters

0.91

-0.00

1.6

1.7

129.60

267.12

pmol/l

—

Secondary lactase deficiency

0.00

-0.00

0.0

1.3

—

231.00

—

Hereditary motor and sensory neuropathy

0.89

-0.00

3.0

1.7

159.00

258.81

pmol/l

—

Cardiovascular disorders originating in the perinatal period

0.00

-0.00

0.0

1.1

—

188.00

—

Other conditions originating in the perinatal period

0.00

-0.00

0.0

1.4

—

258.80

—

Diffuse (eosinophilic) fasciitis

0.00

-0.00

0.0

1.0

—

388.00

—

Hereditary factor IX deficiency

0.00

-0.00

0.0

1.7

—

203.71

—

Coccidioidomycosis

0.00

-0.00

0.0

1.6

—

216.00

—

Cystic fibrosis with pulmonary manifestations

0.00

-0.00

0.0

1.1

—

304.29

—

Labyrinthine dysfunction

0.00

-0.00

0.0

1.4

—

217.00

—

Other congenital malformations of posterior segment of eye (coloboma)

0.00

-0.00

0.0

2.0

—

216.50

—

0.00

-0.00

0.0

1.2

—

172.67

—

Blindness (ICD-9)

0.00

-0.00

0.0

1.5

—

240.75

—

Use of teriflunomide

0.99

-0.00

1.9

208.00

232.57

pmol/l

—

Plasmodium vivax malaria

0.00

-0.00

0.0

1.6

—

250.86

—

Congenital absence, atresia and stenosis of small intestine

0.00

-0.00

0.0

1.5

—

206.00

—

Phlebitis and thrombophlebitis of unspecified site, drug-induced

0.00

-0.00

0.0

2.3

—

230.83

—

Fetus and newborn affected by complications of placenta, cord and membranes

0.00

-0.00

0.0

1.4

—

147.88

—

Histoplasmosis

0.00

-0.00

0.0

1.8

—

239.20

—

Atypical mycobacterium lung infection

1.02

-0.00

1.5

1.6

163.67

242.21

pmol/l

—

Tetraplegia

0.88

-0.00

1.8

1.7

143.33

242.76

pmol/l

—

Use of benzatropine

0.00

-0.00

0.0

1.0

—

291.60

—

Brucellosis

0.00

-0.00

0.0

1.5

—

183.00

—

Traumatic shock

0.00

-0.00

0.0

1.8

—

210.83

—

Polydactyly

0.00

-0.00

0.0

1.1

—

152.25

—

Macular pucker, drug-induced

0.00

-0.00

0.0

1.8

—

213.17

—

Perioral dermatitis, drug-induced

0.00

-0.00

0.0

1.4

—

402.20

—

Encephalopathy

0.88

-0.00

1.8

2.0

153.17

228.87

pmol/l

—

Sequelae of hyperalimentation

0.00

-0.00

0.0

1.9

—

230.13

—

Keratosis follicularis et parafollicularis in cutem penetrans [Kyrle]

0.00

-0.00

0.0

1.3

—

221.57

—

Severe bullous disorders, KELA reimbursement

0.00

-0.00

0.0

1.6

—

159.63

—

Mucinosis of skin

0.00

-0.00

0.0

1.4

—

222.67

—

Benign neoplasm of mesothelial tissue

0.00

-0.00

0.0

1.2

—

109.80

—

Other eccrine sweat disorders

0.00

-0.00

0.0

1.3

—

214.13

—

Toxic liver disease with cholestasis, drug-induced

0.00

-0.00

0.0

1.4

—

294.80

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Testosterone Free [Moles/volume] in Serum or Plasma by calculation

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS